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Retrotransposons constitute around 40% of the mammalian genome and their aberrant 
activation can have wide ranging detrimental consequences, both throughout 
development and into somatic lineages. DNA methylation is one of the major 
epigenetic mechanisms in mammals, and is essential in repressing retrotransposons 
throughout mammalian development. Yet during normal mouse embryonic 
development some cell lineages become extensively DNA hypomethylated and it is 
not clear how these cells maintain retrotransposon silencing in a globally 
hypomethylated genomic context.  
In this thesis I determine that hypomethylation in multiple contexts results in the 
consistent activation of only one gene in the mouse genome - Tex19.1. Thus if a generic 
compensatory mechanism for loss of DNA methylation exists in mice, it must function 
through this gene. Tex19.1-/- mice de-repress retrotransposons in the hypomethylated 
component of the placenta and in the mouse germline, and have developmental defects 
in these tissues. In this thesis I examine the mechanism of TEX19.1 mediated genome 
defence and the developmental consequences upon its removal. I show that TEX19.1 
functions in repressing retrotransposons, at least in part, through physically interacting 
with the transcriptional co-repressor, KAP1. Tex19.1-/- ES cells have reduced levels of 
KAP1 bound retrotransposon chromatin and reduced levels of the repressive 
H3K9me3 modification at these loci. Furthermore, these subsets of retrotransposon 
loci are de-repressed in Tex19.1-/- placentas. Thus, my data indicates that mouse cells 
respond to hypomethylation by activating expression of Tex19.1, which in turn 
augments compensatory, repressive histone modifications at retrotransposon 
sequences, thereby helping developmentally hypomethylated cells to maintain genome 
stability. 
I next aimed to further elucidate the role of Tex19.1 in the developing hypomethylated 
placenta. I determine that Tex19.1-/- placental defects precede intrauterine growth 
restriction of the embryo and that alterations in mRNA abundance in E12.5 Tex19.1-/- 
placentas is likely in part due to genic transcriptional changes. De-repression of LINE-
1 is evident in these placentas and elements of the de-repressed subfamily are 
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associated with significantly downregulated genes. If retrotransposon de-repression is 
contributing to developmental defects by interfering with gene expression remains to 
be determined, however I identify a further possible mechanism leading to placental 
developmental defects. I determine that Tex19.1-/- placentas have an increased innate 
immune response and I propose that this is contributing to the developmental defects 
observed. 
Developmental defects and retrotransposon de-repression are also observed in 
spermatogenesis in Tex19.1-/- testes, the molecular basis for which is unclear. I 
therefore investigate the possibility that the TEX19.1 interacting partners, the E3 
ubiquitin ligase proteins, may be contributing to the phenotypes observed in Tex19.1-
/- testes. I show that repression of MMERVK10C in the testes is dependent on UBR2, 
alongside TEX19.1. Furthermore, I have identified a novel role for the TEX19.1 
interacting partner, UBR5, in spermatogenesis, whose roles are distinct from those of 
TEX19.1. 
The work carried out during the course of this thesis provides mechanistic insights into 
TEX19.1 mediated genome defence and highlights the importance of protecting the 













Lay Abstract  
 
Every cell in humans and mice contains DNA; precise instructions necessary for life. 
Staggeringly, almost half of human and mouse DNA is made up of old viruses, which 
can copy and paste themselves to new places in the DNA. In normal circumstances 
these cause no problems to how the cell works. This is because defence mechanisms 
have evolved alongside these to stop them becoming active. In the development of the 
mouse one of these major defence mechanisms called DNA methylation is lost at 
defined time points, making the developing cells vulnerable to activation of these old 
viruses. The consequences of this can be wide ranging, causing problems in 
development, through to adulthood.  
Extra levels of defence, in addition to DNA methylation, ensure continued safety from 
the activation of these old viruses. One gene called Tex19.1 is activated when DNA 
methylation is lost and limits the activation of some of these retrotransposons. How 
Tex19.1 does this is unclear and is the primary focus of this thesis. Proteins often work 
in combination with other proteins to do a particular job in the cell. Because of this, I 
investigated a different protein called KAP1 that binds to TEX19.1 and showed that 
these work together to stop the activation of some of the old viruses. I also indicate 
that this may contribute to problems in the development of the placenta. 
Along with problems in the placenta, development of sperm does not happen as normal 
when TEX19.1 is not present. It is not known how these problems occur. I therefore 
looked at another set of proteins binding to TEX19.1. I show that UBR5, is important 
for development of sperm but is unlikely to be contributing to the problems in animals 
without TEX19.1. I show that one of these other sets of proteins, UBR2, is important 
for stopping the activation of the same retrotransposon as TEX19.1 in testes.  
Together, this thesis identifies how Tex19.1 works to stop the activation of 
retrotransposons when the major layer of defence, DNA methylation, is reduced and 
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E. coli   Escherichia coli 
EDTA   Ethylenediamineotetra-acetic acid 
ERV   Endogenous retrovirus 
ES    Embryonic stem 
EtBr   Ethidium bromide 
EtOH    Ethanol 
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ExE   Extra embryonic ecotoderm 
 
FCS    Foetal calf serum 
 
g    Relative centrifugal force 
G   Guanine 
GFP    Green fluorescent protein 
GMEM   Glasgow’s modified eagle medium 
 
H3K4me  Histone H3 lysine 4 monomethylation 
H3K4me3  Histone H3 lysine 4 trimethylation 
H3K9me3  Histone H3 lysine 9 trimethylation 
H3K27ac  Histone H3 lysine 27 acetylation 
H3K27me3   Histone H3 lysine 27 trimethylation 
HAT    Histone acetyltransferase 
Het   Heterozygous 
HCl    Hydrochloric acid 
HDAC   Histone deacetylase 
HDM   Histone demethylase 
HMT    Histone methyltransferase 
HP1    Heterochromatin associated protein 1 
 
IAP   Intracisternal A particle 
ICC   Immunocytochemistry 
ICM    Inner cell mass 
IHC   Immunohistochemistry 
IF   Immunofluorescence 
IFN   Interferon 
ISH   In situ hybridisation 
ISRE   Interferon stimulated response element 
IUGR   Intrauterine growth restriction 
 
Kb    Kilobase pairs of DNA 
kDa    KiloDaltons 
KO   Knockout 
 
LB    Luria-Bertani 
LINE    Long interspersed nuclear element 
LIF    Leukaemia inhibitory factor 
LTR    Long terminal repeat 
 
M    Molar 
MBD    Methyl-CpG binding domain 
MBP    Methyl-CpG binding protein 
MEF    Mouse embryonic fibroblast 
mES    Mouse embryonic stem (cell) 
MgCl2   Magnesium chloride 
MI   Meiosis I 
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MII   Meiosis II 
µg   Microgram 
µl   Microlitre 
min   Minute 
miRNA   Micro RNA 
mRNA   Messenger RNA 
Mw    Molecular weight 
 
NBT    Nitro-Blue Tetrazolium Chloride 
NP-40   Nonidet NP-40 
nt    Nucleotide 
N-terminal   N amino-terminal 
NTP    Nucleotide triphosphate 
 
Oligo    Oligonucleotide  
ORF    Open reading frame 
 
P    Postnatal day 
PAGE   Polyacrylamide gel electrophoresis 
PBS   Phosphate buffered saline 
PBST    Phosphate buffered saline (plus 0.2% w/v Tween-20) 
PCR    Polymerase chain reaction 
pen    Penicillin 
PFA    Paraformaldehyde 
PGC    Primordial germ cell 
piRNA   Piwi-interacting RNA 
PRC    Polycomb repressive complex 
 
qRT-PCR   Quantitative reverse-transcriptase PCR 
 
RBCC   RING finger B boxes coiled coil motif 
RNA    Ribonucleic acid 
RT-PCR   Reverse transcriptase polymerase chain reaction 
rpm    Revolutions per minute 
RT    Room temperature 
 
S. cerevisiae   Saccharomyces cerevisiae 
SDS    Sodium dodecyl sulphate 
SINE    Short interspersed nuclear element 
SSC   Spermatogonial stem cell 
strep    Streptomycin 
 
TAE    Tris-EDTA acetic acid buffer 
TBE    Tris-EDTA boric acid buffer 
TBS(t)   Tris buffered saline (plus 0.05% w/v Tween-20) 
TDG   Thymine-DNA-glycosylase 
TdT   Terminal deoxynucleotidyl transferase 
TE    Trophectoderm 
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Tex19    Tex19.1 
TKO   Triple knockout 
TSS    Transcription start site 
 
Ub   Ubiquitinated 
UTR    Untranslated region 
 
Vol    Volumes 
 
WT    Wild-type 
 














































1.1 The Tex19.1 Genome Defence Gene  
 
Tex19.1 is a mammalian-specific gene of unknown biochemical function which is 
expressed in germ cells, pluripotent stem cells and the placenta (Hackett et al., 2012; 
Ollinger et al., 2008; Reichmann et al., 2013). Tex19.1 was originally identified as a 
‘testis expressed’ gene, following a screen to identify genes expressed in 
spermatogonia but not in somatic cells and is a putative target of DAZL, a germline 
specific RNA-binding protein (Reynolds et al., 2005; Wang et al., 2001). It is well 
conserved between mammals, with humans, macaque and chimpanzee having a single 
copy of Tex19, with a premature stop codon which truncates the protein to 164 amino 
acids in length when expressed (Kuntz et al., 2008)(figure 1.1). In mice, Tex19 has 
undergone a duplication event to give rise to two Tex genes, Tex19.1 and Tex19.2 
expressed in different tissues (Kuntz et al., 2008)(figure 1.1). Tex19.1 expression is 
restricted to pluripotent or hypomethylated tissues and is primarily and causally 
regulated by promoter DNA methylation, as determined by a study to detect gene 
expression changes in somatic cells when treated with the DNA methyltransferase 
inhibitor, the cytidine analog 5aza-deoxycytidine (5-Aza) followed by recovery 
(Hackett et al., 2012). Genes retaining increased expression after recovery from 5-Aza 
treatment and in mouse embryonic fibroblasts (MEFs) lacking the maintenance 
methyltransferase, Dnmt1 were largely germline genes with roles in spermatogenesis 
and defence against retrotransposons in the germline (see section 1.2)(Hackett et al., 
2012). Previously in the Adams lab the association of Tex19.1 expression with 
pluripotency, placental and germline development has been explored by the generation 
of Tex19.1-/- mice (Ollinger et al., 2008; Reichmann et al., 2012). This identified 
numerous roles for Tex19.1 in spermatogenesis, placental development and 
retrotransposon repression (discussed further in section 1.12)(Ollinger et al., 2008). 
Tex19.1-/- males are sterile and exhibit severe testicular atrophy, meiotic chromosome 
asynapsis and meiotic pachytene arrest (Ollinger et al., 2008). Additionally, Tex19.1-/- 
pups exhibit intrauterine growth restriction (IUGR) with defective placental 
development (Reichmann et al., 2012). Alongside these developmental defects, both 
Tex19.1 testis and placenta have increased retrotransposon de-repression (Ollinger et 
al., 2008; Reichmann et al., 2012). As Tex19.1 is expressed at hypomethylated time 
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points permissive for the activation of retrotransposons, TEX19.1 is likely activated in 
response to reduced DNA methylation to protect the genome from excessive 
retrotransposon activation, which may have potentially deleterious consequences 
(Crichton et al., 2014; Hackett et al., 2012; Seisenberger et al., 2012). The potential 
TEX19.1 mediated transcriptional mechanism of retrotransposon repression remains 
unclear and despite being well conserved among mammals, Tex19.1 does not share 
sequence similarities with any known protein domains, therefore imparting potential 
mechanistic functions is difficult (Kuntz et al., 2008). This thesis therefore investigates 
TEX19.1 interacting partners such as KAP1 and UBR5 to unravel the potential 
mechanisms contributing to Tex19.1-/- phenotypes, from retrotransposon de-repression 







Figure 1.1 Schematic diagram of the human and rodent Tex19 gene locus. (A) 
Human TEX19 resides on chromosome 17 and has not undergone a gene duplication 
event unlike in rodents. Human TEX19 is comprised of two exons (boxes) with a 
459bp ORF in the second exon (bold box). The premature stop codon, when 
compared to rodent Tex19.1, is indicated by the red arrow. (B) Rodent Tex19.1 and 
the duplicated gene, Tex19.2 are transcribed in opposite directions (bold arrows). 
Rodent Tex19.1 is comprised of three exons (boxes) with the 1056bp ORF encoded in 









1.2 Retrotransposons  
 
First described by Barbara McClintock over 60 years ago (McClintock, 1950, 1956), 
transposable elements have shaped the mammalian genome throughout evolution 
(Cordaux and Batzer, 2009). Transposons are mobile genetic elements that comprise 
around 40% of the mammalian genome, a remarkable figure when considering that 
protein coding regions account for around 1.5% (Lander et al., 2001; Waterston et al., 
2002). Transposable elements can be separated into two major classes; DNA 
transposons which mobilise via a ‘cut and paste’ mechanism and retrotransposons 
which mobilise using a ‘copy and paste’ mechanism, to allow integration at new 
genomic locations (Goodier 2016). Propagation of retrotransposons across generations 
relies on successful retrotransposition in the germline or pluripotent cells early in 
development (Zamudio and Bourc’his, 2010). The potentially high mutagenic 
consequences of novel insertions at these vulnerable time points has resulted in the 
evolution of a diverse array of host genome defence mechanisms that limit their 
retrotransposition capacity (Goodier 2016). Retrotransposons can be split into three 
main classes comprised of the long interspersed nuclear element (LINE), short 
interspersed nuclear element (SINE) and endogenous retroviruses (ERVs) also known 
as long terminal repeat (LTR) retrotransposons (referring to the 5’ and 3’ repetitive 
sequences flanking the internal sequence of the ERV). Each class are repressed by 




LINE-1 is arguably the most successful retrotransposon in mammals as it accounts for 
around 17% of the sequenced genome (Waterston et al., 2002). Full length LINE-1 
elements in both mouse and human are approximately 6 to 7kb long however their 
internal promoter differs both between species and between different subfamilies of 
LINE-1 within species (Khan et al., 2006). Many LINE-1 elements are also 5’ 
truncated (Sookdeo et al., 2013). Of the half a million LINE-1 elements in the human 
genome only around 100 of the human specific L1H subfamily are thought to be 
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retrotranspositionally competent (Beck et al., 2010; Brouha et al., 2003; Solyom et al., 
2012). Evidence of de novo spontaneous LINE-1 integrations have been reported to 
cause disease and phenotypic changes in both humans and mice with approximately 
1:1000 spontaneous cases of human disease attributable to LINE-1 insertions (Levin 
and Moran, 2011). Mouse LINE-1 mRNA encodes two open reading frames 
(ORF)(figure 1.2A),  whereas humans have an additional ORF (Denli et al., 2015; 
Moran et al., 1996). ORF1p encodes an RNA binding protein with nucleic acid 
chaperone activity and ORF2 encodes a protein with endonuclease and reverse 
transcriptase activities, both of which are required for autonomous retrotransposition 
(figure1.2A)(Moran et al., 1996). Recent evidence also points to a previously 
overlooked but highly important promoter of human LINE-1 elements. When 
analysing the human 5’UTR of LINE-1 for ORFs with an upstream promoter and a 
strong kozak sequence, Denli et al identified a primate specific antisense open reading 
frame named ORF0, which enhances LINE-1 mobility (Denli et al., 2015).  
Transcription of LINE-1 is mediated by RNA polymerase II from an internal L1 
promoter in the 5’UTR which also produces antisense transcripts that can affect 
expression of neighbouring genes (figure 1.2A)(Cruickshanks et al., 2013; Mätlik et 
al., 2006; Speek, 2001). The youngest, most intact LINE-1 subfamilies appeared in the 
mouse genome less than 2 million years ago and are called L1MdTf, L1MdGf and 
L1MdA. These are defined by the monomeric repeats in their 5’UTRs with the many 
polymorphisms reflecting ongoing retrotransposition and evolution (Sookdeo et al., 
2013). Older subfamilies such as L1MdF and L1MdF2 are estimated to be between 
7.3 million and 3.8 million years old, with older, more degenerate LINE-1 subfamilies 
such as L1mus1 to L1Mus4 inserted into the mouse genome between 12 and 7 million 




In mice short interspersed nuclear elements (SINEs) make up around 10% of the 
mammalian genome and rely on the endonuclease and reverse transcriptase activity of 
LINE-1 ORF2 to facilitate their retrotransposition (Dewannieux et al., 2005; 
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Waterston et al., 2002). The two main SINE elements are B1 and B2, derived from a 
7SL RNA gene (figure 1.2B) and a tRNA gene respectively (Kramerov and Vassetzky, 
2011). B1 is closely related to human Alu sequences which also rely on LINE-1 to 
catalyse their retrotransposition and are the most prevalent SINE subfamilies in human 
and mouse genomes (Dewannieux et al., 2003). Conversely, SINE B2 has a greater 
LINE-1 dependent retrotransposition capacity than B1, despite fewer genomic copies 
which is likely indicative of historic bursts of B1 transposition throughout evolution 
(Dewannieux et al., 2005). As with LINE-1, de novo integrations of SINE and Alu 
elements in humans and mouse have been associated with disease but also have 
intriguing roles in regulation of gene expression (Hancks and Kazazian, 2016; Lunyak 
et al., 2007).     
 
1.1.3 LTRs  
 
LTRs comprise around 9% of the human and mouse genome and can be split into 4 
families in the mouse based on their phylogenetic relationships (Reichmann et al., 
2012; Waterston et al., 2002). The ERV1, ERVK, ERVL and MaLR families comprise 
around 400 diverse elements with differing evolutionary origins and genic 
composition (Reichmann et al., 2012). Generally, LTRs contain genes essential to 
facilitate their autonomous retrotransposition, which are usually found in exogenous 
retroviruses (Dewannieux et al., 2004). The gag gene encodes structural proteins to 
make virus like particles in the cytoplasm of the host cell, where reverse transcription 
occurs (figure 1.2C). The enzymatic proteins are provided by the pol gene encoding a 
protease, a reverse transcriptase and integrase, necessary for cDNA synthesis and 
insertion into the host genome (figure 1.2C)(Havecker et al., 2004). The major 
difference between retrotransposons and infectious retroviruses is the absence of an 
env gene which allows for viral infection of different cells, however some elements 
retain env like ORFs which have lost the capacity to form viral envelopes (figure 
1.2C)(Havecker et al., 2004). This gene cluster is usually flanked by terminal repeat 
regions from which LTR elements get their name, with RNA transcribed from a 
promoter in the 5’ LTR flanking the internal sequence (figure 1.2C). The LTR 
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elements in the mouse genome are retrotranspositionally active, whereas human LTR 
elements are thought to have lost this capacity with no de novo insertions detected in 
human disease (Bannert and Kurth, 2006; Maksakova et al., 2006). Around 600,000 
solo LTRs exist throughout the human genome with recent evidence suggesting many 
have been co-opted as regulatory regions controlling neighbouring gene expression as 






Figure 1.2: Schematic diagram of the structure of mouse LINE-1, SINE B1 and LTR 
MMERVK10C elements. Shaded areas represent transcriptional regulatory regions 
with transcriptional start sites indicated by arrows. The molecular function of each 
protein coding region are discussed in the main text. MMERVK10C represents the LTR 






1.3 DNA Methylation 
 
In many species, the transcription of retrotransposons and selected genes is stably 
repressed in a tissue specific manner both throughout development and into terminally 
differentiated cell types (Bird, 2002).  This control of stable transcriptional repression 
is mediated by DNA methylation, an epigenetic modification of the DNA whereby, a 
methyl group is physically added to the 5th position of the pyrimidine ring of a cytosine 
base when present in a CpG dinucleotide. This modified nucleotide is known as 5-
methylcytosine (5mC) (Bird, 2002). Transcriptional regulation as a consequence of 
methylated CpGs can be explained by two primary models. In the first; methylation of 
cytosines can prevent transcription factors and regulatory proteins from binding to 
DNA (Bell and Felsenfeld, 2000), and in the second; DNA methylation can create sites 
for methyl-CpG binding proteins (MBPs), which recognise methylated CpGs and 
recruit co-repressors to modify chromatin structure. This in turn leads to the formation 
of inaccessible, compacted regions of DNA known as heterochromatin and 
transcriptional repression (Boyes and Bird, 1991).  
In eukaryotes, DNA methylation is present in fungal, animal and plant species. CpG 
methylation plays an essential role in vertebrate development (Li et al., 1992), however 
some invertebrates such as Caenorhabditis elegans and Drosophila melanogaster and 
the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe have very low 
or largely undetectable levels of genomic DNA methylation (Zemach and Zilberman, 
2010). This suggests that DNA methylation is not a prerequisite for development. 
However, important roles are being identified for DNA methylation in these organisms 
where the levels of DNA methylation are very low. For example, methylation of 
cytosines regulates retrotransposon silencing and integrity of telomeres in Drosophila 
(Phalke et al., 2009).  
Most of the mammalian genome is heavily methylated, however CpG methylation is 
highly dynamic and undergoes extensive changes during differentiation, especially in 
regulatory regions outwith genic promoters (Meissner et al., 2008). Global methylation 
is interrupted by stretches of DNA with high densities of unmethylated CpGs, called 
CpG islands (CGIs). These CGIs overlap the promoter regions of around 60%-70% of 
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all human genes (Weber et al., 2007). CpG density affects the behaviour of these 
promoters and CGIs are generally associated with constitutively expressed genes (Zhu 
et al., 2008), however many CGI-associated genes remain transcriptionally repressed 
despite the absence of methylation, indicating additional regulatory mechanisms such 
as histone modifications (Weber et al., 2007). In mammals, DNA methylation is 
critical for embryonic development, genomic imprinting, X-inactivation, gene 
repression and repression of transposons (Bird, 2002). Furthermore, the existence of 
DNA methylation has been suggested to have primarily evolved to facilitate this 
transcriptional control of retrotransposons (Yoder et al., 1997). For DNA methylation 
to be a truly epigenetic system it needs to be mitotically and meiotically heritable, 
criteria that are achieved via distinct de novo and maintenance DNA methylation 








Table 1.1. DNA methyltransferases and their functions and mutant phenotypes in 
mouse  
 
1.2.1 De novo DNA methylation  
 
DNA methylation is added to CpG dinucleotides via two distinct but related DNA 
methyltransferases, DNMT3A and DNMT3B, whose activity is stimulated by the non-
catalytic co-factor, DNMT3L (table 1.1).  Expression of these enzymes is greatest 
during embryonic development, where their primary role is genome wide de novo 
methylation (Okano et al., 1999). The DNMT3 proteins both have essential but 
differing roles in development as determined by genetic knockouts of Dnmt3a or 
Dnmt3b. Dnmt3a-/- mice develop to term but are runted and die by 4 weeks post-
partum, however global DNA methylation patterns are retained (table 1.1)(Okano et 
al., 1999). In contrast, no viable Dnmt3b-/- mice are born, due to embryonic lethality 
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at around E10.5 (table 1.1)(Okano et al., 1999).  The more severe phenotype of 
Dnmt3b-/- mice suggests a more important role for DNMT3B in embryonic 
development compared to DNMT3A. Consistent with this, Dnmt3b is expressed 
earlier during embryonic development with DNMT3B protein detected at E4.5 in the 
inner cell mass at the implantation stage but being reduced in embryos by E10.5 and 
absent from the trophoblast at each stage (Watanabe et al., 2002). In contrast, 
DNMT3A is detectable in the embryo at E10.5 onwards with low levels of DNMT3A 
detectable in the trophoblast component (Oda et al., 2013; Watanabe et al., 2002).  
Despite these different requirements, both have overlapping functions as indicated by 
the more severe phenotype of double knockout Dnmt3a-/-Dnmt3b-/- embryos. These 
embryos die around E8.5 due to growth arrest shortly after gastrulation (Okano et al., 
1999). 
It is also important to note that there are also some distinct differences in the loci 
targeted. For example, DNA methylation at centromeric minor satellite repeats is 
perturbed in Dnmt3b-/- mice but not in Dnmt3a-/- mice (table 1.1)(Okano et al., 1999). 
Interestingly, some genomic loci such as imprinted regions remain methylated even in 
the combined absence of both Dnmt3a and Dnmt3b, due to the activity of the 
maintenance methyltransferase, DNMT1 (Hirasawa et al., 2008; Li et al., 1993; Okano 
et al., 1999). Also DNA methylation at the Intracisternal A particle (IAP) family of 
LTRs is relatively resistant to this global hypomethylation (Okano et al., 1999). This 
supports a role for the maintenance of DNA methylation at these loci by the 
maintenance methyltransferase mechanisms (Okano et al., 1999; Walsh et al., 1998).  
The differing targets of each of these proteins in embryonic development suggested 
that they may also have differing genomic targets in the germline. Conditional deletion 
of Dnmt3a or Dnmt3b in primordial germ cells (PGCs) using TNAP-Cre knock-in 
mice, which is expressed in PGCs from E9.5 to late gestation, showed that DNMT3A 
has distinct roles from DNMT3B in establishing de novo methylation at imprinted 
genes during male and female gametogenesis (Kaneda et al., 2004; Kato et al., 2007). 
Conditional Dnmt3a-/- mice are viable but offspring of conditional Dnmt3a-/- female 
mice exhibit embryonic lethality around E9.5 and lack methylation at maternally 
imprinted loci leading to loss of their allele specific expression (table 1.1)(Kaneda et 
al., 2004; Kato et al., 2007). DNMT3A is also necessary for some paternal imprints 
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(Kaneda et al., 2004; Kato et al., 2007). Despite the embryonic lethality of complete 
Dnmt3b-/- knockout mice, offspring from germline conditional Dnmt3b-/- exhibit no 
apparent phenotype, however the methylation of at least one paternally imprinted gene, 
Rasgrf1, is dependent on DNMT3B, along with DNMT3A (Kaneda et al., 2004; Kato 
et al., 2007). Interestingly, the defects observed in offspring of conditional Dnmt3a-
/- females were very similar to the maternal-effect seen in offspring from Dnmt3L-/- 
females (Bourc’his et al., 2001). Both Dnmt3a and Dnmt3L are also individually 
required for maternal and paternal imprinting (table 1.1)(Bourc’his et al., 2001).  
Dnmt3a and Dnmt3b are also critical in the female germ line. Conditional double 
knockout oocytes null for both Dnmt3a and Dnmt3b give rise to offspring with defects 
in DNA methylation at imprinted regions and non-imprinted genes, resulting in 
defective gene expression driving loss of cell adhesion in methylation-deficient 
trophoblast cells (Branco et al., 2016). Thus de novo methylation is restricted to 
regulation of genomic imprinting but also plays a role in regulating gene expression 
during development. 
The activity of DNMT3A and DNMT3B is stimulated by the catalytically inactive 
DNMT3L which is essential for de novo methylation and maternal imprints during 
spermatogenesis and oogenesis, but dispensable in somatic tissues (table 1.1)(Jaenisch 
and Bird, 2003). This requirement of DNMT3L for establishing de novo DNA 
methylation on paternally imprinted genes in the developing germline was indicated 
by a severe reduction in methylation at paternally imprinted loci in Dnmt3l conditional 
knockout prospermatogonia (Kato et al., 2007). Evidently, de novo DNA methylation 
is highly important for embryonic and germ cell development with many distinct but 
often overlapping genomic targets of DNMT3A and DNMT3B. The overlapping but 
often different requirement for each methyltransferase at particular loci in different 
developmental contexts demonstrates the importance of partially redundant de novo 
DNA methyltransferases.  In summary, DNMT3A is globally dispensable for de novo 
methylation in the early embryo but is required for gametic methylation. In contrast, 
DNMT3B is generally not required for gametic methylation, however is required for 
de novo methylation in the early embryo. Both Dnmt3a and Dnmt3b play minor roles 
in de novo methylation of the trophoblast lineage, possibly leading to the general 




1.2.2 Maintenance of DNA methylation 
 
It is critical to faithfully reproduce DNA methylation patterns between cell 
generations, not only to maintain imprinting but also to facilitate faithful regulation of 
transcriptional networks and retrotransposons in daughter cells upon mitotic division. 
Maintenance of DNA methylation is performed by the DNMT1 maintenance 
methyltransferase, whereby hemi-methylated loci carrying a methyl group on the 
parental strand is perpetuated to the new strand (Cedar and Bergman, 2012). 
Recruitment of DNMT1 to these loci is facilitated by NP95 which binds to 
heterochromatin associated H3K9me histone modifications during DNA replication to 
mark hemi-methylated loci (Rothbart et al., 2012). Dnmt1 is essential for embryonic 
development as mice hypomorphic for Dnmt1 die around E8.5 (Li et al., 1992). Dnmt1 
is also essential for DNA methylation as Dnmt1 hypomorphic mice exhibit a 95% 
reduction in genomic methylation levels, along with dramatic increases in transcripts 
of the LTR element IAP which is repressed by DNA methylation in developing and 
somatic cells (Lei et al., 1996; Li et al., 1992; Walsh et al., 1998). Global and 
conditional deletion of Dnmt1 in maternal and zygotic stages of mouse development 
also results in demethylation of imprinted genes and their aberrant expression in the 
blastocyst and post-implantation embryos (table 1.1)(Hirasawa et al., 2008; Li et al., 
1993). Similar phenotypes arise in embryos carrying catalytically inactive mutant 
versions of Dnmt1 suggesting the defects observed are likely due to the failure to 
maintain DNA methylation (Takebayashi et al., 2007).  
 
1.4 Global Epigenetic Reprogramming  
 
Despite the highly important role for DNA methylation in a plethora of cellular 
processes, at two distinct time points in development global epigenetic reprogramming 
occurs where DNA methylation is globally removed from the genome (figure 
1.3)(Cantone and Fisher, 2013). This provides a relatively DNA methylation free 
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genome ready for re-establishment of DNA methylation by de novo DNA 
methyltransferases (Smallwood and Kelsey, 2012). 
 
1.3.1 Epigenetic reprogramming of primordial germ cells 
  
During germ cell development, epigenetic reprogramming occurs leading to profound 
remodelling of the DNA methylation landscape to remove parental epigenetic marks. 
Existing DNA methylation patterns from the parental genomes are erased by E13.5 to 
around less than 10% of starting methylation (figure 1.3)(Popp et al., 2010). This 
global wave of DNA demethylation seemingly occurs in two phases (Seisenberger et 
al., 2012). Shortly after gastrulation around E7.25 approximately 50 primordial germ 
cells are specified from the developing epiblast (Smallwood and Kelsey, 2012). These 
then undergo extensive proliferation and migration to the genital ridge at around E10.5 
where the gonads develop. The first phase of this demethylation is proposed to occur 
in a DNA replication dependent, passive manner during this proliferation event prior 
to E9.5, with bulk methylation levels already reduced to 30% at most loci 
(Seisenberger et al., 2012; Smith and Meissner, 2013). Interestingly, DNA methylation 
is maintained at imprinted genes at this time point (Seisenberger et al., 2012; Seki et 
al., 2005). The second wave of DNA demethylation is more likely an active process 
which contributes to reducing DNA methylation at imprinted regions around E10.5 to 
E12.5 (Seisenberger et al., 2012). This is presumably necessary to facilitate sex 
specific establishment of de novo methylation marks at imprinted loci in the sexually 
differentiating germ cells (Smallwood and Kelsey, 2012). A minority of sequences 
such as IAP retrotransposons are resistant to complete DNA methylation 
reprogramming as indicated by bisulphite sequencing on PGCs at E11.5 and E13.5, 
however more recent genome wide DNA methylation techniques has allowed 
detection of more specific subsets of retrotransposons resistant to these 
reprogramming events  (Hajkova et al., 2002; Lane et al., 2003).  
Genome wide bisulphite sequencing covering different time points of PGC DNA 
demethylation has provided further evidence of differing dynamics and resistance of 
some genomic loci to these events (Hackett et al., 2013, Popp et al., 2010, Seisenberger 
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et al., 2012). Retrotransposons such as LINE, SINE and the majority of LTR class are 
hypomethylated to around 20% in PGCs at E13.5 compared to 80% in the embryo 
(Popp et al., 2010). During this global reprogramming, one LTR family of elements 
called intracisternal A particles (IAP) remain heavily controlled by DNA methylation 
and retain around 60% of methylated CpGs (Popp et al., 2010; Seisenberger et al., 
2012). Despite the dramatic loss in DNA methylation at the majority of 
retrotransposon loci creating a window permissive of their de-repression (figure 1.3), 
most retrotransposons are not de-repressed at E13.5. Interestingly, LINE-1 is 
specifically expressed in female PGCs at E16.5 (Seisenberger et al., 2012), however 
the reason for this specific window of de-repression is unclear. Together this data 
indicates additional genome defence mechanisms exist to limit any retrotransposition 
events in reprogrammed PGCs to protect future generations (Seisenberger et al., 2012).    
Throughout the whole PGC reprogramming event the de novo methyltransferases are 
transcriptionally silenced (DNMT3A) or excluded from the nucleus (DNMT3B) 
supporting the absence of any de novo methyltransferase activity during PGC 
epigenetic reprogramming (Hajkova et al., 2002). The regulators of active DNA 
demethylation in PGCs are steadily being identified with the first protein identified 
being the deaminase protein, AID but also the Ten-eleven translocation (TET) 
enzymes (Hackett et al., 2013; Popp et al., 2010). No genetic mouse mutants have yet 
been identified which retain DNA methylation in PGCs, possibly indicating that there 
may be more, as yet unknown, mechanisms of DNA removal at work. 
This genome wide DNA demethylation event precedes any alterations in histone 
modifications in post-migratory PGCs, suggesting that erasure of DNA methylation 
may be an initiating event for reprogramming at this stage. Global levels of many 
histone modifications associated with transcriptional repression or activation are 
reduced at E11.5 such as histone H3 lysine 9 trimethylation (H3K9me3), histone H3 
lysine 27 trimethylation (H3K27me3), histone H3 lysine 9 acetylation (H3K9ac) and 
the linker histone H1 (Cantone and Fisher 2013). This reduction is transient as these 
marks are thought to be globally re-established by E12.5 (Hajkova et al., 2008). The 
reason for the highly regulated timing of this reduction and re-establishment is still 
unclear.  The combined loss of DNA methylation and histone modifications acts to 
completely epigenetically reprogram the PGC genome at E11.5 (figure 1.3). In PGCs 
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specified for the male lineage, DNMT3A and DNMT3B dependent de novo 
methylation begins around E16.5 in prospermatogonia during mitotic arrest (figure 
1.3)(Seisenberger et al., 2012). In contrast, developing female oocytes remain in a state 
of global hypomethylation during meiotic arrest in prophase I until after birth when 
growing oocytes establish de novo DNA methylation patterns until puberty (figure 
1.3). Meiosis is resumed upon oocyte extrusion followed by consequent arrest in 
metaphase II until fertilisation (Smallwood and Kelsey 2012).  
 
 
1.3.2 Epigenetic reprogramming post-fertilisation  
 
Upon fertilisation, parental genomes remain physically separated for around 24 hours 
in their own pronuclei until syngamy takes place. During this period the maternal and 
paternal genomes have asymmetric epigenetic marks and undergo distinct 
reprogramming events, with loss of DNA methylation occurring quicker in the male 
pronucleus compared to the female pronucleus (figure 1.2)(Cantone and Fisher, 2013). 
Two hypotheses as to the mechanism of removal of DNA methylation have recently 
been explored. The first; active DNA demethylation where 5mCs are removed without 
the requirement for DNA replication and the second; replication dependent 
demethylation where the 5mC on the parental strand is not copied to the newly 
synthesised daughter strand during S phase (Piccolo and Fisher, 2014). Demethylation 
of the paternal pronucleus was initially thought to be mainly performed by active DNA 
demethylation as it occurs before DNA replication and in the presence of DNA 
replication inhibitor (Oswald et al., 2000). More recently, the detection of 5-
hydroxymethyl cytosine (5hmC) by immunostaining indicates the active conversion 
of 5mC to 5hmC via the TET3 enzyme (see section 1.4.2)(Gu et al., 2011; Wossidlo 
et al., 2011). This was originally not thought to be occurring in the female pronucleus, 
however low levels of 5hmC have recently been detected by more sensitive genome 
wide scale reduced representation bisulphite sequencing and a modified version to 
detect 5hmC and derivatives (Guo et al., 2014; Hu et al., 2014). This suggests that 
active DNA demethylation may play a role in the female pronucleus, albeit to a lesser 
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extent than in the male pronucleus (Guo et al., 2014). However, bulk DNA 
demethylation in both male and female pronuclei appears to be due to passive, 
replication dependent depletion of 5mC. This was shown after culture of male and 
female pronuclei with aphidicolin to block DNA replication, which prevented 
extensive demethylation (Guo et al., 2014; Shen et al., 2014). This replication 
dependent demethylation is also supported by the increase in hemimethylated DNA 
molecules after first round replication in the zygote (Arand et al., 2015). Throughout 
these demethylation events, DNA methylation is maintained at imprinted genomic 
differentially methylated regions (gDMRs) (figure 1.3). In addition to genome wide 
demethylation of DNA, the paternal spermatogenic chromatin is decondensed and 
protamines are exchanged for newly synthesised ooplasm derived histones (Santos et 
al., 2002). 
By approximately E3.5 in mice the inner cell mass (ICM) is extensively globally 
hypomethylated (figure 1.3)(Cantone and Fisher 2013; Smallwood and Kelsey 2012). 
At E6.5, specification to PGC lineage can occur which primes these cells for another 
wave of global DNA demethylation. DNA methylation is fully re-established in the 
embryonic lineages but only partially in extraembryonic trophectoderm lineages of the 
blastocyst, creating a striking global epigenetic asymmetry (Chapman et al., 1984; 
Rossant et al., 1986). DNA methylation levels of ES cells in laboratory culture can 
vary dependent on the conditions used (Habibi et al., 2013). 
 
Figure Overleaf 
Figure 1.3 DNA methylation dynamics during the two phases of global epigenetic 
reprogramming. Primordial germ cells are specified around E7.25 and DNA 
methylation is erased until E12.5 where levels are extremely reduced. Germ cell sex 
determination occurs around E12.5 and the male and female germ cells undergo sex 
specific de novo DNA methylation with differing timings. Following fertilisation loss 
of DNA methylation occurs quicker in the male pronucleus than the female 
pronucleus to lowest levels in pre-implantation embryos. De novo DNA methylation 
is then re-established to varying extents in the embryo, ES cells and the 
trophectoderm derived cells of the placenta. The purple line denotes male patterns 
of DNA methylation erasure and the orange line represents where the female specific 
reprogramming differs from male. The green line indicates maintenance of DNA 







1.5 Removing DNA Methylation 
 
DNA methylation can be removed from the genome in a passive manner dependent on 
DNA replication or actively removed by a family of catalytic proteins called the Fe(II) 
2-oxoglutarate dioxygenase Ten-eleven translocation (TETs) enzymes, which convert 
5mC to 5hmC, 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) (figure 
1.4)(Seisenberger et al., 2013). Further potential mechanisms of active removal of 
DNA methylation exist such as deamination by AID/APOBEC DNA editing family 
enzymes (Morgan et al., 2004; Popp et al., 2010) which converts 5mC to thymine with 
the resulting T:G mismatches removed by thymine-DNA-glycosylase (TDG) and the 
base excision repair (BER) pathway (figure 1.4)(Hajkova et al., 2010; He et al., 2011; 
Yan et al., 2011). 
 
Figure 1.4: Schematic diagram of passive and active TET dependent DNA 
demethylation. 5mC can be removed in a passive, replication dependent manner or 
via activity of the TET enzymes which subsequently oxidise 5mC to 5hmC, 5fC and 
5caC prior to removal via TDG and the BER pathway. AID/APOBEC provide an 
additional active removal mechanism whereby 5mC is deaminated and converted to 







1.4.1 Passive DNA demethylation 
 
Passive loss of DNA methylation can occur by blocking the maintenance machinery 
in dividing cells by exclusion, enzymatic inhibition or loss of expression of the 
maintenance methyl transferases (Piccolo and Fisher, 2014). Shortly after post 
fertilisation, the maternally derived genome of the zygote undergoes progressive 
demethylation upon cleavage divisions (Mayer et al., 2000). This may be due to the 
oocyte specific isoform of the maintenance methyltransferase, Dnmt1o being excluded 
from the nucleus of one cell, two cell and four cell embryos (Cardoso and Leonhardt, 
1999; Meyenn et al., 2016). During mammalian development PGCs undergo several 
rounds of cell division where DNA methylation is not maintained, which has been 
proposed to be due to exclusion of the Dnmt1 co-factor NP95 from the nucleus 
(Meyenn et al., 2016; Seisenberger et al., 2012).  
 
1.4.2 Active removal of DNA methylation 
 
Active DNA demethylation has been shown to be facilitated by a family of three 
catalytic TET enzymes which catalyse the conversion of 5mC to 5hmC and the more 
oxidised forms 5-fC and 5-caC (figure 1.4)(Ito et al., 2011; Tahiliani et al., 2009). 
Mammalian TET1 and TET2 have highly specific binding to 5mC in a CpG context 
with little specificity for flanking DNA sequences. Their enzymatic oxidative capacity 
was demonstrated by in vitro enzymatic assays which showed human and mouse TET 
proteins are significantly more active on 5mC-DNA substrates than 5hmC and 5fC 
substrates (Hu et al., 2015; Ito et al., 2011).  
TET enzymatic function has common outcomes but genetic studies suggest that TET 
proteins are functionally non-redundant. For example, oocyte and early 
preimplantation embryonic expression of Tet enzymes is restricted to Tet3 but its 
expression decreases as pre-implantation development progresses (Gu et al., 2011). 
Tet1 and Tet2 expression is high in the inner cell mass (ICM) and ESCs, but Tet1 is 
downregulated upon differentiation, whilst Tet3 is upregulated (Rasmussen and Helin, 
2016). Tet2 and modest expression of Tet3 is present in a large number of adult tissues, 
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however the tissue specific importance of each TET enzyme is still under debate 
(Rasmussen and Helin, 2016; Szwagierczak et al., 2010; Tahiliani et al., 2009). 5mC 
levels are relatively constant between tissues, however 5hmC levels in the mouse vary 
drastically dependent on cell type, possibly as a consequence of differing activity of 
TET enzymes (Globisch et al., 2010).  
Recently, mapping of 5hmC across the whole genome in human and mouse ESCs has 
provided insights into the genomic location and scale of TET protein function 
(Rasmussen and Helin, 2016). Traditional bisulphite sequencing cannot discriminate 
5mC from 5hmC as both resist deamination upon bisulphite treatment (Yu et al., 2012). 
Therefore, a modified genome wide bisulphite sequencing approach was developed, 
whereby all 5mC is oxidised to 5-caC by an excess of recombinant TET1, but all 5hmC 
is protected from oxidation by the addition of a glucose to 5hmC (Yu et al., 2012). 
This showed that in ESCs 5hmC is enriched in regions with low CpG content, 
including promoters associated with lowly expressed genes, gene bodies, intragenic 
regions and at active enhancers with varying distributions in different tissues (Stroud 
et al., 2011; Yu et al., 2012). This distribution data provides further understanding of 
the potential roles for 5hmC in genome regulation, alongside it being a by-product of 
DNA demethylation.   
The physiological developmental relevance of TET proteins has been investigated by 
genetic knockout of the Tet genes and further indicates distinct roles for the different 
TET proteins. Tet3 constitutive deletion leads to death shortly after birth indicating an 
essential role in development (Gu et al., 2011). Maternally inherited TET3 also has 
roles in reprogramming the paternal pronucleus (Gu et al., 2011). In contrast, 
individual Tet1-/- or Tet2-/- mice are viable and fertile with no evident developmental 
phenotype, however these proteins were determined to have redundancy in 
development as double Tet1-/-Tet2-/- mice exhibit some embryonic lethality with a 
spectrum of disorders such as exencephaly, growth retardation and defective 
imprinting (Dawlaty et al., 2013). Despite this, around 40% of Tet1-/-Tet2-/- mice are 
born grossly normal and are fertile (Dawlaty et al., 2013). TET enzymes contribute to 
reprogramming methylation patterns at some sequences throughout development and 
recent findings indicate that addition of vitamin C to embryonic stem cells (ESCs) 
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promotes TET activity leading to a global increase in 5hmC and reductions in 5mC at 
different loci in mESCs (Blaschke et al., 2013; Walter et al., 2016).  
Recent evidence indicates roles for TET enzymes in active removal of DNA 
methylation in developing PGCs. TET1 and TET2 enzymes peak in expression in 
PGCs between E10.5 and E11.5 at the height of DNA methylation removal (Hackett 
et al., 2013). This reduction in 5mC was accompanied by a global enrichment of 5hmC 
suggesting conversion by the TET proteins (Hackett et al., 2013). To confirm the 
conversion was due to TET1 and TET2, inducible knockout Tet1/Tet2 PGC-like cells 
were specified from epiblast-like cells and indicated that upon knockdown of Tet1 and 
Tet2 there was a substantial inhibition of DNA demethylation, not only genome wide 
but at imprinted regions, LINE-1 elements and some IAP loci (Hackett et al., 2013). 
Furthermore, components of the BER pathway such as poly(ADP-ribose)-polymerase 
1 (Parp1) and Tet1 are upregulated in E11.5 PGCs (Hajkova et al., 2010) which 




1.4.3 TDG catalysed base excision and base excision repair 
 
Another major driver of active DNA demethylation involves thymine-DNA-
glycosylate (TDG) catalysed base excision and DNA base excision repair (BER). TDG 
is a mismatch repair enzyme which was found to bind and excises G:U and G:T base 
pairs (Lindahl and Wood, 1999). More recently, TDG has been shown to be a critical 
step in the TET mediated active DNA demethylation pathway (figure 1.4). No binding 
or catalytic activity of TDG was detected for 5hmC in vitro and indicated the 
specificity of TDG for 5fC and 5caC, the more highly oxidised forms of 5mC (He et 
al., 2011; Zhang et al., 2012). TDG is first recruited to 5fC and 5caC and then catalyses 
base excision of these oxidised cytosine bases, which are replaced by an unmodified 
cytosine by BER (Nabel et al., 2012). This mechanism was supported by experiments 
in ESCs null for Tdg which had an increase in 5fC and 5caC and HEK293T cells 
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overexpressing Tdg having reduced 5fC and 5caC levels (Nabel et al., 2012). 
Furthermore, the biological relevance of TDG in development was highlighted by Tdg-
/- mice which died by E11.5 with haemorrhages and problems with vasculature 
development, among other defects (Cortázar et al., 2011). In support of the in vivo 
functional studies, these mice exhibited hypermethylation affecting the expression of 
developmental genes. Failure to establish and maintain correct DNA methylation 
patterns was proposed to be the likely cause of developmental defects (Cortázar et al., 
2011). 
Aside from TET and TDG/BER pathways, alternative mechanisms can exist to 
perform active DNA demethylation. For instance, DNA repair mechanisms such as 
deamination by the AID/APOBEC family of cytidine deaminases results in conversion 
of 5hmC to 5hmU followed by BER and replacement with an unmodified cytosine 
(figure 1.4)(Popp et al., 2010; Morgan et al., 2004). AID has clear activity in PGCs at 
E13.5, however the phenotype upon Aid deletion in PGCs is moderate, indicating the 
presence of additional mechanisms which actively remove DNA methylation in the 
absence of AID (Popp et al., 2010). Each of these components of the active DNA 
demethylation mechanisms have roles in the global epigenetic reprogramming events 
occurring shortly after fertilisation and in the developing primordial germ cells.  
 
1.6 DNA Methylation Associated Interferon Response 
 
Experimental removal of DNA methylation using DNA demethylating drugs has 
provided a method to induce retrotransposon de-repression in a variety of cell types 
and assess the molecular and physiological consequences for many cellular processes.  
Removing DNA methylation in differentiated cells using 5-Aza de-represses LTR 
retrotransposons (Chiappinelli et al., 2015; Davis et al., 1989; Roulois et al., 2015; 
Rowe et al., 2010), suggesting DNA methylation is playing an important role in 
repressing these retrotransposons in these cells. Interestingly, retrotransposon de-
repression in cells treated with 5-Aza induces a type I interferon β response, leading 
to apoptosis of the treated cells, possibly through the accumulation of retrotransposon-
encoded nucleic acids in the cytoplasm (figure 1.5). This mimicks infection by an 
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exogenous retrovirus (Chiappinelli et al., 2015; Kassiotis and Stoye 2016; Roulois et 
al., 2015). Repression of retrotransposons by DNA methylation and potentially also 
by other mechanisms may therefore be important to prevent inappropriate activation 
of innate immune responses in mammals.  
 
 
Figure 1.5: Nucleic acid intermediates of transcriptionally de-repressed 
retrotransposons. (A) Transcriptional de-repression of LINE-1 and LTR 
retrotransposons (proviral DNA, internal blue helix) can result in production of 
retroviral RNA (single red line) followed by reverse transcription to double stranded 
cytosolic DNA (dsDNA)(isolated blue helix), due to the increased availability or 
‘hijacking’ of LINE-1 reverse transcriptase (RT). (B) Additionally, increased 
complementary sense and antisense single-stranded RNA (ssRNA)(single red lines) 
transcripts that may form double-stranded RNA (dsRNA)(red helix). Cytosolic dsRNA 
and dsDNA molecules are visible to RNA and DNA sensors respectively. Dark blue 
shading denotes the nucleus and light blue, the cytoplasm (Figure modified from 
Kassiotis and Stoye, 2016)   
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The immune system is frequently activated in response to invasion of cells via non-
self-pathogens, resulting in host cell death (Platanias, 2005). One such mechanism of 
immune response is the interferon pathway (figure 1.6). The effects of the interferon 
pathway and activation of interferon stimulated genes are wide ranging as they are pro-
inflammatory, enhance adaptive immunity, and are directly antiviral (Schneider et al., 
2014). Type I interferons are largely comprised of interferon α (IFN) and IFNβ 
produced by a broad range of cell types (Platanias, 2005). The type II interferon 
response is reliant on IFNγ which is predominantly produced by T cells and natural 
killer cells. Type III interferons are comprised of IFNλ and are largely restricted to 
epithelial cell surfaces (McNab et al., 2015). 
All type I interferons bind a receptor comprised of two subunits known as IFNAR1 
and IFNAR2 on the surface of the cell (figure 1.6). The receptor is associated with the 
Janus kinase (JAK) / Tyrosine kinase (TYK) which when bound by IFNα/β results in 
tyrosine phosphorylation of STAT1 and STAT2 (Paludan and Bowie, 2013). These 
then form a trimeric complex, translocate to the nucleus with IRF9 and bind IFN-
stimulated response elements (ISREs) in DNA, initiating the transcription of interferon 
stimulated genes (figure 1.6)(Platanias, 2005). The type II IFN pathway functions via 
a similar pathway mainly reliant on STAT1 (Platanias, 2005). Depending on the type 
of viral insult detected, from cytosolic dsRNA or cDNA, different proteins facilitate 
the immune response. RIG-1 and MDA5 are cytosolic dsRNA sensors and TMEM173 







Figure 1.6: Schematic diagram of activation of the JAK-STAT pathway by type-I 
interferon. IFN-alpha or beta is sensed by IFNAR receptors which results in 
phosphorylation (green circles) of STAT1 or STAT2. STAT1 and STAT2 dimerise and 
translocate to the nucleus with IRF9 and bind to ISREs upstream of the transcriptional 
start sites of interferon stimulated genes, inducing transcriptional activation. Figure 






Activation of a type I interferon response is associated with the chronic autoimmune 
disease, Aicardi-Goutières Syndrome (AGS) in humans (Behrendt and Roers, 2014). 
The syndrome is caused by mutations in one of several enzymes involved in nucleic 
acid metabolism; TREX1, ADAR1 and SAMHD1 (Kassiotis and Stoye 2016). 
Information about the pathogenic mechanisms contributing to AGS has been gained 
from studies on mouse mutants in these key genes. For instance, Trex1-/- mice die 
around 6 months of age (Morita et al., 2004). They exhibit upregulation of interferon 
stimulated genes which suggested that loss of Trex1 results in a spontaneous activation 
of an anti-viral type I IFN response (Morita et al., 2004; Stetson et al., 2008). This 
autoimmune response was found to be causative as the IFN response and disease 
pathogenesis was lost when crossing Trex1-/- mice with mice lacking the type-I IFN 
receptor, IFNAR (Stetson et al., 2008). The pathogenic type I IFN response is triggered 
by increased levels of endogenous nucleic acids in Trex1-/- mice (Stetson et al., 2008). 
Interestingly, ssDNA fragments from both LINE-1 and LTR retrotransposons were 
found to be in the cyotosol of Trex1-/- cells and were proposed to be endogenous 
substrates for TREX1 in the heart (Stetson et al., 2008)(figure 1.5). In general, excess 
cytosolic nucleotides are detected by a cytosolic DNA sensing pathway, reliant on 
IRF3 and STING (TMEM173). These sensors were deemed to be essential for auto-
immune activation as the Trex1-/- phenotype was rescued by crossing with mice null 
for Irf3 or Sting indicating the phenotype was likely arising due to the increase in 
cytosolic DNA (Gall et al., 2012; Stetson et al., 2008). 
The association of AGS and retrotransposon de-repression was further confirmed as 7 
out of the 8 known SAMHD1 mutations in human AGS cause increased L1 
retrotransposition when analysed with a GFP reporter screen (Zhao et al., 2013). Along 
with TREX1 and SAMHD1, ADAR1 protein is also associated with AGS, immune 
response and retrotransposon activity. The ADAR1 adenosine deaminase proteins bind 
dsRNA and convert adenosine to inosine to promote an antiviral response (Kim et al., 
1994). To determine a role for ADAR1 in retrotransposon repression, transcript 
expression of livers null for Adar and the cytoplasmic dsRNA sensing pathway 
component, Mavs were compared to Adar-/- livers (Mannion et al., 2014). This 
abrogated the cytoplasmic double-stranded RNA removal common to MAVs and 
indicated increased transcripts of the LTR retrotransposon, MMERVK10C (Manion et 
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al., 2014). This indicates that ADAR is not only involved in AGS pathogenesis but 
also in retrotransposon repression in the absence of a type I interferon response 
(Manion et al., 2014). In summary, each of these studies demonstrate retrotransposon 
increases which are associated with increased type I interferon response contributing 
to disease state.  
 
1.7 Histone Modifications 
 
A fundamental principle of genome regulation is the ability to dynamically manipulate 
chromatin state. The first line mechanism of genome regulation is reliant on epigenetic 
modifications distinct from DNA methylation; modifications to the histones of the 
nucleosome core of DNA. DNA methylation has then been suggested as a secondary 
mechanism to ‘lock in’ transcriptional repression of genes and retrotransposons that is 
first set up by histone modifications (Cantone and Fisher, 2013).  
The nucleosome core has 147 base pairs of DNA periodically wound around a histone 
octamer comprised of two H2A – H2B dimers and a tetramer of histone H3-H4 
(Bannister and Kouzarides, 2011). This forms a ‘beads-on-a-string’ arrangement 
which is folded into more condensed fibres to facilitate packaging of around 2 meters 
of DNA into the nucleus of each cell (Bannister and Kouzarides, 2011). Conserved 
throughout evolution, histones have a ‘tail’ of amino acid residues which are subject 
to post translational modifications such as methylation, acetylation, phosphorylation, 
ubiquitination, SUMOylation and citrullination which mediate chromatin folding and 
histone function (Peterson and Laniel, 2004).  Chromatin modifications are generated 
and removed by specific ‘writer’ and ‘eraser’ enzymes which can influence chromatin 
function by directly altering its structure or by recruiting ‘reader’ proteins that 
recognise these modifications. Such modifications play important roles in the 
regulation of gene expression, chromosome compaction and organisation, DNA repair 
in mitotic cells and transcriptional control of retrotransposons (Bannister and 




1.6.1 Methylation of histones 
 
The most prevalent modification of core histones is methylation, which mainly occurs 
in combinations of mono, di or tri-methylation on lysine tails or mono or 
demethylation on arginine residues. These methylation marks can be deposited or 
removed by groups of enzymes referred to as histone methyltransferases (HMTs) and 
histone demethylases (HDMs) respectively. Varying combinations and numbers of 
methylated sites can be associated with repression of a gene or retrotransposon due to 
the formation of heterochromatin around those repressed loci (table 1.2)(Kouzarides, 
2007). Histone methylation itself does not alter chromatin structure, as the charge of 
methylated histones is unaltered. Instead histone methylation recruits downstream 
protein complexes which recognise methylated residues through chromo-domains 
(Kouzarides, 2007). This is unlike acetylation and phosphorylation which alter the 
charge of modified histones disrupting their interaction with DNA and therefore the 
stability of the local chromatin architecture (Bannister and Kouzarides 2011). 
Importantly, histone methylation appears to be the primary mechanism of 
retrotransposon repression in ESCs (Goodier 2016). They have been shown to play a 
lesser role in differentiated somatic cells where retrotransposon repression is largely 
facilitated by DNA methylation, however a few recent examples appear to be 
exceptions to this rule (Bulut-Karslioglu et al., 2014; Ecco et al., 2016; Fasching et al., 
2015; Karimi et al., 2011; Mikkelsen et al., 2007; Wolf et al., 2015a). 
 
Table 1.2: Repressive histone marks, histone methyltransferases and their 
association with retrotransposon repression 
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1.6.2 The SUVAR proteins 
 
The first histone methyltransferase detected in mice and humans was of the SUVAR 
family of proteins and are homologues of Drosophila Su(var)3-9. This homologue 
contained a conserved SET domain known to methylate histones (Rea et al., 2000). 
The histone tail residues targeted by mammalian SUVAR proteins were unclear and 
in 2000, Rea et al. showed that in somatic cells lysine 9 of histone 3 was tri-methylated 
by SUV39H proteins in humans and mice (table 1.2)(Rea et al., 2000). This was 
demonstrated by in vitro methylation assays using tagged human and mouse 
SUV39H1, free histones and a methyl donor (Rea et al., 2000). Recent genome wide 
chromatin immunoprecipitation sequencing experiments (ChIPseq) have revealed 
SUV39h proteins and SUV39h dependent H3K9me3 are enriched at many 
retrotransposon sequences in the genome (Bulut-Karslioglu et al., 2014). The majority 
of intact LINE-1 and some LTR elements are bound by SUV39H and marked for 
transcriptional repression by H3K9me3 in mouse embryonic stem cells (mESCs). The 
H3K9me3 was determined to be at least partly SUV39H dependent as mESCs null for 
SUV39H proteins exhibited reduced SUV39H and H3K9me3 at these loci (Bulut-
Karslioglu et al., 2014). This was accompanied by de-repression of the younger 
L1MdA and L1MdT subfamilies of elements and to a far lesser extent some LTR 
elements in mESCs (Bulut-Karslioglu et al., 2014). Interestingly, upon differentiation 
of Suv39h null mESCs to neural progenitor cells, SUV39H dependent H3K9me3 was 
not diminished at LTR or LINE repeats excluding the SUV39H histone 
methyltransferases from a role in the regulation of retrotransposons in more committed 
cells, which is mainly provided by DNA methylation (Bulut-Karslioglu et al., 2014; 
Karimi et al., 2011). Furthermore, the SUV39H proteins play essential roles in 
development as double knockout mice lacking Suv39h1 and Suv39h2 are born at sub-
Mendelian ratios with growth retardation of viable pups, sterility and perturbations in 
H3K9 methylation at pericentric heterochromatin made up of major satellite repeats 
(Peters et al., 2001a). This indicates functional histone methyltransferase activity of 






Another member of the SUV39 family of histone methyl transferase is SET domain, 
bifurcated 1 (SETDB1/ESET) which is related but distinct from SUV39H1 and 
SUV39H2 proteins. SETDB1 is involved in many aspects of development and genome 
regulation, indicated by its many interacting partners (Kang, 2014). Interactions with 
important regulators of chromatin state such as KAP1 and DNMT3A (Li et al., 2006; 
Schultz et al., 2002) along with the presence of a catalytic SET domain indicated the 
potential importance of SETDB1 in genome regulation (Kang, 2014; Schultz et al., 
2002). In initial research aimed to determine the functionality of the SET domain of 
SETDB1, Schultz et al performed elegant experiments whereby the SET domain of 
SETDB1 was mutated and was shown to reduce its catalytic histone methyltransferase 
activity (Schultz et al., 2002). The methyl transferase activity was shown to be highly 
selective for H3K9 when using recombinant SETDB1 protein, histone tail proteins and 
methyl donors. Interestingly, unlike SUV39h, SETDB1 can catalyse mono, di or tri 
methylation of H3K9 (Schultz et al., 2002). This H3K9 methylation was then shown 
to recruit heterochromatin protein 1 (HP1) to facilitate heterochromatin formation and 
transcriptional repression (Schultz et al., 2002).  
Setdb1 is expressed from the blastocyst and is ubiquitous during post implantation 
development of the mouse (Dodge et al., 2004). SETDB1 is critical in development as 
shown by genetic knockout studies which indicated that Setdb1-/- embryos arrest at the 
blastocyst stage of development around E4.5 (Dodge et al., 2004). This is far earlier 
than the arrest of other H3K9 methyltransferases such as perinatal death of SUV39H1 
knockouts (Peters et al., 2001a) and lethality at E9.5 for GLP and G9A knockouts 
(Tachibana et al., 2002, 2005).  Each of these HMTs are expressed at the blastocyst 
stage, however they fail to compensate for the loss of Setdb1 (Cho et al., 2011). This 
highlights the significance of SETDB1 function in early mouse development and 
implies non-redundant roles for HMTs throughout gestation. No global alterations in 
H3K9me3 were detected in Setdb1-/- blastocysts by immunostaining and it was 
proposed that this was due to a maternal stock of SETDB1 rescuing global H3K9me3 
(Dodge et al., 2004). Despite this, the role of SETDB1 in transcriptional control across 
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the genome in mESCs has been characterised using refined ChIPseq and RNAseq 
studies (Bilodeau et al., 2009; Maksakova et al., 2006). 
Many loci are susceptible to SETDB1 dependent repression, from genic loci to 
retrotransposons. SETDB1 is enriched at some subtypes of LTR retrotransposons, 
along with H3K9me3 in mESCs (Matsui et al., 2010). This H3K9me3 deposition was 
shown to be SETDB1 dependent as it was reduced in conditional Setdb1 null mESCs 
resulting in dramatic de-repression of many LTR and LINE-1 retrotransposons (table 
1.2)(Karimi et al., 2011; Matsui et al., 2010). The DNA methylation state at these 
LINE-1 and LTR loci does not change, suggesting that silencing of most 
retrotransposons in ESCs occurs relatively independently of DNA methylation (Leung 
and Lorincz, 2012; Matsui et al., 2010). The overlap in SETDB1 and SUV39H binding 
and activity at some loci, such as LINE-1 elements, provides redundancy in 
retrotransposon repression in ESCs, despite SETDB1 having a far greater repertoire of 
retrotransposon targets (Leung and Lorincz, 2012). When the extent of upregulation 
of retrotransposons in Setdb1 null mESC and Suv39h-/- mESC was compared by 
RNAseq, there was a far greater de-repression of LTRs in Setdb1 null mESCs (Bulut-
Karslioglu et al., 2014; Karimi et al., 2011). This indicates the SETDB1 repressive 
mechanism is far more widespread at LTRs but that LINE-1 is likely co-ordinately 
regulated by both proteins (Bulut-Karslioglu et al., 2014). Similarly to Suv39h null 
somatic cells, Setdb1 null embryonic fibroblasts have only limited de-repression of a 
subset of MLV retrotransposons which is likely an indirect effect as no retrotransposon 
loci are bound by SETDB1 in this cell type, further indicating a lesser role of histone 
modifications in differentiated cell types (Hutnick et al., 2010; Matsui et al., 2010). 
Interestingly, recent studies are finding direct roles for SETDB1 in retrotransposon 
silencing in somatic cells such as the de-repression of LTRs in Setdb1-/- B-lymphocytes 
(Collins et al., 2015).  
Recent evidence also indicates that SETDB1 is required for germline development and 
silencing of H3K9me3 marked LTRs in primordial germ cells (Liu et al., 2014b). The 
technical challenges associated with genome wide DNA methylation and ChIP 
analysis of histone marks during PGC reprogramming have recently been overcome 
and has provided extensive knowledge of the extent of SETDB1 mediated repression 
at specific genomic loci at E13.5 (Liu et al., 2014). This analysis misses the window 
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of lowest histone modifications at E11.5, therefore it is unclear if histone marks are 
retained at retrotransposon loci during reprogramming, however it indicates many 
retrotransposons from LTR (IAP, MMERVK10C) to LINE-1 elements (L1MdA, 
L1MdT, L1MdG and L1MdF) are heavily marked by H3K9me3 and H3K27me3 in 
E13.5 PGCs of both sexes (Liu et al., 2014). Global decreases in this mark were 
detected by refined small sample ChIPseq experiments for H3K9me3 in PGCs with 
conditional deletion of Setdb1. A reduction of this mark was detected at LTR elements 
such as IAP, along with some LINE-1 subfamilies (Liu et al., 2014). Interestingly, a 
decrease in H3K27me3 was also observed in conditional null Setdb1 PGCs suggesting 
possible interdependence of SETDB1 and polycomb repressive mechanisms in PGCs 
(Liu et al., 2014). SETDB1 mediated repression appeared to be relatively sex specific 
as IAP elements are highly de-repressed in male Setdb1 null PGCs and whereas 
MMERVK10C was most highly de-repressed in female PGCs, with only modest 
changes in IAP expression (Liu et al., 2014). The reason for this sex specific nature of 
repression remains unclear but may be reflective of the differing reprogramming 
dynamics associated with sex specific PGC development. Alternative transcriptional 
or post-transcriptional silencing pathways for LINE-1 in PGCs were proposed as 
LINE-1 elements exhibited very little reactivation in Setdb1 null PGCs despite reduced 
H3K9me3 (Liu et al 2014). 
 
1.6.4 KAP1 and KRAB-ZFP mediated retrotransposons repression 
 
The binding of SETDB1 to retrotransposon loci is largely dependent on the 
transcriptional repressive co-factor, KRAB domain-associated protein 1 
(KAP1/TRIM28). Potential roles for KAP1 in transcriptional repression were 
indicated when KAP1 was demonstrated to have an N-terminal RING finger B boxes 
coiled coil motif (RBCC) which facilitates targeting to or assembly of different protein 
complexes (Saurin et al., 1996) and a C-terminal region containing a PHD finger and 
a bromodomain, which are present in many transcriptional cofactors acting at the 
chromatin level (Aasland and Stewart, 1995; Friedman et al., 1996). Further early 
analysis indicated that the RBCC domain is necessary and sufficient for KAP1 binding 
as a homotrimer to the KRAB repression motif of KRAB-ZNFs (figure 1.4)(Peng et 
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al., 2000, 2002) and that the PHD finger and bromodomain are both required to obtain 
maximum levels of KAP1 mediated transcriptional repression via targeting to genic 
and retrotransposon loci by KRAB-ZFPs (figure 1.7)(Iyengar et al., 2011; Schultz et 
al., 2001; Sripathy et al., 2006).  
After recruitment to the genome by KRAB-ZFPs, KAP1 induces repressive histone 
modifications by recruiting multiprotein chromatin modifying complexes including 
SETDB1 which adds the H3K9me3 mark to facilitate transcriptional repression (figure 
1.7). SUV39H proteins are not thought to be recruited to retrotransposon loci by KAP1 
(Bulut-Karslioglu et al., 2014). The interaction with SETDB1 is dependent on the 
sumoylation of the KAP1 bromodomain by its PHD domain (figure 1.7)(Ivanov et al., 
2007). Heterochromatin protein 1 (HP1) can bind to the PxVxL motif of KAP1 and to 
H3K9me3 at repressed loci, stabilising the bound repressive complex (Schultz et al., 
2002; Sripathy et al., 2006). KAP1 also binds to the NuRD histone deacetylase 
complex (HDAC) which removes histone acetylation, an active mark of transcription 
as an additional mechanism of repression (Schultz et al., 2001, 2002). Furthermore, 
KAP1 has been reported to interact with DNMT3A and DNMT3B and the KRAB-
ZFP:KAP1:SETDB1 repressive complex can direct de novo DNA methylation to 
LTRs (Li et al., 2008; Quenneville et al., 2011; Rowe et al., 2013a; Zuo et al., 2012). 
As KAP1 is generally important to the function of each of these interacting partners, 
it is unsurprising that removal of KAP1 in many different contexts results in dramatic 







Figure 1.7: Schematic diagram of the mechanism of KRAB-ZFP:KAP1:SETDB1 
mediated transcriptional repression. KRAB-ZFPs bind to distinct genomic loci in a 
sequence dependent manner and recruit KAP1 via binding to its RBCC domain. The 
PHD domain of KAP1 sumoylates the Bromodomain to facilitate the interaction 
between SETDB1. SETDB1 then trimethylated histone 3 lysine 9 (red pentagons) to 
transcriptionally repress the target loci. Interactions of KAP1 with HP1, NuRD or the 





Kap1 is expressed ubiquitously and extensive roles for KAP1 have been characterised 
throughout development and beyond. The importance of the protein in early 
development was demonstrated by Kap1-/- mice which die at E5.5 (Cammas et al., 
2000). Kap1-/- embryos did not undergo gastrulation and those embryos surviving 
longer exhibited severe defects in development of the 3 germ layers (Cammas et al., 
2000). In addition to this important role in embryonic development, KAP1 exhibits 
diverse roles across many different aspects of physiology. Roles in cell differentiation, 
DNA damage response, virus replication, tumourigenesis and repression of 
retrotransposons have been determined in a variety of conditional Kap1 knockout 
models in numerous cell types and tissues (Cammas et al., 2000; Cheng, 2014; 
Friedman et al., 1996; Iyengar and Farnham, 2011).  
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As genetic knockout of Kap1 has a severe embryonic lethal phenotype the role of 
KAP1 in transcriptional regulation in ES cells was studied by conditional removal of 
Kap1 (Rowe et al., 2010). Kap1 null ES cells exhibited dramatically increased 
expression of many LTR retrotransposons such as IAP and MMERVK10C but more 
modest de-repression of LINE-1 elements (Rowe et al., 2010). To determine if this de-
repression was a consequence of reduced H3K9me3, Rowe et al performed ChIPseq 
and indicated dramatic reductions at de-repressed retrotransposons (Rowe et al., 2010). 
De-repression of IAP was also detected in E5.5 – E6.5 Kap1-/- embryos and cultured 
Kap1 depleted blastocysts by in situ hybridisation (ISH) and qRT-PCR (Rowe et al., 
2010). This KAP1 dependent retrotransposon repression appears to be restricted to 
pluripotent cells as knockout of Kap1 in murine embryonic fibroblasts (MEFs), 
hepatocytes and white blood cells has little effect on the expression of retrotransposons 
(Bojkowska et al., 2012; Rowe et al., 2010; Sio et al., 2013). Taken together, it was 
thought that the KAP1/SETDB1 mediated repression of retrotransposons in early 
embryogenesis leads to irreversible silencing, which is maintained independently of 
KAP1/SETDB1, by DNA methylation following differentiation (Matsui et al., 2010; 
Rowe et al., 2010; Wiznerowicz et al., 2007; Wolf et al., 2015a).  Recently however, 
this hypothesis is being questioned by various studies which indicate roles for 
continued KAP1 mediated retrotransposon repression beyond development. For 
example, de-repression of IAP and MMERVK10C elements occurs in conditional 
Kap1 null neural progenitor cells, accompanied by decreases in H3K9me3, indicating 
that histone mediated repression is more dynamic than previously thought (Fasching 
et al., 2015). This dynamic, tissue specific nature of repression is likely due to differing 
transcription factors or KRAB-ZFPs in differing tissues (Ecco et al., 2016; Fasching 




The mechanism of KAP1-KRAB-ZFP mediated transcriptional repression was 
investigated by tethering KAP1 to DNA as a Gal4-KAP1 fusion protein (Sripathy et 
al., 2006). This facilitated repression of reporter genes only when bound, indicating 
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that for KAP1 to elicit its repressive capacity it must be bound to DNA (Sripathy et 
al., 2006). Furthermore, KRAB-ZFPs were proposed to be auto-regulated by KAP1 
and sufficient to direct KAP1 and H3K9me3 to the genome in human cells (Iyengar et 
al., 2011; O’Geen et al., 2007). Recent evidence suggests the vastly widespread nature 
of this KAP1 dependent mechanism with examples of KRAB-ZFP KAP1 dependent 
retrotransposon repression in mouse and human ESCs and even somatic, terminally 
differentiated tissues, in a highly cell type specific manner (Castro-Diaz et al., 2014; 
Ecco et al., 2016; Wolf et al., 2015a).  
Two studies present compelling evidence to suggest that early embryonic control of 
LINE-1 in humans and mice is an evolutionarily dynamic process in which the KRAB-
ZFP KAP1 repressive mechanism has evolved alongside LINE-1 elements (Castro-
Diaz et al., 2014; Jacobs et al., 2014). Both indicate, using genome wide chromatin 
immunoprecipitation experiments (ChIP), that KAP1 binds to particular subfamilies 
of LINE-1 in both human and mESCs. Using a candidate based (Jacobs et al., 2014) 
and a more global approach (Castro-Diaz et al., 2014) they further identify the KRAB-
ZFPs responsible for targeting KAP1 and H3K9me3 to particular LINE-1 
retrotransposon sequences. Generally the younger LINE-1 elements are regulated by 
DNA methylation until a specific KRAB-ZFP has sufficient time to evolve to target it 
with the KAP1 mediated H3K9me3 repressive mechanisms, which are mainly active 
on the intermediate aged LINE-1 elements (Castro-Diaz et al., 2014; Jacobs et al., 
2014).  
The role for KRAB-ZFPs in differentiated cells has, until recently, been unclear. As 
mentioned, retrotransposon silencing has been proposed to be established early in 
development by KAP1, which induces H3K9me3 repressive chromatin domains, 
followed by DNA methylation (Playfoot and Adams, 2016). It was thought that this 
silencing could then be maintained independently of KRAB-ZFP and KAP1 function 
in differentiated cells, however this analysis was based on low numbers of KRAB-
ZFPs and retrotransposons (Rowe et al., 2010; Wolf et al., 2015). Recently, a targeted 
GFP repression-based functional screen of over 200 KRAB-ZFPs in somatic cell lines, 
identified KRAB-ZFPs that recognise selected retrotransposon derived sequences in 
the mouse somatic cells and are necessary for their repression (Ecco et al. 2016). 
Firstly, the retrotransposon repressive capacity of two of these, ZFP932 and its paralog 
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Gm15336 were demonstrated in mESCs. They then show that in multiple somatic 
contexts, depletion of the specific ZFPs or KAP1 are sufficient to de-repress their 
target retrotransposon loci, indicating that for at least some retrotransposons 
transcriptional repression in somatic cells is achieved through the persistent 
identification by KRAB-ZFPs and the continual recruitment of KAP1 (Ecco et al., 
2016). The evolutionary drive to evolve ZFPs that target rapidly evolving 
retrotransposons has been proposed to contribute to the large number of species-
specific ZFPs typically found in mammalian genomes (Wolf et al., 2015b). 
 
1.8 Retrotransposons in Genome Regulation 
 
Retrotransposon activation in permissive epigenetic reprogramming phases, along 
with retrotransposon de-repression in experimental contexts can pose a mutational 
threat to the genome with potentially deleterious consequences. Far from this negative 
aspect of retrotransposon biology, recent studies have shown that retrotransposons 
have played a prominent role in shaping the regulatory landscape of the mammalian 
genome (Thompson et al., 2016). The idea that retrotransposons could participate in 
gene regulation was proposed by the founder of transposable elements, Barbara 
McClintock over 60 years ago (McClintock, 1950). This was based on studies in maize 
whereby transposition resulted in gain of new traits for the recipient crop. Recently 
evidence has arisen that cements retrotransposons as drivers of genome regulation by 
their co-option as regulatory elements independent of their capacity for 
retrotransposition (Thompson et al., 2016). Many studies are now indicating 
mechanisms for this repetitive element mediated genome regulation. In normal mouse 
development, there is evidence of repeat elements with enhancer function (figure 
1.8)(Chuong et al., 2013, 2016), or alternative promoter activities which regulates the 
expression of neighbouring genes (figure 1.8)(Peaston et al., 2004; Thompson et al., 
2016). A study by Chuong et al in 2013 showed that LTRs are acting as enhancers for 
core factors necessary for defining the trophoblast stem cell (TSC) transcriptional 
network. Enhancer associated marks histone H3 lysine 4 monomethylation 
(H3K4me1) and histone H3 lysine 27 acetylation (H3K27ac) were enriched at 
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particular LTRs in TSCs as determined by ChIPseq and these elements were 
functionally capable of driving expression in a rat placental cell line (Chuong et al., 
2013). LTRs can also function as alternative promoters in development (figure 1.8). 
An early version of a genome wide expression study from mouse oocytes used a cDNA 
library and analysed the amount of repetitive element expressed sequence tags 
(Peaston et al., 2004). They identified relatively high expression of the MaLR class of 
retrotransposons in full grown oocytes and determined that retrotransposon LTRs were 
functioning as primary or alternative promoters contributing to oocyte specific gene 
expression by analysis of chimeric transcripts (Peaston et al., 2004). Importantly, 
studies to date have indicated that co-opted LTRs are particularly prevalent in early 
embryonic development, germ cells and pluripotent stem cells (Thompson et al., 
2016). 
Alongside normal roles in development, aberrant de-repression of retrotransposons in 
genetic knockout contexts can result in non-developmentally programmed effects on 
neighbouring genes (Herquel et al., 2013; Rowe et al., 2013b). Conditional knockout 
of the transcriptional co-repressor Kap1 in ES cells results in dramatic de-repression 
of LTR retrotransposons and their loss of repressive histone marks due to replacement 
with the marks of putative enhancers, H3K4me1 and H3K27ac (Rowe et al., 2010, 
2013). Aberrantly de-repressed retrotransposon acting as alternative promoters has 
also been reported in ES cells lacking Setdb1 or Kap1 (Ecco et al., 2016; Karimi et al., 
2011). Despite the wealth of evidence of de-repressed retrotransposons altering genic 
transcription in mouse knockout contexts (Ecco et al., 2016; Herquel et al., 2013; 
Rowe et al., 2013b), evidence of transcriptional effects on genes with functional 
relevance to the disease phenotype is yet to be shown. This presents an interesting 
possibility when determining the possible cause of disease phenotypes, correlating 





Figure 1.8: Effects of retrotransposons on neighbouring genes. Repression of 
retrotransposons (blue ovals) via DNA methylation or histone modifications (black 
diamonds) limits their activity (bar arrows). During normal pre-programmed 
development or when these epigenetic repressive mechanisms are perturbed, 
retrotransposons can become de-repressed, enabling them to gain alternative 
promoter activity (corner arrow) or ectopic enhancer function (asterisk) to stimulate 
transcription of nearby genes (wavy lines). Figure modified from Playfoot and Adams 
2016. 
 
1.9 Methylation Sensitive Genome Defence Genes  
 
Numerous genes involved in supressing retrotransposons in the germline have been 
shown to be regulated by DNA methylation (Crichton et al., 2013; Hackett et al., 
2012). Genes such as Mael, Mvh, Zfp42 and Dazl require the de novo methyltransferase 
Dnmt3b dependent promoter DNA methylation to silence their expression in the early 
embryo (Borgel et al., 2010). Additional methylation sensitive genes were identified 
from a study to detect gene expression changes, whose expression is primarily and 
causally regulated by promoter DNA methylation in multiple hypomethylatated 
somatic cell models (Hackett et al., 2012). Mouse embryonic fibroblasts (MEFs) were 
treated with the DNA methyltransferase inhibitor, 5-Aza and allowed to recover of 
expression. Genes identified in this screen were then intersected with genes expressed 
in MEFs lacking the maintenance methyltransferase, Dnmt1 (Hackett et al., 2012). 
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This largely identified methylation sensitive germline genes with roles in 
spermatogenesis and defence against retrotransposons in the germline such as Tex19.1, 
Mili, Miwi2, Dazl, Asz1 and Mov10L among others (Hackett et al., 2012). The 
promoters of these genes are not enriched for repressive histone modifications when 
repressed in somatic cells indicating why they are highly responsive to DNA 
methylation. 
In an in vivo developmental setting, the initial passive reduction in DNA methylation 
from E8.5 to E9.5 in PGCs correlates with increases in Tex19.1 and Mili expression, 
the early responders to this epigenetic reprogramming (figure 1.9)(Hackett et al., 
2012). Dazl, Asz1 and Mov10l are induced during the proposed active DNA 
demethylation in PGCs from E10.5 to E11.5 (figure 1.9)(Hackett et al., 2012). 
Expression of both groups of methylation sensitive genes is maintained through germ 
cell development and adult oocytes, whilst expression declines in pachytene 
spermatocytes and round spermatids (figure 1.9)(Crichton et al., 2014). This induction 
of expression of methylation sensitive genome defence genes during the epigenetic 
reprogramming of PGCs and into spermatocyte development provides an essential 
level of retrotransposon repression when the genome is especially vulnerable to 
potentially deleterious retrotransposition events (Crichton et al., 2014; Goodier et al., 
2016).  Surprisingly, the hypomethylated state of the placenta results in the 
hypomethylation and expression of only one of the methylation sensitive genome 




Figure 1.9 Germline genome defence gene expression throughout spermatogenesis 
and in the placenta and mutant phenotypes. The stages of spermatogenesis from 
PGCs to mature sperm are indicated along the top of the diagram. The placenta is at 
the farthest right and indicates that Tex19.1 is the only methylation sensitive genome 
defence gene expressed in this tissue. Expression patterns of the indicated germline 
genome defence genes are indicated by the blue bars, with red crosses indicating the 
stages at which mutant mice have defects in progression through spermatogenesis.  
Modified from Crichton et al., 2014. 
  
Experimental removal of each of these defence genes in mice results in de-repression 
of particular retrotransposons in germ cells and defects in progression through meiosis 
leading to sterility, alongside placental defects in Tex19.1-/- animals. Tex19.1-/- 
pachytene spermatocytes have increased MMERVK10C RNA, whereas Mael, Mili, 
Miwi, Mov10l and Asz1 individual knockout mice have increases in LINE-1 expression 
and in some cases, IAP (Carmell et al., 2007; De Fazio et al., 2011; Ma et al., 2009; 
Ollinger et al., 2008; Soper et al., 2008; Zheng et al., 2010). The latter genes are all 
core components of the PIWI-piRNA mechanism which direct DNA methylation to 
retrotransposon loci for silencing in spermatocytes. MILI and MIWI physically 
interact with PIWI-interacting RNAs (piRNAs) from retrotransposons and piRNA 
clusters and facilitate retrotransposon silencing predominantly in the germline via 
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ping-pong amplification of piRNA. An antisense piRNA directs the cleavage of a 
complimentary mRNA from a piRNA cluster or retrotransposon sequence, generating 
sense piRNAs to further increase the amount of cleavage of complimentary mRNA. 
This then directs de novo DNA methylation to target loci for repression (figure 
1.10)(Crichton et al., 2014). Male mice null for any one of these genes largely results 
in arrest at pachytene of meiosis I. Some mutant animals also exhibit defects earlier, 
in spermatogonial stem cell divisions (Crichton et al., 2014). Mutations in PIWI-
piRNA genes result in defects largely restricted to spermatogenesis, with little effect 
on post-pachytene progression of oocytes (Crichton et al., 2014).  
Together, these methylation sensitive germline defence genes are critical for germ cell 
development and the repression of retrotransposons at a time when active 






Figure 1.10: The piRNA ping-pong amplification loop. The primary processing 
pathway generates primary piRNAs from the long transposon transcript by nuclease 
cleavage in either sense or antisense directions (red and blue lines). piRNAs associate 
with PIWI proteins (green ovals) such as MILI and MIWI and guide PIWI proteins to 
complementary sequences on antisense transcripts from the same retrotransposon 
or piRNA cluster and use their slicer activity to cleave the transcript to generate new 











1.10 Spermatogenesis  
 
1.9.1 The spermatogenic cycle 
 
PGCs are one of the main globally identified hypomethylated cell types which 
eventually give rise to all subsequent germ cells throughout spermatogenesis. In this 
section I will describe the development of spermatocytes arising from these 
hypomethylated PGCs. Spermatogenic lineage development occurs in a complex but 
orderly, synchronised manner within seminiferous tubules and is referred to as the 
spermatogenic cycle (Clermont, 1963). Germ cells at all stages of development are 
closely supported by somatic sertoli cells, the ‘nurse’ cells of spermatogenesis (figure 
1.11B). These have both structural and hormonal secretory roles to facilitate germ cell 
development (Griswold, 1998).  In mouse there are 12 stages of spermatogenesis, 
characterised by a combination of spermatogonia, spermatocytes and spermatids in 
different stages of their respective development or cell divisions (figure 1.11B). The 
duration of each stage is precisely timed with a complete spermatogenic cycle lasting 
around 35 days in mice and 75 days in humans (Clermont 1963; Oakberg 1956).  
Spermatogenic lineage development occurs when PGCs undergo sex specification at 
E11.5-E12.5 in response to signals that depend on Sertoli cells in the developing male 
gonad (Adams and McLaren, 2002). Sertoli cells are induced to differentiate along a 
male pathway by expression of the Y-encoded Sry gene in gonadal somatic cells 
(Palmer and Burgoyne, 1991) and by around E12.5 the male-committed 
prospermatogonia are surrounded by clusters of Sertoli cells which have organised into 
cord structures which later differentiate into seminiferous tubules. After a period of 
quiescence, the prospermatogonia resume proliferation a few days after birth and give 
rise to both mitotic spermatogonia and spermatogonial stem cells (SSCs). The process 
of self-renewal of SSCs provide the basis for all subsequent spermatogonia and germ 
cells necessary for spermatogenesis throughout the majority of a males lifespan (De 




1.9.2 Spermatogonial differentiation 
 
Individual diploid SSCs called Asingle (As) cells undergo mitotic division to form either 
two new diploid As spermatogonia or two clones called Apr connected by an 
intercellular cytoplasmic bridge to facilitate exchange of gene products allowing for 
synchronised development (figure 1.11A)(Kato et al., 2004; Weber and Russell, 1987). 
Each Apr spermatogonia will undergo mitosis to form spermatogonial clones of 
increasing length from 4, 8 and 16 Aaligned cells connected by these bridges (figure 
1.11A). Each of these cells are negative for the marker of differentiation of 
spermatogonia C-Kit and positive for undifferentiated spermatogonia specific genes 
such as Plzf and are therefore considered undifferentiated (Costoya et al., 2004; 
Nakagawa et al., 2006). C-kit begins to be expressed when Aaligned spermatogonia 
undergo cellular transformation to A1 differentiated spermatogonia (figure 
1.11A)(Schrans-Stassen et al., 2001). This is followed by rounds of mitosis and the 
formation of A2, A3 and A4 spermatogonia (figure 1.11A)(De Rooij and Russell, 2000). 
A4 spermatogonia number around 128 cells originating from the initial As 
undifferentiated spermatogonia and give rise to more mature intermediate 
spermatogonia (In) which further divide to form around 500 type B spermatogonia 
ready to undergo a final mitotic division, before entering meiotic prophase as pre-





Figure 1.11 Spermatogenesis in murine testes. (A) As represents spermatogonial 
stem cells which give rise to all subsequent germ cells via Apr spermatogonia which 
mitotically divide to give rise to Aal(4) spermatogonia followed by Aal(8) and Aal(16) 
connected via cytoplasmic bridges. More mitotic division occur finally giving rise to 
type B spermatogonia. These enter meiosis and give rise to haploid spermatids which 
will undergo spermiogenesis to produce mature spermatozoa. Figure from Oatley 
and Brinster 2008. (B) Schematic cross section through a seminiferous tubule in the 
murine testis. Spermatogenesis occurs in a synchronous wave from the basal 
membrane to the lumen of the tubule supported by Sertoli cells. Type A 
spermatogonia are adjacent to the basal membrane. Cells undergoing the first round 
of meiosis are called primary spermatocytes whereas during meiosis II they are 
known as secondary spermatocytes. This final reductional division results in haploid 







1.9.3 Meiosis and spermatogenesis 
 
Meiosis is a specialised cell division involving a single round of DNA replication 
followed by two rounds of chromosome segregation. The first reductional division 
involves an extended prophase, whereby various meiosis specific events occur to 
ensure exchange of genetic material can occur between homologous chromosomes 
from the mother and father (Crichton et al., 2014). The initiation of meiosis begins 
with pre-leptotene where DNA replication occurs. During leptotene, individual 
chromosomes condense and become visible. Zygotene follows, with synapsis of 
homologous chomosomes and the formation of a proteinaceous scaffold between 
homologous pairs named the synapotenamal complex. At pachytene this synapsis is 
complete, with homologues joined by the synaptonemal complex (Crichton et al., 
2014). The synaptonemal complex is then lost at diplotene with homologous 
chromosomes being held by physical crossovers (chiasmata). Diakinesis sees 
homologous chromosomes shorten and condense whilst preparing to align at the 
metaphase plate (Ollinger et al., 2010). Cells then undergo metaphase I, anaphase I 
and telophase I to produce two diploid daughter nuclei. A further round of meiosis 
called meiosis II results in four haploid nuclei which then undergo spermiogenesis and 
extensive chromatin remodelling to form elongated spermatozoa that are released into 




1.10.1 Placental development 
 
The cell divisions occurring shortly after fertilisation are arguably the most 
fundamental decisions in development. Fertilised gametes form a totipotent zygote 
which is able to differentiate into all of the tissues necessary for development of the 
fetus (Li et al., 2013). The zygote undergoes a series of cleavage divisions leading to 
the early preimplantation blastocyst and the first definitive differentiation event occurs 
around the 32 cell stage at E3 (Li et al., 2013). This leads to the establishment of the 
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hypomethylated, extraembryonic trophoblast cells, the specialised precursor to part of 
the placenta (figure 1.12). The remaining inner cells of the blastocyst eventually form 
the epiblast, which gives rise to the embryo proper, extraembryonic mesoderm, and 
the primitive endoderm, which contributes to the yolk sac (figure 1.12)(Cockburn and 
Rossant, 2010; Copp, 1978). Evidently, establishing a physical connection between 
embryo and the mother is one of the first priorities in development and maintenance 
of a healthy placenta is essential throughout gestation.   
The outer trophectoderm monolayer of the blastocyst gives rise to many specialised 
hypomethylated trophoblast structures necessary for the complex molecular 
interactions occurring between the embryo and the uterus during implantation 
(Cockburn and Rossant, 2010). At E4.5 the blastocyst hatches from the surrounding 
protective zona pellucida matrix to implant into the uterine wall (Cockburn and 
Rossant 2010). Endoreduplication of outer trophoblast cells, distal from the ICM, form 
highly polyploid primary trophoblast giant cells (TGCs) which facilitate a process of 
active invasion into the maternal uterine stroma necessary for implantation (figure 
1.12)(Ain et al., 2003; Hu and Cross, 2010). These cells are the first to achieve terminal 
differentiation during rodent embryogenesis and are the endocrine cells of the placenta 
responsible for hormone production. This is necessary to regulate the maternal immune 
and endocrine systems, whilst promoting maternal blood flow to the implantation site 
(Hu and Cross, 2010; Simmons et al., 2007). The polar trophectoderm cells nearby the 
ICM continue to proliferate forming both the extraembryonic ectoderm and the 
implanted ectoplacental cone surrounded by secondary TGCs at E6 (figure 
1.12)(Rossant and Cross, 2001). The extraembryonic ectoderm then expands to form 
the chorion, a membrane which contacts with the allantois at the posterior end of the 
embryo at E8.5 to form the umbilical cord, a process called chorioallantoic fusion 
(Rossant and Cross, 2001). After chorioallantoic fusion feto-placental blood vessels 
develop inwards to the placenta from the allantois to form the fetal component of the 
torturously branched, complex vascular network of the placenta (figure 1.12). This 
area is called the labyrinth and is comprised of syncytial trophoblast cells called the 
syncytiotrophoblast, two layers of which line fetal blood vessels to facilitate feto-
maternal nutrient and gas exchange (Rossant and Cross 2001). Overall there are five 
TGC subtypes in the mature placenta, Blood vessels are in apposition to sinusoidal-
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TGCs formed around E10.5 (Simmons et al., 2007). In mid gestation maternal blood 
canal associated TGCs are found in the canal bringing maternal blood to the base of 
the labyrinth and spiral artery TGCs are associated with remodelling uterine spiral 
arteries to regulate blood flow to the placenta (Hu and Cross 2010). Additionally, 
channel-TGCs lining the channels that drain the deoxygenated blood from the 
labyrinth have been recently identified (Rai and Cross, 2014). Following implantation, 
parietal TGCs border the ectoplacental cone and invade the uterus via remodelling the 
uterine extracellular matrix and phagocytosis of uterine cells (Cross et al., 1994). The 
different TGC subtypes are defined based on localisation, cell morphologies and 
differential gene expression analyses (Simmons et al., 2007). In the mid-gestation 
placenta, secondary P-TGCs border the decidua and the junctional zone which is 
comprised of two distinct trophoblast populations; spongiotrophoblast cells and 
glycogen trophoblast cells (GlyT)(figure 1.12).  
As with TGCs, the spongiotrophoblast is responsible for the secretion of hormones, 
angiogenic promoting factors, vascular endothelial growth factor and tissue 
remodelling factors (Rossant and Cross, 2001). GlyT cells harbour stores of glycogen 
thought to provide energy for placental processes (Coan et al., 2006). 
Spongiotrophoblast and glyT cells have distinct behaviours with spongiotrophoblast 
cells being nonmigratory and having a modest four-fold increase in number from 
E12.5 to E16.5 (Coan et al., 2006). Conversely, glyT cells with extensive glycogen 
stores are barely detectable at E12.5 but have an 80 fold increase in number to E14.5 
and invade through the P-TGC barrier into the maternal decidua (Coan et al., 2006). 
From E16.5 to E18.5 there is a 50% drop in glyT numbers across the whole placenta 
which is thought to contribute to the decreased junctional zone volume at E18.5, 
possibly as a result of continued use of glycogen stores, alongside the migration of 
glyT cells into the maternal decidua (Coan et al., 2004, 2006). This is combined with 
continued expansion of the labyrinth (Coan et al., 2004, 2006). Maternal blood passes 
through the spongiotrophoblast via arterial sinuses towards the labyrinth where it 





Figure 1.12: Murine placental development from the blastocyst to the placenta. (A) 
Diagram demonstrating the development of the murine placenta from the pre-
implantation blastocyst to the ectoplacental cone and the placenta with all three 
established layers. Blue shading denotes the hypomethylated, trophoblast derived 
tissues whereas orange indicates normally methylated embryonic derived tissue 
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(Figure modified from Rossant and Cross 2001). (B) Histological haematoxylin and 
eosin (H+E) stained PFA sections of E14.5 placenta in I and semi-thin plastic, toluidine 
blue stained insets (J-L). The dashed line represents the boundary between the 
maternal decidua and the junctional zone. Dec, decidua; GlyT, glycogen trophoblast; 
SpT, spongiotrophoblast; Lab, labyrinth; TGC, trophoblast giant cell; m, maternal 
blood sinusoid space; f, fetal capillary space. (Figure taken from Simmons and Cross, 
2005)   
  
1.10.2 Differences between mouse and human placentas 
 
It is important to note the similarities and differences between the mouse and human 
placenta when extrapolating findings from mice to humans. Both species have a 
haemochorial placenta, whereby the trophoblast layer is in direct contact with maternal 
blood (Schmidt et al., 2015). This is distinct from other species, such as dogs which 
possess endotheliochorial placentas, where the maternal blood vessels are enclosed in 
fetal epithelium, and pigs, which have epitheliochorial placentas where the chorion is 
next to the uterine lining with no uterine invasion (Schmidt et al., 2015). Both mouse 
and human placentas develop three distinct regions called the labyrinth, junctional 
zone and maternal decidua in mice which correlate to the fetal placenta, basal plate 
and maternal decidua in humans. The decidua of both species is largely analogous, 
based on their spatial location and the extent of trophoblast invasion into the maternal 
uterus (Georgiades et al., 2002). In contrast, the structure of the labyrinth and fetal 
placenta are relatively distinct between mice and humans. The chorionic projections 
within the murine labyrinth form a maze like, interconnected network, whereas the 
human fetal placenta has villous projections from the chorion, with extensive 
branching. In both, syncytiotrophoblasts are bathed in maternal and fetal blood 
allowing nutrient, gas and waste exchange, however this is performed by a monolayer 
of multinuclear syncytiotrophoblast in humans and two layers of multinuclear 
syncytiotrophoblast and a mononuclear layer in mice (Georgiades et al., 2002). In both 
species the junctional zone and basal plate is devoid of fetal blood and is thought to 
have an endocrine function, however the precise roles for this layer are unclear. Each 
is comprised of two types of cytotrophoblasts, one resembling glycogen cells and the 
other, endovascular trophoblasts, proposed to be analogous to mouse 
spongiotrophoblasts (Georgiades et al., 2002). The arrangement of this layer is distinct 
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from murine placenta as is loosely arranged proximal to column cytotrophoblasts 
associated with the villus. Despite the structural and cell composition differences 
between mice and human placentas, studies of the analogous roles of the labyrinth and 
related cell types throughout the placenta have led to many discoveries applicable to 
both normal and abnormal human placentation, leading to an understanding of the 
molecular basis of disorders such as intrauterine growth restriction (Rossant and Cross 
2001). 
 
1.10.3 Defects in placentation  
 
Targeted genetic mutations in the mouse genome have provided insights into the role 
of different genes, structures, trophoblast cell types and essential signalling processes 
throughout development of the placenta. Interestingly, imprinted genes appear to play 
an important role in controlling placental and fetal growth (Tunster et al., 2013). 
Imprinted genes can be described as genes exhibiting monoallelic expression in a 
parent of origin dependent manner, with silencing of one parental allele brought about 
by DNA methylation (Reik and Walter, 2001). The evolution of genomic imprinting 
has been proposed to be due to “parental conflict”, whereby asymmetry between 
parental contributions to the fetus during development is regulated by imprinted genes 
(Haig and Graham, 1991). This theory arose due to studies of the imprinted gene Igf2 
and its receptor Igr2r. Igr2 is expressed from the paternal allele and imprinted on the 
maternal allele, with the converse being true for Igf2r (Barlow et al., 1991; DeChiara 
et al., 1991). Offspring receiving a disrupted Igf2 allele from their father are smaller 
than if it is inherited from the mother, indicating the paternally expressed Igf2 is 
responsible for enhanced growth of the embryo (DeChiara et al., 1991). By promoting 
embryonic growth the fathers genes gain fitness through the greater success of larger 
offspring, at the expense of the mother (Haig, 2000). Deletion of numerous imprinted 
genes can lead to a variety of placental defects in different trophoblast cell subtypes or 
placental layers, resulting in intrauterine growth restriction (IUGR) of mouse embryos 
or embryonic lethality (Tunster et al., 2016). 
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IUGR is defined as the failure of the fetus to reach its genetic growth potential and 
generally applies to babies born in the lowest 10th percentile of birthweights (Monk 
and Moore, 2004). IUGR in humans is associated with neonatal problems such as 
perinatal asphyxia, hypoglycaemia and premature death whereas problems into 
adulthood extend to growth retardation, neurodevelopmental defects and enhanced 
susceptibility to adult onset disease such as type II diabetes, ischemic heart disease and 
neurological disorders such as depression (Sharma et al., 2016). Mice have provided a 
good system to model human IUGR, whereby aberrant expression of evolutionary 
conserved genes in both species contributes to growth restriction. For example, 
deletion of the paternally expressed Igf2 gene throughout placenta and embryo leads 
to reduction of the labyrinth layer and glycogen cell number, however deletion of the 
placental specific p0 Igf2 promoter also led to a smaller placenta with compensatory 
increases in maternal amino acid transport and late onset IUGR (Constância et al., 
2002; Sandovici et al., 2012).  
Furthermore, when the maternally expressed, paternally imprinted gene, Phlda2 is 
experimentally overexpressed in mice, it drives a reduction of the spongiotrophoblast 
compartment, with reduced amounts of placental glycogen and causes IUGR (Tunster 
et al., 2014, 2016). A potential role for IUGR in humans was suggested for the 
conserved human protein, PHLDA2. PHLDA2 was found to be significantly elevated 
in expression in IUGR placentas with no alteration in DNA methylation at the locus 
(McMinn et al., 2006). Consequently, different studies in humans have found differing 
associations with PHLDA2 expression and IUGR, such as overt differences in fetal 
weight, more subtle differences in placental weight, to milder associations with 
reduced fetal femur growth velocity and reduced infant bone mineral content 
(Apostolidou et al., 2007; Lewis et al., 2012).  Regardless, the experiments on mice 
indicate the important role of imprinted genes in the regulation of placental endocrine 
function, and embryonic growth in mammals. 
Interestingly, loss of imprinted genes can also result in an overgrowth of the placenta 
as observed for loss of function of Phlda2, which results in increased placental 
glycogen and increased fetal weight (Tunster et al., 2016). Additionally, one paternally 
imprinted gene encoding the cyclin dependent kinase inhibitor Cdkn1c negatively 
regulates cell proliferation (Takahashi and Nakayama, 2000). This was shown by 
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genetic knockout of Cdkn1c in C57BL/6 mice which resulted in a doubling of the 
spongiotrophoblast and labyrinth cell numbers, despite no alterations in TGC or 
glycogen cell number at E17.5 (Takahashi et al., 2000). Most Cdkn1c embryos died 
after birth, however those that survived were severely growth restricted (Takahashi 
and Nakayama, 2000). Interestingly, more recent analysis of Cdkn1c-/- placentas has 
been performed on 129S2/SvHsd background and again indicated large overgrowth of 
the placenta, accompanied by severe disruption of the labyrinth (Tunster et al., 2011). 
Sinusoidal trophoblast giant cell (S-TGC) number was reduced, along with impaired 
vascularisation and collagen deposits in the labyrinth and a reduction in 
spongiotrophoblast lineage (Tunster et al., 2011). Cdkn1c pups were born a similar 
weight to control animals despite having a growth advantage during late gestation 
which is not maintained (Tunster et al., 2011). This highlights the diverse defects 
which can lead to embryonic growth perturbations in mice and indicates strain specific 
defects arising in different genetic backgrounds. 
Another example of placental overgrowth is observed upon disruption of the X-
imprinted, homeobox transcription factor Esx1 (Li and Behringer, 1998). When the 
Esx1 null mutation is inherited by heterozygous females from their mother, this leads 
to a hypertrophic labyrinth compartment with a reduced vascular density (Li and 
Behringer, 1998). The overgrowth of labyrinth may be to compensate for the reduced 
blood flow and nutrient exchange due to the poor vascularisation of the labyrinth, 
however hemizygous female pups inheriting the maternal null allele are still born with 
IUGR (Li and Behringer, 1998).   
The severity of placental defects upon disruptions in imprinted genes can have 
profound effects on embryonic development. For example, the paternally imprinted 
Mash2 (Ascl2) encodes a basic-helix-loop-helix transcription factor and null embryos 
die at E10.5 due to absence of the spongiotrophoblast layer, with little effect on 
secondary TGCs (Guillemot et al., 1994; Tanaka et al., 1997). Aggregation of Mash2-
/- morulas with wild type tetraploid embryos, which contribute solely to 
extraembryonic tissues (Guillemot et al., 1994), results in viable embryos suggesting 
that the essential function of Mash2 is in the placenta. Further studies on the chimeric 
mice indicated that Mash2-/- cells are unable to contribute to the spongiotrophoblast 
layer, however are abundant in the labyrinth of chimeric placenta (Tanaka et al., 1997). 
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This indicates a cell autonomous role of Mash2 in the spongiotrophoblast layer in 
development of the placenta and embryo.   
It is important to note that placental defects not only arise from disruptions of 
imprinted gene expression but also non-imprinted genes, many of which exhibit roles 
in different cell lineages or compartments of the placenta with differing consequences 
for embryonic development. Hand1 is a non-imprinted basic-helix-loop-helix 
transcription factor and mice null for Hand1 arrest at E7.5 of gestation due to defects 
in trophoblast giant cell differentiation (Riley et al., 1998). A similar tetraploid 
aggregation assay rescued this mutant, indicating an initial placental defect until E10.5 
when embryos died with defects in ventricular myocardial differentiation (Riley et al., 
1998). 
Labyrinth development is another key process in placental development which when 
disrupted in a variety of mouse mutants of non-imprinted genes results in embryonic 
lethality, such as in mice null for Gcm1 and Gjb2. Gcm1 is a transcription factor 
expressed in the chorionic plate from E8.0 (Anson-Cartwright et al., 2000). 
Chorioallantoic branching fails to initiate in Gcm1-/- mice leading to absence of the 
labyrinth along with failure to form syncytiotrophoblast cells (Anson-Cartwright et al., 
2000). Together, experiments on mice indicate the important role of imprinted and 
non-imprinted genes in the regulation of placental development, function and 
embryonic growth in mammals. 
 
1.12 Tex19.1-/- phenotypes 
 
TEX19.1 plays highly important roles in the development of both male germ cells and 
the placenta with de-repression of retrotransposons present in both Tex19.1-/- contexts. 
In the male gonad Tex19.1 is expressed in the cytoplasm of spermatogonia and early 
spermatocytes, but not in late pachytene spermatocytes (Ollinger et al., 2008). Tex19.1 
is essential for spermatogenesis as Tex19.1-/- spermatocytes initiate meiotic 
recombination and homologous chromosomes assemble the axial elements of the 
synaptonemal complex but fail to fully synapse in around half of mutant nuclei 
(Ollinger et al., 2008). Of those Tex19.1-/- spermatocytes progressing through meiosis, 
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two thirds have univalent chromosomes at metaphase I, instead of pairing as bivalents 
(Ollinger et al., 2008). The spermatocyte asynapsis phenotype is similar with other 
germline genome defence genes such as Miwi2, Mili and Mov10L which correlates 
with de-repression of retrotransposon transcripts. Tex19.1-/- spermatocytes show 
increases of RNA from the MMERVK10C LTR retrotransposon as indicated by in situ 
hybridisation (Ollinger et al., 2008). The TEX19.1 mediated MMERVK10C repression 
is likely distinct from piRNA mediated mechanisms (figure 1.10) as LINE-1 and IAP 
element RNAs do not accumulate in Tex19.1-/- testes like in PIWI-piRNA mutants, and 
no differences in DNA methylation were detected at MMERVK10C loci in the absence 
of Tex19.1 (Ollinger et al., 2008). 
Recent evidence from our lab indicates that Tex19.1 is operating to repress 
retrotransposons at multiple levels in their life cycle. Tex19.1-/- spermatocytes have 
increases in L1Orf1p protein levels determined by western blot and 
immunofluorescence but no change in the amount of LINE-1 RNA (MacLennan et al., 
submitted). This suggests TEX19.1 is post-translationally repressing LINE-1 to 
prevent its retrotransposition in the germline. In humans, TEX19 also regulates LINE-
1 protein abundance at the post-translational level by stimulating its ubiquitination and 
subsequent turnover (MacLennan et al., submitted). This results in reduced 
retrotransposition of both mouse and human LINE-1 constructs (MacLennan et al., 
submitted). This post translational regulation of LINE-1 protein is in contrast to the 
transcriptional or post-transcriptional mechanisms leading to increases in RNA from 
MMERVK10C (Ollinger et al., 2008). The reasons for this specificity in repressing 
different retrotransposons at discrete time points in their lifecycle remains unclear, 
however it may be a consequence of the various interacting partners of TEX19.1 in the 
germline, such as the interaction with the E3 ubiquitin ligase, UBR2 (Yang et al., 
2010).  
As Tex19.1 expression has been shown to be sensitive to DNA methylation (Hackett 
et al., 2012), its expression was investigated in the naturally hypomethylated tissue of 
the placenta (Reichmann et al., 2013). Of all the methylation sensitive germline 
genome defence genes identified in the previously discussed epigenetic screen (section 
1.9)(Hackett et al., 2012), only Tex19.1 was methylation sensitive and expressed in the 
placenta (Reichmann et al., 2013). TEX19.1 protein was restricted to the 
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hypomethylated trophectoderm derived cells detectable in the spongiotrophoblast 
layer and S-TGCs of the labyrinth. Surprisingly, TEX19.1 appeared to be partly 
nuclear in these cells via immunohistochemistry unlike the cytoplasmic localisation 
detected in spermatocytes (Ollinger et al., 2008; Reichmann et al., 2013). In the 
absence of Tex19.1, E18.5 placentas weigh significantly less than controls and have 
thinner junctional zones due to loss of trophectoderm derived spongiotrophoblast and 
glycogen trophoblast cells. S-TGCs of the labyrinth were also reduced in number and 
Tex19.1-/- pups exhibited IUGR. When the transcriptome of E18.5 control and Tex19.1-
/- placentas was assessed by microarray and analysed for retrotransposon RNA, 
increased abundance of LINE-1 and VL30 RNA was detected, which was not detected 
for MMERVK10C (Reichmann et al., 2013). Therefore, Tex19.1 not only facilitates 
repression at different stages in the retrotransposon life cycle in spermatogenesis, but 
also exhibits transcriptional or post-transcriptional repression of different 
retrotransposons in a tissue specific manner (Reichmann et al., 2013). It also remains 
unclear if chromatin marks are perturbed at these de-repressed retrotransposon loci and 
if Tex19.1 is repressing MMERVK10C at a transcriptional or post-transcriptional 
level. Additionally, placental phenotypes have only been investigated at late stages of 
gestation at E18.5 and the role of interacting partners in the Tex19.1-/- defects in 
spermatogenesis have never been investigated. Therefore, the investigation of the 
mechanism of TEX19.1 mediated retrotransposon repression, the molecular etiology 
of the placental developmental defects and the possible contribution of TEX19.1 
interacting partners in the defects in spermatogenesis of Tex19.1-/- mice are 









1.13 Thesis Objectives 
 
The overall aims of this thesis are as follows: 
1) To gain a greater insight into the possible mechanisms of Tex19.1 mediated 
retrotransposon repression 
2) To further characterise the phenotype of the Tex19.1-/- placenta, addressing the 
potential contribution of retrotransposon de-repression towards developmental 
defects. 
3) To determine the contribution of the TEX19.1 interacting partners, UBR5 and 































2.1 Mammalian Cell Culture 
 
2.1.1 Routine cell culture and harvesting 
 
To retrieve cells stored in liquid nitrogen, cells were quickly thawed at 37oC in a water 
bath, added to 9ml of pre-warmed media and pelleted by centrifugation to remove 
DMSO before seeding into T25 or T75 culture flasks. For ES cell culture flasks were 
pre-coated with 0.2% gelatin (Sigma) in PBS which was aspirated prior to the addition 
of media and cells. Cell culture techniques have been described by (Hogan et al., 
1994).  
Feeder independent E14 ES cells (Tex19.1+/+, Tex19.1+/-, Tex19.1-/-) were cultured at 
37oC 5% CO2 in pre-gelatinised flasks in E14 media (GMEM, 10% fetal calf serum 
(FCS), 1% L-glutamine (L-glut), 1% penicillin/streptomycin (P/S),1% sodium 
pyruvate, 1% non-essential amino acids (NEAA), 0.1% β-mercaptoethanol and 1ml 
LIF-conditioned media per 500ml GMEM).  
Feeder dependent J1 ES cells (Dnmt1-/-Dnmt3a-/-Dnmt3b-/- ES, J1 ES) were cultured 
on a fibroblast feeder layer in ES cell media (DMEM, 15% FCS, 1% L-glut, 1% 
P/S,1% sodium pyruvate, 1% NEAA, 0.1% β-mercaptoethanol and 1ml LIF per 500ml 
DMEM. 
Hek293T cells, mouse embryonic fibroblasts (MEFs) (hypomorphic Dnmt1n/n P53-/- 
MEFs and Dnmt+/+ P53 MEFs) and primary embryonic fibroblast cells (for feeders) 
were cultured in STO media (DMEM, 10% FCS, 10% P/S, 10% L-glut). Primary 
embryonic fibroblast cells for use as feeders for J1 ES cells were cultured until 80% 
confluent and treated with 10ug/ml (final concentration) mitomycin C for 2.5 hours at 
37oC. Cells were then washed 2x with PBS, trypsinised and seeded at 2x105 cells/ml 
and incubated at 37oC for at least 1 hour before use as feeders for J1 ES culture. 
All cell lines were passaged by 1x PBS wash then trypsinised for 5 minutes at 37oC. 
To inactivate the trypsin 10 volumes of media containing FCS were added to the cells 
which were then spun down at 300 RCF for 5 minutes. Cells were then resuspended in 
fresh pre-warmed media and reseeded at 2x105 cells/ml or frozen down for stocks. 
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Cells were frozen at 4x106 cells/ml by adding 500µl of freezing media (20% DMSO, 
20% FCS, 60% culture media) to 500µl cell suspension at 8x106 cells/ml and placed 
at -70oC in a polystyrene box for at least 24 hours before storage in liquid nitrogen at 
-150oC. 
Tex19.1-/- ES cells were generated previously by sequential targeting of E14 ES cells 
by Abigail Mann. The Tex19.1 targeting vector was generated by inserting an IRES-
GFP cassette into position chr11:121147942 (mm10 genome assembly) in the 3' 
untranslated region of Tex19.1 in a bacterial artificial chromosome (BAC). A 13 kb 
region (chr11:121143511-121156687) containing Tex19.1 was gap-repaired into 
PL253 vector, then a LoxP site was recombined upstream of the coding exon at 
position chr11:121146376. An Frt-flanked neomycin-resistance cassette and second 
LoxP site from PL451 was recombined downstream of the coding exon at 
chr11:121148877. Electroporation with the resulting targeting vector into E14 ES cells 
was followed by selection for neomycin resistance, and correct integrants identified 
by PCR. The Tex19.1 coding exon in the targeted allele was removed by transfection 
with a Cre-expressing plasmid, and the resulting cells electroporated with the targeting 
vector again, selected for neomycin resistance, and correct integrants on the second 
Tex19.1 allele identified by PCR. ES cells were then transiently transfected with a Flp-
expressing plasmid to generate a conditional Tex19.1fl allele. This was subsequently 
converted to a Tex19.1- allele by transient transfection with a Cre-expressing plasmid 
to remove the Tex19.1 coding exon (MacLennan et al., 2017 Submitted).  
 
2.1.2 2i culture 
 
Where feeder independent Tex19.1+/- ES and Tex19.1-/- ES cells were cultured in 2i 
conditions, 500ml serum free ES medium (SFES) (45% Neurobasal media, 45% 
DMEM/F12, 0.5% N2-supplement, 1% B27+RA, 7.5% BSA, 1% P/S) was aliquoted 
into 10x 50ml falcons and stored at 4oC protected from light. When required, complete 
2i media was made (50ml SFES, 1µM PD0325901, 3µM CHIR99021, 1% L-glut, 
0.63µl monothioglycerol (11.9M), 50µl LIF). 50µl aliquots of 1mM PD0325901 
(Stemgent), 3mM CHIR99021 (Stemgent) and LIF were stored at -20oC and added 
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daily. Where required Vitamin C (Sigma) was added daily at a concentration of 
100µg/ml daily from frozen aliquots. 
When serum/LIF cultured ES cells were 70-80% confluent E14 media was removed, 
the cells washed 1x with PBS and compete 2i media added. The following day, cells 
were washed 1x with PBS and trypsinised for 5 minutes until single cell suspension 
achieved. Trypsin was inactivated with addition of DMEM + 10% FCS, centrifuged 
and washed with DMEM only to remove residual trypsin and FCS. Cells were reseeded 
on pre-gelatinised flasks at 4x105 cells/ml in fresh complete 2i media and split and 
until required.  
   
2.1.3 Cell transfection 
 
Hek293T cells were grown to 50% confluency in a 6 well plate. 1µg plasmid DNA 
was added to 50µl Optimem (Invitrogen). 3µl lipofectamine (Invitrogen) was added to 
50µl optimem and the aliquots combined after 5 minutes with the 100µl added to the 
cells and incubated overnight at 37oC. 
2.1.4 Embryoid body formation 
 
Differentiation of ES cells into embryoid bodies (EBs) was performed by hanging drop 
culture. 50 drops of E14 media without LIF were spotted onto a bacterial petri dish lid 
with each 20µl drop containing 600 ES cells. 10mls of PBS was placed in the tissue 
culture dish, the lid inverted and hanging drops cultured at 37oC for 2 days. EBs were 
then washed from the lid with 10ml E14 media without LIF and cultured in suspension 
in new bacterial petri dishes, changing half of the media every two days. At day 7 the 
EBs were transferred to a gelatinised 10cm tissue culture dish to allow for outgrowths 
and further differentiation to occur. EBs were harvested for RNA at 0, 3, 6, 9 and 12 
days of culture and qRT-PCR performed. 
    




For sperm counts the epididymis from each testes was dissected and homogenised in 
1ml 1% sodium citrate to immobilise sperm and allowed to settle for 5 minutes to 
allow debris to settle. Sperm in the supernatant was then counted with a 
haemocytometer.   
  
2.2 RNA extraction and manipulation 
 
2.2.1 RNA isolation and purification 
 
RNA was isolated from cultured cells and mouse tissues using TRIzol (Invitrogen) 
following the manufacturer instructions. Cultured cells were washed with PBS and 
lysed in 1ml TRIzol. After pipetting to homogenise cells the samples were either stored 
at -70oC until required or incubated for 5 minutes at room temperature. 200µl of 
chloroform was added and shaken by hand for 15 seconds then incubated for 3 minutes 
at room temperature and centrifuged at full speed at 4oC. The aqueous phase was 
collected, mixed with 500µl of 100% isopropanol, incubated for 10 minutes at room 
temperature and centrifuged full speed for 10 minutes at 4oC to isolate the RNA pellet. 
If low numbers of cells were used, 1µl of glycoblue was added to aid RNA 
precipitation and identification. Pellets were washed with 1ml 75% ethanol, vortexed 
and centrifuged full speed at 4oC for 5 minutes. RNA pellets were air dried for 10 
minutes, resuspended in 30µl of RNAse-free milliQ dH2O, incubated in a heat block 
at 55oC for 10 minutes and concentration and purity measured by nanodrop 
(thermofisher). RNA was either diluted to necessary working concentrations with 
dH2O or stored at -70
oC.   
To digest and genomic DNA contamination, RNA was treated with either RQ1 DNAse 
(Promega) or Turbo DNA-free kit (ambion) as per manufacturer instructions and 
purified by an RNeasy mini kit (QIAgen).  
 




20µl of DNAse treated whole placental RNA at a concentration of 100ng/µl was sent 
to Edinburgh Genomics for RNAseq library preparation and sequencing. RNA had 
A260/280 of >1.9 as determined by Nanodrop (Thermo) and RNA integrity scores >7 
determined by BioAnalyser (Agilent). TruSeq stranded mRNA-seq libraries (Illumina) 
were made by Edinburgh Genomics and sequenced on 1 lane of a HiSeq V4 high 
output (Illumina) yielding around 30 million 125 base paired-end reads per sample. 
The same quality control criteria and concentrations of Tex19.1+/- and Tex19.1-/-  ES 
cell RNA were sent to Edinburgh Genomics for hybridisation on an Affymetrix Mouse 
Gene 2.1 array.  
 
2.2.3 cDNA synthesis 
 
1µg DNAse treated RNA was used to produce cDNA for qPCR by the Superscript III 
first strand synthesis system (Invitrogen) according to the manufacturer’s protocol. 
Random primers were used to maximise transcript coverage and to ensure no genomic 
DNA contamination was present, reactions were performed with and without reverse 
transcriptase. cDNA reactions were prepared in 8 strip PCR tubes with 1µg of DNAse 
treated RNA, 0.2µl 250ng random primers, 1µl 10mM dNTP mix and dH2O to 13µl. 
This was incubated in a PCR machine at 65oC for 5 minutes then 2 minutes on ice. 4µl 
5x first strand synthesis buffer 1µl 0.1M DTT, 1µM RNAse Inhibitor, 1µl Superscript 
III Reverse Transcriptase were added to reactions and incubated in a DNA Engine 
Tetrad PCR machine at 25oC for 5 minutes, 50oC for 60 minutes and 70oC for 15 
minutes and cDNA was stored at -20oC.  
      
2.2.4 qRT-PCR 
 
To quantify levels of RNA transcripts, cDNA was used as a template for quantitative 
reverse transcription PCR (qRT-PCR). cDNA was diluted 1:50 in dH2O and the 
standard curve method of quantification was used. 1:10, 1:50, 1:100 and 1:1000 fold 
serial dilutions of cDNA were incorporated on each plate to determine primer 
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efficiency and relative quantity of RNA transcript. Primers from the manufacturer 
(Sigma) were diluted to 100µM stocks and stored at -20oC. Primer sequences are given 
in table 2.1. These stocks were diluted to 1µM working concentration as required. For 
each 20µl reaction (96 well plate), 2.5µl of both forward and reverse primers, 10µl 
SYBR select master mix (LifeTech) and 5µl cDNA (1:50) was added per well. No 
template control reactions were set up with dH2O and no reverse transcriptase reactions 
were set up from cDNA reactions without SuperScript III. qRT-PCR was performed 
on the LightCycler 480 (Roche) with pre-incubation of 50oC for 2 minutes and 95oC 
for 2 minutes. Amplification at 95oC for 15 seconds and 60oC for 30 seconds for 50 
cycles was followed by melt curve generation to check primer binding specificity at 
95oC for 5 seconds, 65oC for 1 minute with 0.5oC increment for 5 minutes to 95oC and 
cooled to 40oC. Only primers with an R2 value of >0.98 were used. All reactions were 
run in triplicate, the Cts averaged and the quantity of transcript determined via standard 
curve. This quantity was normalised to a reference gene such as β-actin and the 
expression levels relative to wild type or heterozygous cultured cells or littermate 
controls are shown. A two tailed t-test was used to determine if gene expression 
changes were statistically significant.     
2.3 DNA Extraction and Manipulation 
 
2.3.1 DNA isolation from tissue and cells 
 
DNA for bisulphite treatment was isolated from mammalian cells and E12.5 placentas 
using the Wizard Genomic DNA purification kit (Promega) as manufacturers protocol. 
Half placentas were mascerated with razorblades and added to 600µl of ice cold nuclei 
lysis solution and homogenised for 10 seconds with a hand homogeniser. The lysate 
was incubated at 65oC for 30 minutes, 3µl of RNase solution added, mixed, incubated 
for 30 minutes at 37oC and allowed to cool to room temperature. 200µl protein 
precipitation solution was added followed by vortexing for 20 seconds and placing on 
ice for 5 minutes to facilitate protein precipitation. The lysed samples were centrifuged 
for 4 minutes at 13000g and the supernatant containing the DNA removed to a fresh 
1.5ml Eppendorf containing 600µl of 100% isopropanol and inverted until visible 
DNA precipitation. Precipitation was followed by centrifugation for 1 minute at 
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13,000g at room remperature and the supernatant discarded. To the white DNA pellet 
600µl of room temperature 70% EtOH was added to wash the DNA and centrifuged 
as previously. The supernatant was removed and DNA allowed to air dry before 
addition of 100µl DNA rehydration solution and incubation at 65oC for 1 hour. DNA 
was stored at 4oC. 
   
2.3.2 Agarose gel electrophoresis 
 
To resolve DNA samples 1 – 2% agarose gels were prepared with 1x 
Tris/Borate/EDTA (TBE) buffer and 0.5µg/ml ethidium bromide was added to molten 
agarose after microwaving and mixed and performed as in (Sambrook and Russel, 
2001). 6X Orange G loadng buffer was added to DNA samples before loading specific 
amounts of DNA dependent on well size. 500ng of 1kb or 100bp DNA ladder (NEB) 
was loaded on each gel and stained DNA was visualised on a transilluminator (Biorad 
Universal hood II) and printed with a thermal printer.  
2.3.3 Gel purification of DNA 
 
Different sized PCR products or cut plasmids were separated from undesired DNA 
fragments by gel electrophoresis, visualised on a transilluminator on low power to 
avoid crosslinking of DNA and excised with clean razorblades. The QIAQuick Gel 
Extraction Kit (QIAGen) was used to isolate DNA following the manufacturer’s 
protocol and has been described by (Sambrook and Russel, 2001).  
 
2.3.4 Quantifying quality and quantity of nucleic acids 
 
Nucleic acid quantification was performed by measuring the absorbance of DNA and 
RNA at 260nm and 280nm using a spectrophotometer (Nanodrop ND-1000, Thermo). 




2.3.5 Bisulphite treatment and sequencing 
 
500ng genomic DNA prepared from the Wizard Genomic DNA kit was bisulphite 
treated using the EZ DNA Methylation kit (Zymo Research). 500ng DNA was diluted 
to 45µl, added to 5µl M-dilution buffer and mixed by pipetting followed by incubation 
at 37oC for 15 minutes. To convert unmethylated cytosines to uracil for detection as 
thymidine after PCR, the DNA mixture was then incubated with 100µl of freshly made 
CT conversion reagent for 50oC overnight on a rotor. 10 minutes on ice was followed 
by adding the 150µl of converted DNA to 400µl of M-binding buffer in a zymospin 
column and mixing. The column was then centrifuged at full speed for 30 seconds, the 
flow through discarded and the column washed with 100µl M-wash buffer and 
centrifuged. 200µl of M-desulphonation buffer was added and left to stand at room 
temperature for 15 minutes followed by centrifugation. For the final washes 200µl of 
M-wash buffer was added and centrifuged twice and the converted DNA was eluted 
in 10µl M-elution buffer and stored at -20oC. Bisulphite primers were designed to 
amplify LINE-1 subtypes of interest (Table 2.1) and PCR amplification was performed 
with the following reaction on 1µl of converted genomic DNA: 1x buffer, 1.5mM 
MgCl2, 200µM dNTPs, 1µM forward and reverse primers, 1.5U Platinum Taq DNA 
polymerase (Invitrogen). Reactions were incubated in a DNA Engine Tetrad PCR 
machine (MJResearch) at 95oC for 5 minutes, 35 cycles of 94oC for 45 seconds, 56oC 
for 45 seconds, 72oC for 90 seconds followed by 1 cycle at 72oC for 10 minutes. PCR 
products were purified by agarose gel electrophoresis on a 1.5% gel. The 250bp band 
was excised for L1A and L1MdF2 bisulphite primers and gel purified as described 
above. No band was visible for the untreated DNA or dH2O in the PCR reaction. 
Purified products were ligated into pGemTEasy Vector (promega) for 1 hour at room 
temperature following manufacturer’s instructions. The plasmids were transformed 
into subcloning efficiency DH5α E.coli and transformants were determined by 
ampicillin selection and those colonies with inserts were determined by X-gal 
blue/white selection as previously described. White colonies were picked and 
sequenced using the M13 forward sequencing primer (performed by MRC HGU 
technical services). Resulting sequences were imported to BioEdit, aligned to the 
reference sequence via ClustalW and CT conversion for the repetitive sequences was 
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measured using the online programme BISMA (Rohde et al., 2010), discarding clonal 
sequences.     
        
2.3.6 Cell and tissue preparation for ChIP 
 
To prepare a single cell suspension from 16dpp testes, the tunica was removed and 
tubules were macerated with a razorblade in 100µl in PBS on ice, resuspended in 4ml 
PBS and left to settle for 10 minutes. The supernatant containing the single cell 
suspension was centrifuged at 2000rpm for 5 minutes and the pellet resuspended in 
2ml of PBS. For preparation of placenta for ChIP, whole placentas were macerated 
with razor blades, added to 500µl ice cold PBS and homogenised with a hand 
homogeniser for 20 seconds. Crosslinked ChIP was performed as previously described 
(Mortazavi et al., 2006).  
Cells were cross-linked by adding formaldehyde to a final concentration of 1% for 10 
minutes and stopped by the addition of glycine to a final concentration of 0.125M. 
Cells were washed once with PBS, followed by resuspension in Farnham lysis buffer 
(5mM 1,4-piperazine-bis-[ethanesulphonic acid] pH8, 85mM KCl, 0.5% NP-40, 
protease inhibitor cocktail [Roche]). The crude nuclear preparation was collected by 
centrifugation and resuspended in 700µl RIPA buffer (1 X PBS, 1% NP-40, 0.5% 
sodium deoxycholate, 0.1% sodium dodecyl sulphate [SDS], protease inhibitor 
cocktail). For placenta, cell lysis buffer (1% SDS, 10mM EDTA, 50mM Tris-HCL 
pH8.1, protease inhibitor cocktail) and IP dilution buffer (0.1% Triton X-100, 2mM 
EDTA, 150mM NaCl, 20mM Tris-HCL pH8.1) was used instead of Farnham and 
RIPA buffers.  Sonication using the MSE SoniPrep 150 Probe Sonicator for three 
cycles of 30 seconds on and 30 seconds off was performed for testes DNA on ice, 
resulting in DNA fragments of size 300 to 500bp. For placental cells 10 cycles of 30 
seconds on and 30 seconds off was required to generate appropriate sized DNA 
fragments. For ES cells 50x 30 seconds on 30 seconds off was used in a Diagenode 
bioruptor. Sonicated DNA was centrifuged at 14000 rpm for 15 minutes at 4oC. 5µl 
H3K4me3 antibody (Millipore 07-473), H3K9me3, Kap1, SetDB1 and IgG isotype 
control antibodies were coupled to 20µl Dynabeads Protein A or G (Life Technologies 
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10002D) in 1ml PBS/BSA for 2 hours at 4oC and resuspended in 100µl of PBS/BSA. 
70µl of supernatant was retained as 10% input in qPCR analysis, whilst 630µl was 
added to the antibody coupled bead suspension, overnight at 4oC on a rotor. The beads 
and associated chromatin were washed four times with LiCl wash buffer (100mM Tris-
HCL Ph7.5, 500mM LiCl, 1% NP-40, 1% Sodium deoxycholate), followed by one 
wash with TE buffer. Chromatin was eluted from beads in 50µl elution buffer (1% 
SDS, 0.1M NaHCO3), vortexing and heating to 65oC for one hour in a shaking 
incubator, followed by collection of supernatant after centrifugation. Crosslinks were 
reversed by incubation of 10% input and eluted IP chromatin at 65oC overnight. 2µl 
of RNAse A (10mg/ml) was added for 30 minutes at 37oC, followed by 2µl of 
proteinase K (10mg/ml) for 1 hour at 42oC.  DNA purification was performed with 
the MinElute PCR Purification Kit (28004) and eluted in 20µl of buffer EB. 
 
2.3.7 Quantitative PCR 
 
Real time PCR analysis was performed on three biological replicates of Tex19.1-/- and 
Tex19.1+/- 16dpp testes, in triplicate on the Roche LightCycler 480, using SYBR Green 
Master Mix (Roche). Oligonucleotides used for ChIP-PCR can be seen in table 2.1. 
10% input and IP DNA was diluted 1:10 and 1µl, along with 2.5µM of forward and 
reverse primers (2.5µl of 1µM stock), 10µl Sybr Green Master Mix (Roche) and 4µl 
dH2O were used per qPCR reaction. 
 




Transfected cells were harvested and washed with PBS after overnight incubation at 
37oC. The cell pellet was resuspended in 200µl lysis buffer (10mM Tris Ph7.5, 150mM 
NaCl, 0.5mM EDTA, 0.5% NP40, 1mM PMSF (Sigma), 1x protease inhibitor cocktail 
EDTA-free (Roche)) and placed on ice for 30 minutes. Cell lystate was spun at full 
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speed for 10 minutes to pellet insoluble material and the supernatant was added to a 
new precooled tube. 20µl of lysate was taken as 10% input material and added to 20µl 
2x loading buffer. 800µl of dilution buffer (10mM Tris pH7.5, 150mM NaCl, 0.5mM 
EDTA, 1mM PMSF (Sigma), 1x protease inhibitor cocktail EDTA-free (Roche)) was 
added for 1ml of cell lysate.  Meanwhile 30µl flag-agarose bead slurry was 
resuspended in 500 µl of ice cold dilution buffer, spun at 2700g for 2 minutes at 4oC 
and repeated 2 times to equilibrate the beads. The 1ml of soluble cell lyste was then 
added to the equilibrated beads and rotated at room temperature for 2 hours followed 
by centrifugation at 2700g for 2 minutes at 4oC. 20µl of supernatant was added to 20µl 
2x loading buffer. The flag-agarose beads and the immunoprecipitated material (IP) 
were washed twice in 500µl dilution buffer and resuspended in 20µl 2x loading buffer. 
Input, supernatant and IP samples were boiled for 2-3 minutes and 12µl of input and 
supernatant samples and 5µl of IP sample were run on 4-12% Bis-Tris gel and standard 
western blot protocol followed.   
   
 
 
2.4.2 Western blotting 
 
Protein samples prepared in 2x Laemmli buffer were run on 4-12% NuPAGE Novex 
Bis-Tris protein gels in an XCell SureLock gel tank. Broad range colour protein 
standard protein ladder (NEB) was used to determine approximate protein weights. 
The gel was washed in dH2O and transferred to an iBlot nitrocellulose membrane by 
iBlot Mini transfer (ThermoFisher) for 7 minutes. Transfer was confirmed by rinsing 
membranes with Ponceau’s stain (Sigma) then washed in 1x PBST (PBS, 0.1% Tween-
20) and blocked with 5% (w/v) non-fat skimmed milk powder in PBST for 30 minutes 
at room temperature. Primary antibodies were diluted in milk and incubated with 
membranes overnight at 4oC or for 2 hours at room temperature with rotation. The 
membrane was washed with three 5 minute washes with PBST and then incubated for 
1 hour at room temperature with horse radish peroxidase conjugated second antibody 
94 
 
in block. Membranes were washed a further 3 times in PBST and proteins detected 
using ECL western blotting substrate (Pierce). Signals were detected by exposure onto 
X-ray film (Kodak). Western blotting procedures were performed as described 
(Sambrook and Russel, 2001). Antibodies used for western blotting are shown in table 
2.2.  
   
2.4.3 In Vivo ubiquitination assay 
 
Hek293T cells were seeded at 2x106 cells/ml in 10cm dishes the day before standard 
co-transfection with 1µg pCMV-TEX19, pCMV-His6-myc-ubiquitin (Ward et al., 
1995), pTRE-Gm6871-HA (Castro-Diaz et al., 2014; Ecco et al., 2016) or pLW-Ubi-
KAP1-HA (Trono lab) using Lipofectamine 2000 (Invitrogen). Control plasmids for 
this experiment were pPgsk3β-HA and empty vector (C-terminal FLAG tag). 
Transfected cells were incubated at 37oC 5% CO2 for 72 hours then harvested and lysed 
in 6M guanidinium-HCL, 0.1 M Na2HPO4, 0.1 M NaH2PO4, 0.01 M Tris–HCl pH 8.0, 
5 mM imidazole and 10 mM β-mercaptoethanol. Lysates were sonicated for 6 times 
10secs on/off with a probe sonicator and rotated with dH2O and lysis buffer washed 
Ni-NTA agarose beads (Qiagen) at room temperature for 4 hours. Protein bound 
agarose beads were washed in lysis buffer without added imidazole, followed by 
washes in lysis buffer II and variants. First wash in 8M urea, 0.1M Na2HPO4, 0.1M 
NaH2PO4, 0.01M Tris-HCl pH 8.0 and 10mM β-mercaptoethanol, second wash in lysis 
buffer II pH6.3 in 0.2% triton X-100, third wash in lysis buffer II pH 6.3 and a fourth 
wash in lysis buffer II pH 6.3 plus 0.1% triton X-100. HIS-tagged proteins were eluted 
from washed beads in 200mM imidazole, 0.15M Tris–HCl pH 6.7, 30% glycerol, 
0.72M β-mercaptoethanol and 5% SDS then analysed by Western blotting.     
 
2.5 Bacterial Culture and Manipulation 
 




Subcloning efficiency DH5α Escherichia coli (E. coli) (Invitrogen) were thawed on 
ice, gently mixed, aliquoted into 50µl and incubated on ice with 1-10ng of DNA for 
30 minutes.  The cells were heat shocked for 20 seconds at 42oC, placed on ice for 2 
minutes and 950µl of pre-warmed LB medium added. The cells were incubated at 37oC 
for 1 hour at 225rpm followed by spreading 100µl on an LB plate with the appropriate 
antibiotic (Ampicillin at 50μg/L or Kanamycin at 50μg/L) for transformant selection. 
Where blue white selection was required, plates were spread with X-gal (50µg/ml) and 
IPTG to 1mM and left to dry before plating. Plates were inverted and incubated 
overnight at 37oC. Growth of bacterial strains was carried out as described (Sambrook 
and Russel, 2001) 
 
2.5.2 Bacterial growth 
 
Plasmid DNA was transformed into chemically competent DH5-α E. coli (Invitrogen) 
followed by growth on either L-agar plates (10g/L NaCl, 10g/L Bacto-tryptone, 5g/L 
Yeast extract, 15g/L Difco Agar) and incubated overnight at 37oC. For plasmid 
preparation for mini-preps or sequencing transformed cells were liquid cultured in LB 
medium (10g/L NaCl, 10g/L Bacto-tryptone, 5g/L Yeast extract). The plates or liquid 
culture were supplemented with the appropriate antibiotic to select for colonies 
transformed with the plasmid of interest (Ampicillin at 50μg/L or Kanamycin at 
50μg/L). 
 
2.5.3 Plasmid DNA isolation 
 
Single transfected DH5α bacterial colonies were picked from agar plates and 
inoculated into 5ml LB medium with the appropriate selective antibiotic. These were 
cultured overnight at 37oC at 225rpm and the following day DNA was isolated from 





2.6 Immunostaining and histology  
 
2.6.1 Chromosome Spreads 
 
Chromosome spreads were performed as previously described (Ollinger et al., 2008). 
Prior to preparation of a single cell suspension, dissected testes were trimmed of excess 
tissue and weighed using a fine balance. The tunica was removed from testes and the 
seminiferous tubules were added to 200µl RPMI media and mascerated with razor 
blades. The macerated material was added to 3mls of RPMI media in a 15ml falcon 
and debris left to settle for 10 minutes at room temperature. The supernatant containing 
the single cell suspension was transferred to a fresh tube and centrifuged at 1000rpm 
for 5 minutes. Cells were resuspended in fresh RPMI media and boiled, cooled 
Superfrost Plus microscope slides were prepared by 5 drops of 4.5% sucrose to the 
centre of each slide in a humid chamber to cause cell swelling. From a height of 15cm 
a single drop of mixed single cell suspension was added to the sucrose prepared slides, 
followed by a single drop of 0.05% Triton-X-100 to permeablise cells for fixation and 
leave for 10 minutes. 8 drops of fix were added to each slide and incubated at room 
temperature for 20 minutes. 4% PFA was prepared by adding 2g paraformaldehyde 
(PFA) to 25ml dH2O in an inactive fume hood and dissolving at 60
oC. The solution 
was adjusted to pH8 with addition of HCl (1M) or NaOH (0.25M) and made to 50ml 
with dH2O. The 4% PFA was aliquoted to 5mls and stored at -20
oC until required then 
made to 2% by the addition of 5ml 0.04% SDS (10µl 20% SDS + 5ml dH2O). Fixed 
chromosome spreads were then washed by dipping slides 5 times and 1 time in two 
beakers of dH2O and left to air dry. Spreads were stored at -80
oC or were directly used 
for immunostaining.  
 
2.6.2 Immunocytochemistry and immunofluorescence 
 
IF was performed as described in (Ollinger et al., 2008). Chromosome spread slides or 
dewaxed tissue sections were warmed in PBS in a coplin jar for 5 minutes then placed 
in a humid chamber and incubated with 50µl block (100µl 1.5% BSA, 10µl 10% 
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Tween-20, 50µl goat serum, 840µl PBS) and covered with a plastic cover slip for 1 
hour. Block was drained off and 50µl primary antibody diluted to the required 
concentration in block was added with a new coverslip and incubated in a humid 
chamber for 2 hours at room temperature or overnight at 4oC. Slides were washed 3 
times for 5 minutes in PBS and incubated with secondary antibody diluted in block for 
1 hour at room temperature in the dark and washed further 3 times. Slides were 
mounted by applying two drops of mounting media (PD) (50mg p-phenylene diamine, 
10% PBS to 90% with glycerol) and a coverslip sealed with nail varnish and imaged 
or stored at 4oC.  
 
2.6.3 TUNEL assay 
 
The fragmented DNA of apoptotic cells was measured using the DeadEnd 
Fluorometric TUNEL system (Promega) as the manufacturer’s instructions. Paraffin 
embedded testes or placental tissue was dewaxed with 2 xylene washes followed by 
rehydration in 100%, 95%, 85%, 70% and 50% concentrations of EtOH. Incubation in 
0.85% NaCl was followed by a 5 minute wash in PBS. Slides were fixed with 4% 
formaldehyde in PBS for 15 minutes then washed 2 times with PBS for 5 minutes each. 
Cells were permeabilised by adding proteinase K (20µg/ml) to each slide for 10 
minutes at room temperature, washed twice for 5 minutes in PBS before further 
fixation with 4% formaldehyde for 5 minutes. Slides were equilibrated with 100µl of 
equilibration buffer for 10 minutes at room temperature. A positive control slide was 
treated with 10units/ml of DNAse I for 10 minutes, washed 4 times with deionised 
water and equilibrated with 100µl of equilibration buffer. Terminal deoxynucleotidyl 
transferase recombinant enzyme (rTDT) incubation mixture was prepared by 45µl 
equilibration buffer, 5µl nucleotide mix and 1µl rTdT enzyme.    
      





A 460bp fragment of the MMERVK10C endogenous retrovirus was previously cloned 
into pBluescript II SK+ (Stratagene) (Ollinger et al., 2008) and cleaved with HindIII 
(NEB) or BamHI (NEB). 1µg linearised plasmid was used in a reaction with 0.1M 
DTT, 50U/µl RNase inhibitor, 10x transcription buffer, 10x DIG-rNTP mix, 20U/µl 
RNA polymerase (T3 for sense, T7 for antisense)(all Roche) and Rnase/Dnase free 
dH2O for in vitro transcription for DIG-labelling of sense and anti-sense RNA. The 
reaction was incubated at 37oC for 2 hours and followed by the addition of 10U/µl 
DNAse I (Roche) at 37oC for 15 minutes. RNA was precipitated by adding 3M sodium 
acetate to 100% EtOH and incubating at -20oC for 2 hours. The RNA pellet was rinsed 
with chilled 70% EtOH and resuspended in RNAse/DNAse free dH2O and RNA 
integrity assessed by gel electrophoresis.  
 
2.6.5 In situ hybridisation 
 
6µm sections of 4% PFA fixed, embedded testes were dewaxed through three xylene 
washes, rehydrated through 100%, 95% and 70% EtOH washes and incubated in 0.2M 
HCL. Slides were washed in dH2O and incubated in 2µg/ml proteinase K in 1M Tris-
pH8, 0.5M EDTA and dH2O. The reaction was stopped with chilled 0.2% glycine for 
10 minutes 4oC and slides washed twice in 0.1M Triethanolamine.HCL (TEA) buffer 
pH8 (Alfa Aesar) for 10 minutes with the addition of acetic anhydride at the second 
wash. A 15 minute wash in 5X SSC (Invitrogen) was followed by a 50oC 2 hour 
incubation in a humidified chamber with prehybridisation buffer of formamide, 3X 
SSC, 1X Denhardts (Fisher) and dH2O. Hybridisation buffer was comprised of 
formamide, 3X SSC, 1X Denhardts, 50% dextran suphate (Alfa Aesar), 100ng/ml 
yeast RNA (Ambion) and dH2O, with 100µl of herring sperm DNA being denatured 
at 100oC for 10 minutes and cooled on ice for 10 minutes and added to the 
hybridisation buffer. 5µl of DIG-labelled RNA sense and antisense probes (~100ng) 
were added to 200µl of hybridisation mix and denatured at 65oC for 5 minutes. 200µl 
was added to each slide, covered with a plastic coverslip and incubated in a sealed 
humidified chamber at 50oC annealing temperature overnight. 
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Slides were washed twice in 2X SSC for 15 minutes and any non-hybridised RNA was 
degraded by washing slides with 20µg/ml RNAseA and 2X SSC in dH2O at 37
oC for 
30 minutes. Slides were washed in a graded series of 2X, 1X and 0.1X SSC solutions 
for 15 minutes each at 50oC, then washed in a maelic acid buffer solution of 0.1M 
maelic acid (Sigma) and 0.15M NaCl at pH 7.5 in dH2O. Roche blocking reagent was 
diluted to 1X in maelic acid buffer pH7.5 with sheep serum and slides were blocked 
for 30 minutes at room temperature. To detect DIG labelled hybridised RNA, slides 
were incubated with 1:1000 alkaline phosphatase anti-DIG antibody (Roche 
11093274910) diluted in 1X blocking solution for 1 hour at room temperature. Slides 
were washed twice for 15 minutes and equilibrated in 100mM Tris pH9.5, 100mM 
NaCl, 50mM MgCl2, 0.1% tween, 0.5mg/ml levamisole (Sigma) and dH2O for 5 
minutes at room temperature then the conjugated DIG alkaline phosphatase antibody 
was detected by developing the signal in BCIP/NBT substrate solution (Vector Labs). 
Development was monitored and stopped by washing in tap water after an overnight 
incubation when signal was detectable. Slides were washed a final time in dH2O and 
mounted with 90% glycerol in PBS and coverslips sealed with varnish. Stained 
sections were imaged by brightfield microscopy with phase contrast using 




Dissected tissue was either fixed with Bouins solution or 4% paraformaldehyde (PFA) 
in PBS. For Bouins and PFA fixation, whole testis and placenta were halved an fixed 
overnight at 4oC, followed by two 15 minute washes in 70% EtOH at room 
temperature. Tissue was stored in 70% EtOH until embedding with the Tissue-Tek 
VIP vacuum infiltration processor (Sakura) and hand embedding into wax moulds 
using the Tissue-Tek Embedding Console System (Sakura). For cryosections tissue 
was fixed in 4% PFA for 30 minutes, followed by 2 15 minute PBS washes and 30 
minutes each in 5% sucrose and 10% sucrose followed by overnight in 20% sucrose. 
Ooptimal cutting temperature compound (OCT) and fixed tissue was placed in a plastic 
mould and frozen on dry ice. 
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6µm thick sections were cut using a microtome (Thermo), floated in a 47oC water bath 
and attached to superfrost non-static slides (Thermo). 12µm thick sections of OCT 
embedded cryofrozen tissue were cut using the Cryostat (Leica Biosystems) and 
attached to cold superfrost slides. 
Haematoxylin and eosin staining of fixed tissue was carried out by dewaxing in 3 
changes of xylene for 5 minutes each, followed by 3 changes of 100% EtOH and 
rehydrated in a series of 90%, 70%, 50% and 30% EtOH and then H2O as described 
(Puchtler et al., 1986). Slides were stained in haematoxylin for 4 minutes, washed in 
tap water and differentiated in acid/alcohol (1% HCl in 70% EtOH) for a few seconds 
followed by washing in tap water. Slides were next immersed in saturated lithium 
carbonate solution for 10 seconds, washed in tap water and stained in eosin for 2 
minues and washed again. Dehydration of slides was by rinsing in 100% EtOH for a 
few seconds, and a further 3 washes with 100% EtOH for 2 minutes each and cleared 
with 3 changes of xylene for 5 minutes each and mounted DPX mountant (Sigma).    
For periodic acid schiffs (PAS) staining sections were deparaffinised as above, 
oxidised in 0.5% periodic acid solution for 5 minutes, rinsed in tap water and placed 
in Schiff reagent for 15 minutes. Slides were counterstained in Mayers haematoxylin 
for 1 minute, washed in tap water for 5 minutes and dehydrated and mounted as 
previously.  
2.6.7 Measurement of placental layers 
 
The area of placental layers was measured using at least three PAS stained selected 
midline sections per individual placentas with 20µm between each section. Sections 
were digitally imaged using the Olympus Dotslide system and areas calculated using 
the Dotslide software. Measurement of cell type abundance was performed on three 
rectangular segments spanning the width of the placenta on PAS stained sections. The 
number of spongiotrophoblast, glycogen trophoblast and sinusoidal trophoblast giant 
cells were counted and the area of each segment calculated using the Dotslide software.     
 




The senescence associated β galactosidase assay was performed using the Abcam 
Senescence Detection Kit (Abcam) to manufacturer’s recommendations. 12µm frozen 
tissue sections were fixed with fixative solution (2% formaldehyde and 0.2% 
glutaraldehyde) for 3 minutes at room temperature and washed 3 times with PBS. 25µl 
20mg/ml X-gal in N-N-dimethylformamide (DMF) was added to 470µl of Staining 
Solution and 5µl Staining Supplement at pH5.5 and slides were incubated overnight 
at 37oC, then counterstained with eosin and imaged with a brightfield microscope 
using Micromanager image capture software.   





2.7.1 Animal welfare and breeding strategy  
 
Animals were housed and experiments were conducted according to UK Home Office 
regulations and local guidelines for animal welfare.  
Tex19.1-/- mice used in this study were from colonies backcrossed to C57BL/6 for 
multiple generations which originated from the knockout line generated by Ollinger et 
al., 2008 in a 129/Ola x CD1 mixed genetic background. Ubr5flox mice were from 
colonies generated on a C57/BL/6 background by Mark Ditzel and Bob Hill (ECRC 
and MRC HGU) (Kinsella et al., 2016). Stra8-CreTg mice were obtained from the 
Jackson Laboratories and the line was maintained in house. The breeding strategy 
employed to produce the male specific conditional Ubr5 knockout genotype Stra8-
Cretg Ubr5flox/Δ (Ubr5CKO) at an expected frequency of 1:16 was used as it produced 
stable litter sizes of an average of 10 pups per mating (section 5.2.3 Table 5.2). These 
matings were of male Stra8-Cretg Ubr5flox/wt mice crossed with heterozygous female 
Stra8-cre- Ubr5flox/wt mice. Far fewer pups were born when the more optimal cross of 
male Stra8-Cretg Ubr5flox/wt and female Stra8-Cretg Ubr5flox/Δ was used and very few 
Ubr5CKO offspring were obtained. The reason for this is unclear. Male Stra8-Cretg 
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Ubr5flox/flox mice had smaller testes and a reduced sperm count and were therefore not 
used in the breeding strategy.  
 
2.7.2 Embryo and placenta dissection 
 
Females found plugged after mating were scored as positive for insemination and 
embryos were classed as E0.5 the morning the plug was observed.  Pregnant dams 
were culled and recorded in accordance with home office regulations and the uterine 
sack containing embryos was removed and retained for embryo and placental 
dissection on ice. Individual embryos and their placenta were removed from the uterus 
and separated via cutting the umbilical artery, ensuring the yolk sac containing the 
embryo remained intact. Excess tissue was trimmed from the placenta and the embryo 
after removal from the yolk sac and weighed on a fine balance.   
To dissect the placenta into its three constitutive layers of the decidua, junctional zone 
and labyrinth a Leica dissecting microscope was used. The placenta was placed with 
the dark red labyrinth facing upwards. The maternal decidua was removed from the 
placenta by inserting fine forecepts along the boundary between the pale decidua and 
darker junctional zone. This was repeated around the whole of the placenta getting 
progressively deeper into the tissue. Once sufficiently separated, the decidua was 
peeled from the darker junctional zone and labyrinth. This was repeated to separate the 
junctional zone from the labyrinth taking care to avoid contamination from the 
neighbouring layer. 
 
2.7.3 Genotyping PCR 
 
DNA was isolated from ear clips or embryo tail tips by using DNAreleasy (Anachem) 
and heating to 75oC for 5 minutes and 96oC for 2 minutes. Generally genotyping PCRs 
contained 0.5 units (U) Platinum Taq polymerase (Invitrogen), 0.5mM dNTPs 
(Invitrogen), 1X PCR buffer, 2.5mM Magnesium Chloride, 1mM each primer (Sigma) 
and 1µl DNA from the DNAreleasy reaction. Sequences of genotyping primers are 
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given in table 2.1. Typical PCR conditions were 95oC for 5 minutes, 30 cycles of 95oC 
for 30 secs, 65oC for 30 secs, 72oC for 1 minute and followed by 72oC for 5 minutes 
on a DNA Engine Tetrad PCR machine (MJ Research). The 65oC annealing 
temperature was optimal for Tex19.1 genotyping but was altered to 58oC for Ubr5 
primers, 66oC for sex primers and 67oC for Stra8-Cre transgene genotyping. PCR has 




2.8.1 RNAseq data 
 
Paired end sequencing data was provided in the format of .sanfastq files from 
Edinburgh Genomics and quality of data generated was assessed using FastQC. If data 
passed quality criteria, remaining adapter sequences were removed using TrimGalore. 
Command line parameters: trim_galore --fastqc --stringency 5 --length 20 –paired. 
Sequencing reads were aligned to the mouse ensemble mm10 reference genome 
downloaded from UCSC using TopHat read aligner allowing mapping to the genome 
with 2 mismatches (Trapnell et al., 2012). Command line parameters: tophat -g 1 -p 8 
--transcriptome-index --mate-inner-dist -62 --mate-std-dev 59 --no-coverage-search -
-b2-sensitive –o. –g = The number of alignments to the reference for a given read. –p 
= Number of threads to align reads (parallel processing). –transcriptome-index = 
Location of the .GTF mm10 known transcript file. –mate-inner-dist = Distance 
between paired end reads. –b2= sensitivity of Bowtie mapper. –o = Output file. The 
aligned reads from TopHat in a .bam file were converted to .bed format with genomic 
coordinates of mapped reads. To accurately quantify the expression level of transcripts 
with aligned reads, counts of aligned reads per transcript were consolidated and 
differential expression analysis was then performed on control and Tex19.1-/- RNAseq 
data with EdgeR (Robinson et al., 2009) with expression levels denoted as counts per 
million reads and a false discovery rate adjusted P value indicating significance values. 
The R programme was used for further analysis and plotting of gene expression levels 
using R base graphics. Distance to nearest repetitive element was determined utilising 
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BEDtools closest to report only the closest gene to each repetitive element in the 
RepeatMasker dataset (Smit, AFA, Hubley, R & Green, P. RepeatMasker Open-
4.0.2013-2015 http://www.repeatmasker.org). Analysis of repeats was performed 
essentially as for genic transcripts. Aligned reads from the TopHat output file were 
intersected with genomic coordinates from the RepeatMasker dataset to generate 
repeat loci with mapped transcripts. Reads mapping to multiple repeat loci were 
distributed between all multimapping loci of that repeat and differential expression 
analysis was performed with EdgeR as for genic transcripts.  
 
2.8.2 Microarray data 
 
Affymetrix Mouse Gene 2.1 microarray data was imported to the affy Bioconductor 
package (Gautier et al., 2004) in R. Probe level expression was background corrected 
using the robust multi-array average algorithm (RMA) in affy. Expression from probes 
was quantile normalised and for gene level analysis summation of expression across 
gene probe sets was performed. Differential expression of summated gene probe sets 
in control and Tex19.1-/- ES cells was assessed using limma in R (Smyth, 2004) and 
data was graphed using R. For repeat probe analysis, defined repeat aligned probes 
were extracted from the affymetrix dataset and differential expression was analysed 
with limma as previously described (Reichmann et al., 2012). 
Publically available microarray datasets from Affymetrix Mouse Genome 430 2.0 
arrays were located on the Gene Expression Omnibus database (GEO). For gene 
expression in hypomethylated contexts datasets were obtained for fetus 
(GSE9954)(Thorrez et al., 2008), placenta (GSE9954)(Thorrez et al., 2008), 2i ES 
(GSE42580) (Yamaji et al., 2013) and primordial germ cell like cells 
(GSE45941)(Schemmer et al., 2013)analysed using the affy and limma in R to generate 
comparative gene expression values for placenta, 2i ES and primordial germ cell 
compared to fetal gene expression as described. For tissue specific analysis of Ubr5 
expression testis, placenta, ovary, muscle, heart, liver, lung, kidney, spleen and brain 
tissue microarray data was obtained from (GSE9954, Thorrez et al., 2008) and gene 





   
 
Gene / Retrotransposon Forward Reverse Purpose of primer
Ubr5 wt GTTTCTGGCAAGGTTCAGTGC CACACATGCTGCACAAACACATG Genotyping
Ubr5 flox CGCGAAGAGTTTGTCCTCAC GCCTCGATCCTCCCTTTATC Genotyping
Ubr5 Δ GACAATAGCAGGCATGCTGG GCCTCGATCCTCCCTTTATC Genotyping
Stra8-Cre +ve ctrl CTAGGCCACAGAATTGAAAGATCT GTAGGTGGAAATTCTAGCATCATCC Genotyping
Stra8-Cre transgene GTGCAAGCTGAACAACAGGA AGGGACACAGCATTGGAGTC Genotyping
Tex19.1 CTTCAGGAGGTCTGATGCCCTCT GAGTGTTGTGTGGTGGGTGTTATGG Genotyping
Tex19.1 CTTCAGGAGGTCTGATGCCCTCT CACCGCCTGTGCTCTAGTAGCTT Genotyping
XY TGGTCTGGACCCAAACGCTGTCCACA GGCAGCAGCCATCACATAATCCAGATG Genotyping
β Actin CCTCGATGCTGACCCTCATCC GACACTGCCCCATTCAATGTCTC ChIP
Pol2 Promoter GACTCCGAACTGCACTCTCT CAGCCTTTCCCTCCCTATCC ChIP
Intergenic CTGTCTCCAGGTCATTGAGAAGG GTTGATCTTGGAACCCTTGGCTCC ChIP
MMERVK10C TTCGCCTCTGCAATCAAGCTCTC   TCGCTCRTGCCTGAAGATGTTTC   ChIP
LINE-1 5'UTR  AATCTGTCTCCCAGGTCTGC CCTTTCGCCATCTGGTAATC ChIP
L1MdF2 CGTAGTGTCTGTATAACCTGTCCA GCAGGCCTATCAGAATTACAGC ChIP, qRT-PCR
Peg3 GCCACTGCGGCAAAACA GGTCTTCGCAATCTAGCCATCT ChIP
KvDMR1 GGTCTATGATGGTGCATTTTGGT AAGCCCACCGAAGTAATCCA ChIP
IAP LTR GATGGTGCTGACATCCTGTG CTGACGTTCACGGGAAAAAC ChIP
IAPEz GCTCCTGAAGATGTAAGCAATAAAG CTTCCTTGCGCCAGTCCCGAG ChIP
L1Orf1 ATCCAGGAAATCCAGGACAC TTTGCTGGACCTTTGAGTTG ChIP
Tex19.1 AAAATGGGCCACCCACATCTC CCACTGGCCCTTGGACCAGAC qRT-PCR
VL30 CAGCCTTGGCCTGAGAGTTT CTTTCTGGGCTGAAGTCCCT qRT-PCR
MMERGLN CCTGGAGGATTTGACCTAGACA CCCAGGTATACCCTTTTGTCC qRT-PCR
L1Orf2 GGAGGGACATTTCATTCTCATC GCTGCTCTTGTATTTGGAGCATAGA qRT-PCR
IAPEz GCACCCTCAAAGCCTATCTTA TCCCTTGGTCAGTCTGGATTT qRT-PCR
Nanog TCCTCGCCCTTCCTCTGAA CAGGACTTGAGAGCTTTTGTTTGG qRT-PCR
Gapdh CGTCCCGTAGACAAAATGGT TTGATGGGCAACAATCTCCAC qRT-PCR
L1G CCTGTGCCACAAACCTCTCA GTGCCAGCCGTTTCTGGGACG qRT-PCR
L1A GCTTGTGCCTGCCCCAATCCAATC GCAAGGTAGCCTGGGGCTCG qRT-PCR
L1Mus1 GGAGTGCTGACAGAGGCTAA GTCTTGCTTTTCGGGTGTGT qRT-PCR
L1Mus2 CAGAGCTTCTTGGACAGGGT GAGCTCAGATCCACCTCCTG qRT-PCR
Lx CAGAGCTGACCCTGTACCAC ACTGGGTTCTGATGATGCCA qRT-PCR
MMERVK10C AACTGGTCGCAGGAGCTG GGTAAAGTCTCCGAGGGTCA qRT-PCR
β Actin GGCTGTATTCCCCTCCATCG ACATGGCATTGTTACCAACTGG qRT-PCR
Cdx2 GGGTGGGGGTAGCAATACTT CCCTTCCTGATTTGTGGAGA qRT-PCR
Ctsq AGAACAGCTGGGGTAGACG GCCACATGCTTTCTTGTGAA qRT-PCR
Prl8a8 AAATTATGTGGGTGCCTGGA TCACGCAGAATTTGTCTGTTG qRT-PCR
Gjb3 GGGGCTCTCCATCAGACATA GTGCCAAACCTTCTCATGGT qRT-PCR
Tmem173 CCTCAGTTGGATGTTTGGCC AGATCAACCGCAAGTACCCA qRT-PCR
Ifitm2 CTCTTCTTCAACGCCTGCTG TGGGGTGTTCTTTGTGCAAA qRT-PCR
Ifitm3 TATGAGGTGGCTGAGATGGG TCACCCACCATCTTCCGATC qRT-PCR
Oasl1 CTGCTCCAGGATCATGAGCT TTCTGCCACATTGTTGGTGG qRT-PCR
Oasl2 CCGGCAATCTACGAGACTCT GCTCTCTGTACCCATCTCCC qRT-PCR
Irf7 GTGTACTGGGAGGTAGGCAG TGCCCAAAACCCAGGTAGAT qRT-PCR
Ifi44 ATGGAGACCTGGTTCAGCAA ACTGTCATCCTTGGCCTTGA qRT-PCR
Psg18  L1 Antisense CTATGGCTCTCAGGACACGT ATCTAACACAGCGCTCCCTT qRT-PCR
Psg28 L1 Antisense CTATGGCTCTCAGGACACGT GCATCTAACACAGCACTCCC qRT-PCR
Psg21  L1 Antisense CCAGACACTCAGAGCCAGAA CCAGAAGGGCAGTATTGATGC qRT-PCR
L1A Bis TTATTTTGATAGTAGAGTT CRAACCAAACTCCTAACAA BisSeq
L1MdF2 Bis TAGGTGAGAGGGTGTATTATAGAAT AACAAATCCCAAAAACTATCAACTT BisSeq
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Table 2.1: Primer sequences are shown for each gene or genomic loci analysed Each 
primer pairs experimental usage is shown in the right most column (ChIP, chromatin 
immunoprecipitation; qRT-PCR, quantitative reverse transcription polymerase chain 
reaction, BisSeq, bisulphite sequencing) 
 
Table 2.2: Antibodies used in experiments. Species, catalogue number, working 
concentration and experiments where the antibody was used are indicated. (ICC, 
immunocytochemistry; IF, immunofluorescence; ChIP, chromatin 









Antibody Species Origin reference Concentration Use 
Anti-SYCP1 Rabbit Abcam, ab15090-100 1:200 ICC
Anti-SYCP3 Mouse Santa Cruz, D-1, sc-74569 1:200 ICC
Anti-UBR5 Rabbit Bethyl, A300-573 1:250 IF
Anti-PLZF (D-9) Mouse Santa Cruz, sc-28319 1:100 IF
Anti-H3K9me3 Rabbit Abcam, ab8898 5µg ChIP
Anti-H3K4me3 Rabbit Millipore, 07-473 5µg ChIP
Anti-KAP1 Mouse Abcam, ab22553 1:2000/5µg WB/ChIP
Anti-HA Rabbit Santa Cruz, sc-805 1:5000 WB
Anti-C-MYC Mouse Sigma, M4439 1:5000 WB
Anti-H3 Rabbit Abcam, ab1791 1:100,000 WB
Anti-β-ACTIN Mouse Abcam, ab8226 1:1000 WB
Anti-P-STAT1 (Phos.Y7D1) Mouse Abcam, ab29045 1:500 WB
Anti-GFP Rabbit Abcam, ab290 1:5000 WB
Anti-LAMIN B1 Rabbit Abcam, Ab16048 1:5000 WB
Anti-Mouse Alexa Fluor 488 Goat Invitrogen, A-11001 1:500 IF
Anti-Mouse Alexa Fluor 594 Goat Invitrogen, A-11005 1:500 IF
Anti-Rabbit Alexa Fluor 488 Goat Invitrogen, A-11008 1:500 IF
Anti-Rabbit Alexa Fluor 594 Goat Invitrogen, A-11012 1:500 IF
Anti-Mouse IgG HRP conjugate Goat BioRad, 1706516 1:1000 WB













Chapter 3: Investigating the mechanism of 














The expression of the germline genome defence gene, Tex19.1 is restricted to 
pluripotent cells, germ cells and the placenta (Kuntz et al., 2008; Ollinger et al., 2008; 
Reichmann et al., 2013). Tex19.1, along with other DNA methylation-sensitive 
germline genome defence genes such as the piRNA pathway associated Mili, Mov10l1 
and Asz1, are activated upon loss of methylation to repress retrotransposons (Crichton 
et al., 2013; Hackett et al., 2012). Genetic deletion of Tex19.1 results in increased RNA 
of the MMERVK10C elements in the pachytene stage of meiosis in the germline, 
whereas deletion of Mili, Mov10l1 and Asz1 results in de-repression of the non-LTR 
class of retrotransposons, LINE-1 and the IAP LTR retrotransposons (Crichton et al., 
2013; Ollinger et al., 2008). Taken together, the promoter hypomethylation and 
activation of these germline genome defence genes appear to be a compensatory 
response to loss of methylation which serves to prevent any consequent activation of 
retrotransposons. However, it is unclear if any of these methylation sensitive genes 
represent a generic global response in different hypomethylated contexts.  
A hypomethylated tissue distinct from the germline is the trophectoderm derived 
murine placenta which is the first organ to form during embryogenesis. The 
hypomethylation occurs in the trophectoderm derived components of this tissue and is 
globally hypomethylated to around 40 to 50% methylation (Popp et al., 2010). 
Interestingly, the only DNA methylation-sensitive germline genome defence gene to 
be expressed in the placenta is Tex19.1 (Reichmann et al., 2013). The increases in 
MMERVK10C RNA in Tex19.1-/- testis is not detected in the placenta. Instead, LINE-
1 and VL30 RNA are increased in the absence of Tex19.1 in this tissue. This indicates 
that the activation of Tex19.1 may be an important generic compensatory mechanism 
for retrotransposon repression in response to hypomethylation. The main aim of this 
chapter is to investigate the potential compensatory mechanisms working through 
TEX19.1 to facilitate retrotransposon repression in vitro and in vivo. 
It is not clear if the retrotransposon RNA increases are transcriptional or what gives 
Tex19.1 its specificity for particular retrotransposons in particular tissues. Recent 
evidence suggests the transcriptional co-repressor KAP1 and the histone 
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methyltransferases SETDB1 and SUV39H1/2 form complexes acting to repress 
different retrotransposons via the deposition of H3K9me3 (Goodier, 2016; Matsui et 
al., 2010; Rowe et al., 2010). This KAP1 dependent mechanism represents another 
regulatory system acting to repress retrotransposons in the early embryo. KRAB-ZFPs, 
the largest family of transcription factors in the mouse, can target these repressive 
complexes to particular retrotransposon loci. This mechanism has evolved to target 
different classes and even specific subfamilies within different classes of 
retrotransposons (Castro Diaz et al., 2014). It is not clear if the KAP1 system interacts 
with the TEX19.1 pathway, however they do seem to have common retrotransposon 
targets in different cell types (Table 3.1).  
In this chapter I aim to investigate if there is a generic response to repress 
retrotransposons in hypomethylated contexts, and if so, to characterise the potential 
mechanisms facilitating repression.  
 
 
Table 3.1: TEX19.1 represses the same retrotransposon families as in Kap1-/- ES cells 
in different in vivo Tex19.1-/- tissues. Table indicating overlap of retrotransposon 
families de-repressed in Tex19.1-/- animals (Ollinger et al., 2008; Reichmann et al., 








3.2.1 Tex19.1 is the only gene activated in response to DNA 
hypomethylation in all in vitro and in vivo contexts analysed 
 
Previous work from the Meehan and Adams labs has identified Tex19.1 and a number 
of other ‘methylation-sensitive genome defence genes’ as being solely repressed by 
DNA methylation in vitro and in vivo (see appendix table 7.2 for list of genes from 
Hackett et al., 2012). NIH3T3 fibroblast cells were treated with the DNA 
demethylation inducing drug 5aza-dC and allowed to recover their expression (Hackett 
et al., 2012). Those genes which did not recover were deemed to be bona fide DNA 
methylation dependent genes. A further confirmation of this sensitivity to methylation 
was that these genes were also expressed in fibroblasts lacking the maintenance methyl 
transferase Dnmt1. Tex19.1 and 24 other genes were activated in response to this DNA 
hypomethylation in vitro (Hackett et al., 2012).  
To investigate if there is a generic response to hypomethylation, common to all 
hypomethylated contexts in vivo, I took an unbiased, genome wide approach using 
publicly available microarray datasets from 2i treated ‘naive’ ES cells, primordial 
germ cell like cells (PGCLCs) and E16.5 placenta which are all hypomethylated, and 
compared each to whole E16.5 embryo (Schemmer et al., 2013; Thorrez et al., 2008; 
Yamaji et al., 2013)(GEO ascensions in methods). Data was analysed with GEO2R to 
generate expression values and a stringent 6-fold expression increase threshold was 
used followed by intersection of datasets with R (Methods).  
Similar numbers of genes were expressed in the placenta and naïve ES cells, but only 
16% of these overlap in expression (figure 3.1A). Fewer genes were significantly 
expressed in PGCLCs, however 65% of PGCLC genes were also expressed in naïve 
ES cells compared to 16% overlap with placenta, possibly owing to the somatic nature 
of this tissue (figure 3.1A). 41 genes were common to all in vivo hypomethylated 
contexts analysed (figure 3.1A).  
To address if these 41 genes were bona fide responses to loss of DNA methylation I 
intersected these with the 25 methylation sensitive genes identified previously in 
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experimentally induced hypomethylation contexts (Hackett et al., 2012). Surprisingly, 
of around ~20,000 genes, Tex19.1 was the only gene activated in every 
hypomethylated context analysed (figure 3.1B).   
This suggests that if there is a generic repressive mechanism to compensate for loss of 
DNA methylation in silencing retrotransposons then this mechanism must be working 























Figure 3.1: Tex19.1 is the only gene responsive to hypomethylation in all in vivo and 
in vitro contexts analysed. (A) Venn diagram showing the number of differentially 
expressed genes in hypomethylated tissues relative to normally methylated embryo 
from publicly available microarray datasets. The number of genes common to 
different tissues are indicated in the overlaps. A stringent 6 fold differential 
expression threshold and FDR P<0.05 significance criteria were used to determine 
significantly different gene expression. (B) The 41 genes common to each 
hypomethylated dataset in A (see appendix table 7.1) were intersected with the 25 
methylation sensitive genes determined in vivo (Hackett et al., 2012)(See appendix 




3.2.2 TEX19.1 represses retrotransposons at the transcriptional level  
 
Tex19.1-/- has already been shown to repress retrotransposon transcripts in testes and 
placenta as Tex19.1-/- tissue has increased MMERVK10C RNA and LINE-1 RNA 
respectively (Ollinger et al., 2008; Reichmann et al., 2012). However, the mechanism 
by which these retrotransposon RNAs increase in Tex19.1-/- tissues is not known. 
These increases in RNA could be due to an increase in RNA stability or de-repression 
of these retrotransposons at the transcriptional level. H3K4me3 is highly enriched at 
active promoters and can be used as a proxy for increased transcription (Heintzman et 
al., 2007). Therefore, to determine if TEX19.1 is functioning in the transcriptional 
repression of both MMERVK10C and LINE-1 in these different tissues I performed 
chromatin immunoprecipitation polymerase chain reaction (ChIP-PCR) for H3K4me3 
on E12.5 placentas and P16 testes. Prior to these functional ChIP experiments on 
different tissues, the ChIP protocol required considerable optimisation. This was due 
to the limited cell numbers available from placenta and testes, the difficulty of creating 
a single cell suspension, especially from placental tissue, alongside differing 
formaldehyde fixation lengths and sonication lengths required. The optimisation of 
these ChIP experiments is discussed in appendix 7.1 (figure 7.1)   
In the testes the Pol2 promoter region, an active promoter, is shown as a positive 
control, and an intergenic region as a negative control (figure 3.2A). The positive 
control promoter region showed strong enrichment for H3K4me3 in the ChIP assay, 
whereas the negative control intergenic region did not. In addition, H3K4me3 was 
detected at MMERVK10C and LINE-1 5’UTR indicating active transcription of these 
retrotransposons in control and Tex19.1-/- testis. An increase in the abundance of 
H3K4me3 was detected at MMERVK10C promoters in Tex19.1-/- testes compared to 
control animals (P<0.05, Students T-test)(figure 3.2A). This increase was not observed 
for LINE-1 5’UTR. The H3K4me3 profiles correlate with previous reports of 
increased abundance of MMERVK10C RNA but not LINE-1 RNA in Tex19.1-/- testis 
(Ollinger et al., 2008; Reichmann et al., 2012). Therefore, TEX19.1 is responsible for 
transcriptional repression of MMERVK10C in the testes.  
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Similarly, in placentas from control mice, there is enrichment for H3K4me3 at 
MMERVK10C and LINE-1 indicating active transcription of these retrotransposons 
in this tissue in normal circumstances (Reichmann et al., 2013). This enrichment is 
significantly higher at LINE1 5’ UTRs but not at MMERVK10C loci in Tex19.1-/- 
placentas compared to control placentas (figure 3.2B). As with Tex19.1-/- testis, these 
H3K4me3 profiles correlate with the increased abundance in LINE-1 RNA but not 
MMERVK10C RNA in Tex19.1-/- placentas. This indicates that TEX19.1 is 
responsible for transcriptional repression of LINE-1 in the placenta. Taken together, 
these data are consistent with TEX19.1 functioning to transcriptionally repress 











Figure 3.2: TEX19.1 represses MMERVK10C and LINE1 retrotransposons at the 
transcriptional level in different tissues. (A) H3K4me3 ChIP-PCR on 16dpp littermate 
control and Tex19.1-/- testes (biological replicates n=3, *P=0.025, Students T-Test. (B) 
H3K4me3 ChIP-PCR on whole placentas from E12.5 littermate controls and Tex19.1-/- 
animals (n=5, *P=0.012, Students T-Test).  Graphs show mean ± standard error IP 
enrichment as a percentage of the input, relative to the actin promoter. qPCR was 




3.2.3 TEX19.1 interacts with the transcriptional co-repressor KAP1  
 
I next aimed to determine the mechanism of transcriptional regulation of 
retrotransposons by TEX19.1. TEX19.1 is comprised of two structural domains of 
unknown function and the sequence gives no indication to the potential mechanism of 
the TEX19.1 mediated transcriptional regulation of retrotransposons. To address this, 
Marie MacLennan determined the interacting partners of TEX19.1 by co-
immunoprecipitation mass spectrometry on the cytoplasmic fraction of TEX19.1-YFP 
ES cells. YFP is an enhanced yellow variant of GFP which can be detected using GFP 
reagents (Miyawaki et al., 1997). TEX19.1 was found to interact with KAP1; a 
transcriptional co-repressor of retrotransposons, which was the second most confident 
protein detected with 20 peptides matched and 18.7% coverage. The most confident 
interaction was the previously described interaction with UBR2 (Yang et al., 2010)(see 
appendix table 7.3 for full list of interacting peptides from mass spectrometry 
experiment). The interaction determined by mass spectrometry was confirmed by co-
immunoprecipitation by Marie MacLennan (figure 3.3). Western blot for GFP 
confirmed successful immunoprecipitation of YFP or TEX19.1-YFP. In the 
supernatant and input material bands corresponding to endogenous KAP1 are detected 
in both YFP ES cells and TEX19.1-YFP ES cells. After immunoprecipitation with 
GFP-trap beads, endogenous KAP1 is only detected in the TEX19.1-YFP ES cells and 
absent from YFP ES cells. This confirms the mass spectrometry data and indicates that 





Figure 3.3: TEX19.1 interacts with KAP1 in ES cells – Experiment by Marie 
MacLennan. Western blot for KAP1 after co-immunoprecipitation with GFP 
antibodies in TEX19.1-YFP and YFP ES cells. Inputs and supernatants were not 
immunoprecipitated with GFP beads and a band for endogenous KAP1 is detected in 
each non precipitated sample. A band for KAP1 is detected in the IP sample in 
TEX19.1-YFP ES cells but not in YFP-ES cells (KAP1 ~100kDa, TEX19.1-YFP ~80kDa, YFP 









3.2.4 TEX19.1 mediates deposition of the KAP1 dependent H3K9me3 
repressive mark at LINE-1 loci in ES cells 
 
KAP1 facilitates the deposition of tri methylation on H3K9 at retrotransposon loci 
(Rowe et al., 2010). I therefore aimed to determine if there were perturbations in this 
mechanism in the absence of Tex19.1. ChIP-PCR for the H3K9me3 repressive mark 
was performed on Tex19.1-/- ES cells for select retrotransposon candidates which are 
de-repressed in in vivo Tex19.1-/- contexts such as MMERVK10C, LINE-1 and VL30, 
alongside a known KAP1 bound subfamily of LINE-1, L1MdF2 (Castro-Diaz et al., 
2014). As a control, I also analysed KAP1 dependent H3K9me3 levels at imprinted 
genes. H3K9me3 was enriched a similar amount at each genomic loci tested, but while 
there was no difference between the amount of H3K9me3 at MMERVK10C, VL30 or 
IAP elements in control and Tex19.1-/- ES cells, a specific KAP1-bound L1MdF2 
element showed a significant 1.3 fold decrease in the amount of H3K9me3 bound 
(figure 3.4A)(n=6, P<0.01, Students T-test). Similar amounts of KAP1 dependent 
H3K9me3 were also present at the KAP1 imprinted genes, Peg3 and KvDMR in both 
control and Tex19.1-/- ES cells. These results indicate that in the absence of TEX19.1, 
deposition of H3K9me3 is perturbed at a particular LINE-1 subfamily with no effects 
at the other retrotransposon loci or KAP1 dependent imprinted genes tested.  
I then aimed to investigate if this reduced amount of H3K9me3 was due to a reduction 
in the amount of KAP1 binding. ChIP-PCR for KAP1 in Tex19.1-/- ES cells showed 
no significant decrease in KAP1 abundance at MMERVK10C or IAP loci, however 
Tex19.1-/- ES cells have a significant 1.6 fold decrease in the amount of KAP1 bound 
at L1MdF2 elements in Tex19.1-/- (figure 3.4B)(n=5, P<0.05, Students T-test). 
Although the change in H3K9me3 and KAP1 binding is relatively small at this 
particular L1MdF2 element, it is possible that only a subset of the ~3000 full length 
L1MdF2 loci (Sookdeo et al., 2013) are being affected by TEX19.1. This data indicates 
that the physical interaction between TEX19.1 and KAP1 likely represents a functional 
relationship necessary for KAP1 binding and subsequent deposition of H3K9me3 at 
specific retrotransposon loci. Therefore, TEX19.1 acts to augment repressive histone 
modifications at specific retrotransposon loci as a compensatory mechanism for loss 





Figure 3.4: TEX19.1 is necessary for KAP1 binding and subsequent deposition of 
H3K9me3 at L1MdF2 elements in ES cells (A) H3K9me3 ChIP-PCR for selected 
retrotransposon loci in control Tex19.1+/- and Tex19.1-/- ES cells. Actin is shown as a 
negative control, H3K9me3 imprinted genes Peg3 and KvDMR1 as positive controls 
and candidate retrotransposon loci as experimental loci. (n=6, *P=0.0066, Students 
T-test) (B) KAP1 ChIP-PCR for the retrotransposons assayed in A (n=5, *P=0.033, 
Students T-test). IgG negative control is also shown to show the level of non-specific 
binding to beads during IP. Enrichment of H3K9me3 and KAP1 are shown as IP 
material as a percentage of the input material (mean ± standard error). 
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3.2.5 TEX19.1 is not bound to chromatin  
 
I have shown that H3K9me3 and KAP1 are reduced at L1MdF2 loci in Tex19.1-/- ES 
cells, however it is unclear how TEX19.1 may be regulating KAP1 binding to 
retrotransposon loci. The KAP1-SETDB1 repressive complex is targeted to select 
genomic loci via particular KRAB-ZFPs which bind DNA in a sequence dependent 
manner. I aimed to investigate if TEX19.1 could be functioning as part of this complex 
by direct binding to retrotransposon chromatin. Therefore, to investigate if TEX19.1 
is binding to chromatin at a global level, I prepared chromatin from ES cells stably 
expressing TEX19.1-YFP or YFP and performed a Western blot to detect YFP and 
Histone H3 as a loading control. In input and supernatant samples from TEX19.1-YFP 
and YFP ES cells, bands corresponding to the correct sizes of these fusion proteins 
and Histone H3 were detected (figure 3.5). In the TEX19.1-YFP ES samples there was 
a weaker band corresponding to YFP indicating that some cleavage of the TEX19.1-
YFP fusion construct may have occurred (figure 3.5). The band for Histone H3 was 
overexposed, however, no band for TEX19.1-YFP was detected in the chromatin 
fraction, indicating that TEX19.1-YFP is not stably binding to chromatin in these 
conditions and is therefore unlikely to be acting as a KRAB-ZFP in this experimental 





Figure 3.5: TEX19.1 is not bound to chromatin in ES cells. Western blot for GFP on 
chromatin preparations from Tex19.1-YFP ES cells and YFP ES cells. Input and 
supernatants (sup) were probed to indicate the abundance of non-chromatin bound 
Tex19.1-YFP and YFP. Histone H3 was used as a loading control. Pre-stained molecular 








3.2.6 KAP1 protein levels are not affected by Tex19.1 in different 
cellular contexts  
 
TEX19.1 interacts with RING domain E3 ubiquitin ligases (MacLennan et al., 
submitted; Yang et al., 2010) and as TEX19.1 is unlikely to be acting as a KRAB-ZFP, 
it is possible that the reduction in H3K9me3 and KAP1 at L1MdF2 loci is due to 
TEX19.1 affecting global KAP1 protein levels. To see if KAP1 levels are perturbed in 
an in vivo Tex19.1-/- context where LINE-1 is de-repressed, Western blots were 
performed for KAP1 on E12.5 control and Tex19.1-/- placentas (Reichmann et al., 
2013). The highest enrichment in LINE-1 protein is in the junctional zone of Tex19.1-
/- animals (Reichmann et al., 2013), I therefore dissected the junctional zone from the 
placenta to determine if specific reductions in KAP1 were occurring this layer. Control 
and Tex19.1-/- placentas have similar levels of KAP1 in the junctional zone indicating 
that TEX19.1 is likely not affecting global KAP1 stability in the placenta, however the 
band corresponding to KAP1 in the control junctional zone is moderately burnt in 
(figure 3.6). This may have implications for the quantification of KAP1 levels in 
control versus knockout junctional zones and, due to the small sample size more 





Figure 3.6: KAP1 levels are not affected by loss of TEX19.1 in the junctional zone of 
the placenta. (A) Western blot for KAP1 in the junctional zone of E12.5 control and 
Tex19.1-/- placentas. Histone H3 was used as a loading control. Vertical numbers on 
the left correspond to protein size (kDa). (B) Densitometry quantification of KAP1 







I next performed an overexpression experiment to see if higher levels of TEX19 were 
sufficient to reduce KAP1 levels in a different cellular context. HEK293T cells were 
transfected with a vector expressing human TEX19 or an empty vector as control. A 
vector expressing GFP acted as a transfection control. Western blotting for KAP1 
showed that similar levels were present with and without TEX19 indicating that an 
increase in human TEX19 is not sufficient to reduce human KAP1 levels in this 
system. Even loading and transfection was determined by LAMIN B and GFP 
antibodies respectively, however the extent of TEX19 overexpression in each sample 
was not assessed (figure 3.7). Despite no detectable decrease in global KAP1 levels, 
KAP1 has many different functional sub-complexes (Iyengar and Farnham, 2011) 
some of which may be targeted by TEX19.1 and be responsible for the reduction in 




Figure 3.7: Human KAP1 levels are not dependent on TEX19 in HEK293T cells (A) 
Western blot and (B) quantification of KAP1 abundance in HEK293T cells after 
transfection with human TEX19 or an empty vector. Cells were co-transfected with 
GFP to control for transfection efficiency. LaminB1 was used as a loading control. 
KAP1 abundance was measured relative to LaminB1 then normalised to empty 






3.2.7 TEX19.1 does not affect ubiquitination of KAP1 
 
Previous work in the lab by Diana Best indicates that TEX19.1 inhibits the E3 
ubiquitin ligase UBR2 from binding to its N-end rule substrates and stabilises N-end 
rule reporters (Diana Best, unpublished). I therefore aimed to determine if TEX19 
could be regulating ubiquitination of endogenous human KAP1 by performing an in 
vivo ubiquitination assay in HEK293T cells transfected with tagged ubiquitin and 
human TEX19. Samples with and without his-myc-ub were pulled down with Ni2+ 
beads to isolate ubiquitinated KAP1. A band for KAP1 was present in the no his-myc-
ub lane which indicates non-specific binding of KAP1 to the beads (figure 3.8). 
Despite this, the characteristic poly-ubiquitin ladder above the KAP1 band of the plus 
his-myc-ub samples indicates that KAP1 is ubiquitinated to a similar extent with and 
without TEX19 (figure 3.8). Western blot for C-Myc is shown to indicate the amount 
of his-myc-ub present in each sample, however as with figure 3.7, the extent of over 
expression of TEX19 is unknown. The input loading controls exhibited similar levels 
of ACTIN, however different levels of KAP1. Taken together these results indicate 










Figure 3.8: TEX19.1 does not regulate levels of endogenous KAP1 by ubiquitination 
In vivo ubiquitination assay of endogenous human KAP1 in HEK293T cells in the 
presence and absence of human TEX19. Ni2+-pull downs were Western blotted with 
anti-KAP1 antibody. Input samples were Western blotted with anti-KAP1, anti-β-
ACTIN and anti-MYC antibodies. β-ACTIN serves as a loading control and C-Myc shows 
the amount of transfected his-myc-Ub. * indicates endogenous KAP1 whereas 
brackets indicates the faint ubiquitin ladder. A non-specific band at the top of the 
ubiquin ladder is marked by <. Representative Western blot of 3 independent 





3.2.8 Retrotransposons are not de-repressed in Tex19.1-/- ES cells   
 
Retrotransposons are de-repressed in multiple Tex19.1-/- tissues in vivo and the 
reduction in the repressive H3K9me3 mark and KAP1 at L1MdF2 in Tex19.1-/- ES 
cells suggested that this element could also be de-repressed in ES cells. To address this 
globally, I used microarrays to analyse the transcriptome of Tex19.1-/- ES cells cultured 
in serum and LIF. To gain a general overview of any retrotransposon de-repression, I 
first analysed the broad classes of retrotransposon; LINE, SINE, LTR, DNA repeats 
and satellite repeats using probe repeat annotation (Reichmann et al., 2012). No de-
repression of any class of transposon was detected (figure 3.9A). As the LTR 
retrotransposons MMERVK10C and VL30, members of the ERVK and ERVL 
families of elements, are de-repressed in Tex19.1-/- tissues I further extended this 
analysis to specific LTR families (ERV1, ERVK, ERVL and MalR). No upregulation 
of any LTR families was detected (figure 3.9B). This was confirmed by qRT-PCR for 
specific candidates de-repressed in Tex19.1-/- tissues (figure 3.9D). Additionally, as 
LINE-1 is de-repressed in Tex19.1-/- placentas I assessed levels of LINE-1 de-
repression which indicated there was no effect on LINE-1 in ES cells (figure 3.9C & 
D). I further confirmed that there was no transcriptional de-repression of the LINE-1 
class of retrotransposons by ChIP-PCR for H3K4me3 (figure 3.9E). Taken together, 
these data indicate that the decrease in H3K9me3 at LINE-1 loci in Tex19.1-/- ES cells 




Figure 3.9: Genome wide analysis reveals retrotransposons are not de-repressed in 
Tex19.1-/- ES cells cultured in serum and LIF (A & B) Microarray plots showing the 
mean expression level for each expressed probe in Tex19.1-/- ES cell Affymetrics 
MoGene microarray data plotted against the fold upregulation of that probe in 
Tex19.1-/- ES cells. Probes corresponding to retrotransposon classes (A) and subsets 
of the LTR family (B) are coloured as in the legends. (C) Plot showing the expression 
of probes from the entire LINE-1 class of retrotransposons in Tex19.1-/- ES cells. (D) 
qRT-PCR verification of the lack of retrotransposon de-repression in Tex19.1-/- ES 
cells. Expression levels for each element (mean ± standard error) were normalised to 
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β-actin   and then expressed relative to Tex19.1-/- ES cells (Control). (E) H3K4me3 
crosslink-ChIP PCR in control in control and Tex19.1-/- ES cells (n=3). Primers to β-actin 
acted as a positive control for the ChIP with the intergenic region acting as a negative 
control region.    
 
3.2.9 Differentiation of Tex19.1-/- ES cells does not induce 
retrotransposon de-repression 
 
TEX19.1 represses LINE-1 and VL30 elements at the transcriptional level in the 
murine placenta (Reichmann et al., 2013). The placenta is a somatic tissue composed 
of many fully differentiated cell types. It is largely the differentiated cells of the 
junctional zone which have increased LINE-1 ORF1 protein in Tex19.1-/- placentas 
which made me question if LINE-1 de-repression was a consequence of the 
differentiated state of these Tex19.1-/- cells (Reichmann et al., 2013). To test if 
differentiation of Tex19.1-/- ES cells was sufficient to induce retrotransposon de-
repression, Tex19.1+/- and Tex19.1-/- ES cells were differentiated by hanging droplet 
culture and cells were harvested from day 0 to 9. Control and Tex19.1-/- ES cells 
formed spherical three dimensional aggregates over the duration of the time course 
(figure 3.10A) which was accompanied by a reduction in the expression of the 
pluripotency associated gene Nanog, indicating differentiation was occurring (figure 
3.10A), and a reduction in expression of Tex19.1. To check if this differentiated 
cellular state was sufficient for retrotransposon de-repression in the absence of 
TEX19.1, qRT-PCR was performed for L1Orf2, L1MdF2, VL30 and MMERVK10C. 
Tex19.1 expression is absent from Tex19.1-/- ES cells (figure 3.10B).  No increase in 
RNA abundance for any retrotransposon was detected at any point relative to 
Tex19.1+/- cells suggesting that it is a property other than the differentiated state of 
Tex19.1-/- cells which is responsible for retrotransposon de-repression in the placenta 
(figure 3.10B). In contrast, VL30 and MMERVK10C expression was significantly 
decreased in differentiating day 6 Tex19.1-/- ES cells compared to Tex19.1+/- ES cells, 
implying that upon differentiation compensatory mechanisms may be increasing  
repression of these elements in the absence of TEX19.1. Alternatively, differentiation 
may be skewed in Tex19.1-/- ES cells resulting in cell composition differences, 




Figure 3.10: Retrotransposon de-repression does not occur upon differentiation of 
Tex19.1-/- ES cells. (A) ES cells were differentiated by hanging droplet culture in the 
absence of LIF. Embryoid body formation was assessed by phase contrast microscopy 
throughout the timecourse and loss of pluripotency is reflected by reduction in 
Nanog and Tex19.1 expression after qRT-PCR relative to day 0. (d0 is 0 days of 
differentiation, d3 is the third day of differentiation etc.). (B) qRT-PCR for L1Orf2, 
L1MdF2, VL30 and MMERVK10C normalised to β-actin and expressed relative to 
Tex19.1+/- ES cells (mean ± standard error for biological replicates). Tex19.1 is shown 
as confirmation of the absence of Tex19.1 in the cells used. The dotted line indicates 
expression relative to control as 1 (n.d = not detected, *P<0.05 Students T-test) 
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3.2.10 Retrotransposon de-repression in 2i conditions 
 
ES cells cultured in serum and LIF retain around 70-80% of global methylation, with 
around 40 – 60% methylation of LINE-1 elements (Walter et al., 2016). It is possible 
that these high levels of retrotransposon methylation prevent their de-repression in 
Tex19.1-/- ES cells, despite the reduction in H3K9me3 at L1MdF2. To determine if 
retrotransposons would be de-repressed in Tex19.1-/- ES cells upon reduction of DNA 
methylation, I cultured cells in the presence of two small molecule inhibitors of MEK 
and GSK3 (2i) for 14 days, which causes ES cells to enter a naïve pluripotent state and 
global hypomethylation to around 30% and 15- 20% at LINE-1 loci (Ficz et al., 2013; 
Habibi et al., 2013; Leitch et al., 2013; Seisenberger et al., 2012; Walter et al., 2016). 
Retrotransposon expression was then assessed by qRT-PCR every two days from entry 
into 2i conditions. From 0 days of culture to 4 days of culture no increase in LINE-1 
expression was detected in Tex19.1-/- ES cells compared to Tex19.1+/- ES cells (figure 
3.11A). At day 2, L1Orf2 was mildly but significantly decreased, however the reason 
for this is unclear (figure 3.11A). A mild but significant 1.08 fold increase in 
expression of L1MdF2 was detected at 6 days of 2i treatment (figure 3.11A&B)(n=3, 
*P<0.05, Students T-test). These data indicate that treatment with 2i can induce mild 
LINE-1 de-repression in the absence of TEX19.1 at day 6 but that this de-repression 




Figure 3.11: Mild de-repression of L1MdF2 occurs in Tex19.1-/- ES cells at 6 days of 
2i treatment. (A) qRT-PCR for retrotransposon expression in Tex19.1+/- and Tex19.1-
/- ES cells that have been cultured in 2i conditions for 14 days. RNA was harvested 
every other day. Expression levels for each retrotransposon (mean ± standard error) 
were normalised to β-actin and expressed relative to Tex19.1+/- ES cells (*P=0.043 
Students T-Test). (B) Bar chart representation of qRT-PCR results for 6 days culture of 




3.2.11 2i Vitamin C treatment induces de-repression of many 
retrotransposons in Tex19.1-/- ES cells 
 
Recent evidence from the Bourc’his lab indicates that supplementing 2i treatment with 
vitamin C dramatically reduces the DNA methylation levels of ES cells to 
approximately 5% global DNA methylation across all genomic regions, including 
retrotransposons (Walter et al., 2016). A transient spike in retrotransposon de-
repression is observed at 6 days of 2i+vitamin C treatment which is then quenched by 
H3K9me3 or H3K27me3 polycomb based mechanism of repression depending on the 
retrotransposon family (Walter et al., 2016). Due to the global reduction in DNA 
methylation levels to 5% upon 2i + vitamin C treatment, I therefore asked if and when 
retrotransposons would become de-repressed in Tex19.1-/- ES cells relative to 
Tex19.1+/- ES cells in the presence of 2i and vitamin C by performing a time course 
followed by qRT-PCR expression analysis.  
No de-repression of retrotransposons occurs from day 0 to day 4 and at day 6 only 
L1Orf2 is moderately de-repressed 1.09 fold which is lost at day 8 (figure 3.12, 
P<0.05, Students T-test). At 10 days of 2i vitamin C treatment MMERVK10C and 
L1MdF2 become significantly de-repressed in Tex19.1-/- compared to Tex19.1+/- ES 
cells (figure 3.12)(1.47 fold, P<0.01 and 1.42 fold, P<0.05, respectively, Students T-
Test), whereas VL30 and L1Orf2 have more moderate increases in expression (1.16 
fold; P>0.05, and 1.14 fold; P<0.05, respectively, Students T-Test). Interestingly, the 
de-repression of MMERVK10C is completely lost by 12 days, whereas, expression of 
L1MdF2 is moderately reduced compared to day 10 (1.42 fold to 1.22 fold; P>0.059) 
and maintained at this level to 14 days treatment (figure 3.12). IAP retrotransposons 
significantly increased their expression from 8 days to 14 days.  It is important to note 
that the transient spike in retrotransposon de-repression that was observed by Walter 
et al was not detected in either the Tex19.1+/- or Tex19.1-/- ES cells. The reason for this 
is unclear, however vitamin C stability may have been a contributing factor. It is not 
known if the 2i vitamin C treated Tex19.1 ES cells became hypomethylated to the same 
extent as in Walter et al. It was also surprising that upon 2i, vitamin C treatment de-
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repression of all retrotransposons analysed occurred at some stage in the time course. 
This may indicate that in hypomethylated cellular states, TEX19.1 may be repressing 




Figure 3.12: 2i Vitamin C treatment induces retrotransposon de-repression in 
Tex19.1-/- ES cells. qRT-PCR for retrotransposon expression in Tex19.1+/- and Tex19.1-
/- ES cells that have been cultured in 2i plus vitamin C conditions for 14 days. RNA was 
harvested every other day. Expression levels for each retrotransposon (mean ± 
standard error) were normalised to β-actin and expressed relative to Tex19.1+/- ES 
cells. The dashed horizontal line indicates normalised expression in Tex19.1+/- ES cells. 











3.2.12 Transcriptional de-repression of KAP1 bound, H3K9me3 
repressed LINE-1 elements occurs in Tex19.1-/- placentas  
 
I next aimed to extend my findings from hypomethylated cell culture models to in vivo 
hypomethylated placenta tissue. KAP1 ChIPseq on wild type ES cells indicates that 
KAP1 binds predominantly to L1MdF2 elements and at lower levels of the older (LX, 
L1Mus2 and L1Mus1) and younger LINE-1 elements (L1G and L1A) (figure 3.13B) 
(Castro Diaz et al., 2014). As the amount of H3K9me3 and KAP1 was decreased on 
the L1MdF2 subfamily element in Tex19.1-/- ES cells, I aimed to determine if this 
subfamily was de-repressed in Tex19.1-/- placentas to indicate a functional relationship 
between the reduction of H3K9me3 and KAP1 in vitro and LINE-1 de-repression in 
vivo.  
No de-repression was detected for the LX, L1Mus2, L1Mus1, L1G and L1A 
subfamilies, each of which had a low level of KAP1 binding in ES cells (figure 
3.13A&B)(Castro Diaz et al., 2014). The L1MdF2 element had a significant 1.7 fold 
de-repression (Figure 3.13A)(P<0.05, Students T-test,), indicating that the mechanism 
of KAP1 mediated transcriptional repression described in vitro may also be perturbed 
in vivo. This is also supported from RNAseq repeat analysis as discussed in chapter 4. 
To test if H3K9me3 was reduced in the Tex19.1-/- placentas at the L1MdF2 site I 
performed H3K9me3 ChIP-PCR on whole placenta. The active β-Actin promoter acted 
as a negative control and showed no enrichment in H3K9me3 (figure 3.14). 
Enrichment of H3K9me3 was detected at repressed retrotransposon loci in both control 
and Tex19.1-/- placentas, however a reduction in H3K9me3 was not detected at the 
L1MdF2 loci or global LINE-1 loci (figure 3.14). This is possibly due to the inherent 
heterogeneity of the placenta, whereby subtle differences in H3K9me3 levels may be 
difficult to detect compared to a homogenous cell population like ES cells. As Tex19.1-
/- is only expressed in the hypomethylated trophectoderm derived component of the 
placenta it would be expected that only this component would be affected upon loss of 
Tex19.1. Conversely, this result may suggest an alternative mechanism of TEX19.1 





Figure 3.13: KAP1 bound LINE-1 subfamilies are de-repressed in Tex19.1-/- placentas 
(A) qRT-PCR for retrotransposon expression in E12.5 Tex19.1 control and Tex19.1-/- 
whole placentas. Expression levels for each LINE-1 subfamily (mean ± standard error) 
were normalised to β-actin and expressed relative to Tex19.1 control placentas. LINE-
1 subfamilies are ordered on evolutionary age *P<0.05, Students T-test. (B) Figure 
modified from Castro-Diaz et al., 2014. Percentage of full length KAP1 bound LINE-1 
elements per LINE-1 subfamily in ES cells. Subfamilies are arranged from the oldest 





 Figure 3.14: H3K9me3 is not reduced at LINE-1 loci in Tex19.1-/- placentas (A) 
H3K9me3 ChIP-PCR for selected retrotransposon loci in control Tex19.1+/- and 














3.2.13 DNA methylation levels at retrotransposon loci are similar in 
Tex19.1-/- and control contexts 
 
The placenta is globally hypomethylated when compared to other mouse tissues and 
retrotransposons are not resistant to this hypomethylation. Around 50% of cytosines 
in CpG dinucleotides are methylated within LINE-1 elements in the placenta compared 
to around 80% methylation in the embryo (Popp et al., 2010). In order to assess if 
TEX19.1 was affecting methylation of LINE-1 in vivo, I performed bisulphite 
sequencing on whole E12.5 placentas, alongside embryo controls. Two different 
subfamilies were analysed. The first was L1A which has only low level binding to 
KAP1 and is not de-repressed in the Tex19.1-/- placentas. L1A was 94% methylated in 
the embryo compared to 71% and 72% in control and Tex19.1-/- placentas respectively 
(figure 3.15A). I then designed bisulphite sequencing primers to detect CpG 
dinucleotides in the de-repressed L1MdF2 subfamily. Embryos had 82% methylation 
compared to 52% and 54% for control and knockout placentas respectively (figure 
3.15B). This indicates that there does not appear to be a strong effect of loss of Tex19.1 
on the DNA methylation levels of these LINE-1 elements in the placenta.  
L1MdF2 has 1.4 fold lower methylation than L1A which may contribute to the de-
repression of this element in the absence of Tex19.1. As there is no de-repression of 
LINE-1 in Tex19.1-/- ES cells one hypothesis is that this could be due to high levels of 
DNA methylation. Therefore, the DNA methylation level of these particular LINE-1 
subfamilies was assessed in control and Tex19.1-/- ES cells. L1A and L1MdF2 loci had 
approximately 70% and 75% of CpG methylation in both control and Tex19.1-/- ES 
cells respectively, similar to reported levels (figure 3.15C&D)(Popp et al., 2010). 
Therefore, TEX19.1 is not regulating the DNA methylation levels of different LINE-




Figure 3.15: Tex19.1 does not affect DNA methylation of different classes of LINE-1 
element in the placenta or ES cells. Bisulphite sequencing showing the methylation 
status of L1A (A) and L1MdF2 (B) LINE-1 subfamilies in embryo, Tex19.1+/- and 
Tex19.1-/- placentas and ES cells (C & D). Methylated and unmethylated CpGs are 
denoted by filled circles and empty circles respectively, with the percentage of CpG 
methylation shown below each. Empty spaces reflect ambiguous base calls in Sanger 






In this chapter I investigated possible compensatory mechanisms of Tex19.1 mediated 
retrotransposon repression in DNA hypomethylated conditions. Initially, I determined 
that Tex19.1 is the only gene activated in in vivo and in vitro DNA hypomethylated 
contexts and that Tex19.1 facilitates repression of retrotransposons at the 
transcriptional level in different tissues (table 3.2). I then showed that this 
transcriptional repression is likely due to a role of TEX19.1 in the KAP1 mediated 
repressive mechanism, as indicated by reduced KAP1 binding and H3K9me3 at a 
particular subfamily of retrotransposons in vitro (table 3.2). I demonstrate that de-
repression of different retrotransposons occurs upon experimentally induced DNA 
hypomethylation in a temporal manner, in ES cells lacking Tex19.1. Finally, I extend 
these findings in vivo and indicate that the particular retrotransposon subfamily with 
reduced H3K9me3 in ES cells is de-repressed in Tex19.1-/- placentas (summarised in 




Table 3.2: Summary table of histone modifications and the KAP1 repressive 
cofactor binding at LINE-1 and MMERVK10C loci in different Tex19.1-/- contexts. 
Summarised from the ChIP-PCR experiments discussed throughout chapter 3. 
  
3.3.1 Compensatory mechanisms for retrotransposon repression upon 
DNA hypomethylation are working through Tex19.1 
 
Previous work from the Meehan lab shows that upon experimentally induced 
hypomethylation in vitro, methylation sensitive genome defence genes are expressed, 
the majority of which silence retrotransposons (Crichton et al., 2014; Hackett et al., 
2012). I extend these findings to in vivo hypomethylated conditions and show that of 
the in vitro methylation sensitive genes, only one gene, Tex19.1, is expressed in all 
hypomethylated tissues analysed (figure 3.1). This expression of Tex19.1 in placenta, 
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ES cells and PGCs is consistent with previous reports (Hackett et al., 2012; Kuntz et 
al., 2008; Reichmann et al., 2013). In the germline, mutagenic consequences resulting 
from increased retrotransposon activity would be transmitted to the next generation, 
whereas in the placenta no transmission to offspring would occur.  In normal 
circumstances, the placenta has co-opted numerous retrotransposon sequences, mainly 
of the LTR class, to provide dynamic regulation of developmental transcriptional 
networks in trophoblast stem cells, along with divergence of some LTRs into placental 
specific genes (Chuong et al., 2013; Emera et al., 2012; Mi et al., 2000; Thompson et 
al., 2016). This is contrary to aberrant retrotransposon de-repression in Tex19.1-/- 
placentas which are possibly associated with placental developmental defects as 
explored in Chapter 5 of this thesis. There may be other methylation sensitive genes 
expressed in the placenta with previously unappreciated genome defence roles, 
however these genes are unlikely to be methylation sensitive in all tissues, as these 
would have been detected in the Hackett et al. study. It is possible that some important 
methylation sensitive genome defence genes may have fallen below the stringent 6 
fold change cut off compared to normally methylated conditions. Regardless, this 
suggests that utilising developmentally dynamic DNA methylation to switch on 
Tex19.1 is an effective way to defend the genome in multiple developmental contexts 
vulnerable to increased retrotransposon activity (figure 3.16).  
 
Figure 3.16: Tex19.1 augments repressive histone modifications to compensate for 
loss of DNA methylation. Schematic diagram indicating that as DNA methylation is 
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reduced, Tex19.1 expression is induced which acts to augment trimethylation of H3K9 
at particular loci.  
 
3.3.2 TEX19.1 and the KAP1 mediated repressive mechanism 
 
The potential mechanism of Tex19.1 mediated retrotransposon repression at the 
transcriptional level has never been investigated, therefore one aspect of my PhD was 
to attempt to elucidate the molecular basis of this repression. I have shown that 
repression of retrotransposons by TEX19.1 can be transcriptional and data from Marie 
MacLennan indicates that TEX19.1 interacts with the transcriptional co-repressor 
KAP1. I determined that KAP1 and subsequent H3K9me3 levels were reduced at a 
KAP1 repressed LINE-1 subfamily in Tex19.1-/- which suggests that TEX19.1 was 
functioning in this KAP1 mediated mechanism. It is important to note that the small 
but significant 1.3 fold reduction in H3K9me3 binding at specific retrotransposon loci 
in Tex19.1-/- compared to Tex19.1+/- ES cells was in line with other studies where 
KAP1 is being perturbed (Castro-Diaz et al., 2014; Fasching et al., 2015). For example, 
retrotransposon de-repression occurs in neural progenitor cells conditionally deleted 
for Kap1 (Fasching et al., 2015). This is one of the only somatic Kap1 null cell types 
which has retrotransposon de-repression but when H3K9me3 ChIP-PCR was 
performed for the de-repressed IAP1 pol loci, only around a 1.5 fold decrease in 
H3K9me3 levels was detected (Fasching et al., 2015). Additionally, studies on ES cells 
knocked down for the LINE-1 targeting KRAB-ZFP, Gm6871 also revealed only a 
moderate decrease in H3K9me3 upon ChIP-PCR (Castro-Diaz et al., 2014). This 
suggests that additional KAP1 independent mechanisms or particular KAP1 sub-
complexes may also be responsible for H3K9me3 mediated repression in different 
contexts. Furthermore, H3K9me3 ChIP sequencing of these Tex19.1-/- ES cells will 






3.3.3 Possible roles of TEX19.1 in the KAP1 repressive mechanism        
 
The KAP1 repressive mechanism is dependent on the recruitment of the KAP1:HMT 
repressive complex to different loci in the genome by KRAB-ZFPs, often offering 
partial redundancy in the retrotransposon loci targeted in ES and somatic cells (Ecco 
et al., 2016; Najafabadi et al., 2015; Wolf et al., 2015b). KRAB-ZFPs have tissue 
specific expression patterns, therefore the differing retrotransposons de-repressed in 
different Tex19.1-/- contexts may reflect perturbations in tissue specific KRAB-ZFP 
proteins (Ecco et al., 2016; Rowe et al., 2013; Wolf et al., 2015). The co-
immunoprecipitation mass spectrometry experiment performed by Marie MacLennan 
did not detect an interaction between TEX19.1 and either of the HMTs, SETDB1 or 
SUV39H1/2, however it did identify a KRAB-ZFP (ZNF295) as a potential binding 
partner of TEX19.1. In humans ZNF295 (ZBTB21) is a ubiquitously expressed 
transcriptional repressor, however it is not known if this KRAB-ZFP has roles for 
retrotransposon repression (Wang et al., 2005). It is possible that this ZFP could be 
responsible for the TEX19.1 mediated deposition of H3K9me3 at LINE-1 loci in ES 
cells and experiments determining if TEX19.1 is perturbing the interaction of KAP1 
with a particular KRAB-ZFP or HMT would address this further. 
Additionally, the specificity of the H3K9me3 reduction at a particular LINE-1 
subfamily indicates that TEX19.1 may not be affecting global KAP1 function but 
could possibly be perturbing specific KRAB-ZFP function in some way. Indeed, 
global KAP1 levels are not perturbed in Tex19.1-/- placentas or in overexpression 
experiments with human TEX19. Also, it does not appear that TEX19.1 itself is acting 
as a KRAB-ZFP as I have not detected TEX19.1-YFP bound to chromatin in in vitro 
experiments on ES cells. A caveat of this experiment is that endogenous TEX19.1 is 
still present and may be preventing binding of TEX19.1-YFP. I is also unclear if this 
fusion protein is function. One future experiment to address this would be to transfect 
TEX19.1-YFP into Tex19.1-/- ES cells to detect any binding of TEX19.1-YFP to sites 
that otherwise would have been bound by endogenous TEX19.1.  
One way in which levels of KRAB-ZFPs are regulated is by KAP1 dependent 
ubiquitylation. I have shown that the levels of ubiquitylation of KAP1 are similar with 
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and without TEX19, however it is unclear if KAP1 protein is regulated by ubiquitin 
dependent proteolysis. To address this, treatment of cells with a proteasome inhibitor 
such as MG132 followed by an in vivo ubiquitylation assay would determine if KAP1 
turnover is dependent on the proteasome pathway. Regardless, KAP1 turnover itself is 
likely not being affected by TEX19, however KAP1 is also an E3 ubiquitin ligase and 
it is possible that TEX19 is regulating the ability of KAP1 to ubiquitylate a target 
protein. MAGE-I proteins have similar expression patterns to Tex19.1 and have roles 
in binding to KAP1 which promotes the poly-ubiquitination and degradation of 
KRAB-ZFPs, such as ZNF382, leading to decreased binding to particular target loci 
(Xiao et al., 2011). Interestingly, previous work in the lab by Diana Best indicates that 
TEX19.1 inhibits the E3 ubiquitin ligase UBR2 from binding to its N-end rule 
substrates, stabilising N-end rule reporters (Diana Best, unpublished). The role of 
TEX19.1 in perturbing the ubiquitination and turnover of KRAB-ZFPs is yet to be 
investigated. If this is the case, this would provide a mechanism whereby reduced 
recruitment of KAP1 to retrotransposon loci occurs due to a reduced amount of 
KRAB-ZFP, resulting in less H3K9me3.  
 
3.3.4 Combined repressive effects of DNA methylation and TEX19.1 
 
In ES cells, silencing of LINE-1 transcription does not appear to be reliant on DNA 
methylation as ES cells null for the de novo methyltransferases, Dnmt3a/b, and 
maintenance methyltransferase, Dnmt1, have no change in LINE-1 expression (Karimi 
et al., 2011; Reichmann et al., 2012). Tex19.1 becomes more highly expressed in these 
hypomethylated cells than wild type ES cells and may therefore be preventing de-
repression of LINE-1 elements by augmenting H3K9me3 for wild type ES cells as I 
have shown in this chapter (Castro Diaz et al., 2014; Karimi et al., 2011). The levels 
of LINE-1 de-repression upon removal of Kap1 or Setdb1 are relatively small in ES 
cells but far greater in Suv39h1/2 null ES cells indicating that there is redundancy in 
mechanisms of repression (Bulut-Karslioglu et al., 2014; Castro-Diaz et al., 2014; 
Karimi et al., 2011; Matsui et al., 2010). MMERVK10C are also only modestly 
expressed in ES cells null for Dnmt3a, Dnmt3b and Dnmt1, whereas are highly de-
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repressed in Kap1 and SetDB1 null ES cells indicating that H3K9me3 silences these 
MMERVK10C in vitro. Conversely, the tissue specific expression of MMERVK10C, 
LINE-1 or VL30 in different Tex19.1-/- contexts may require specific transcription 
factors that are present in germ cells but absent from the somatic placenta and vice 
versa. This has been shown for MLV retrotransposon expression, a subset of which is 
dependent on the PAX5 transcription factor in Setdb1 null B-lymphocytes (Fasching 
et al., 2015). Interestingly, loss of H3K9me3 did not correlate with retrotransposon de-
repression in these cells, highlighting the importance of tissue specific transcription 
factors in controlling the expression of retrotransposons in different cellular contexts 
(Fasching et al., 2015). 
I have shown that in Tex19.1-/- ES cells cultured in 2i + Vitamin C retrotransposon de-
repression occurs in a temporal manner for different retrotransposons. One caveat of 
this experiment is that the transient spike in retrotransposon expression determined by 
Walter et al. (Walter et al., 2016), was not detected either in the control Tex19.1+/- or 
Tex19.1-/- ES cells. This may be a consequence of cell line differences or the extent of 
DNA hypomethylation achieved in our culture conditions. The levels of DNA 
methylation were not assessed in these cells and would need to be investigated further 
to support this conclusion. The dynamics of histone modifications in these Tex19.1 
null ES cells cultured in 2i and vitamin C was also not investigated in this study but 
would be intriguing to see if compensatory repressive histone modifications are being 
perturbed at different classes of retrotransposon loci than in serum / LIF cultured ES 
cells. It remains unclear why retrotransposons that have no detectable decrease in 
H3K9me3 in serum/LIF cultured ES cells are also de-repressed in the absence of 
Tex19.1 in 2i / vitamin C conditions. 
 
3.3.5 In Vivo de-repression of KAP1 bound LINE-1 elements 
 
Previous work from the Trono lab has shown that particular subfamilies of LINE-1 are 
preferentially bound by KAP1 in ES cells compared to older and younger subfamilies 
(Castro Diaz et al., 2014). I show in this chapter that it is the most highly KAP1 bound 
LINE-1 subfamily, L1MdF2 which is de-repressed in the Tex19.1-/- placenta (figure 
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3.13). I demonstrate that this de-repression is transcriptional (figure 3.2), however 
changes in H3K9me3 at L1MdF2 loci could not be detected in Tex19.1-/- placentas 
(figure 3.14). This is possibly due to the heterogeneous nature of placental tissue 
masking any changes that may be occurring in subsets of hypomethylated 
trophectoderm-derived cells. Alternatively trophoblast cells are distinct from ES cells, 
therefore the mechanism of de-repression detected in ES cells may not be operating in 
different contexts. Indeed, KAP1 is known to regulate different retrotransposons in ES 
cells compared to relatively few examples in somatic cells and the roles for KAP1 or 
SETDB1 mediated transcriptional regulation have never been assessed in a placental 
context (Ecco et al., 2016; Fasching et al., 2015; Rowe et al., 2010). Furthermore, 
TEX19.1 is largely cytoplasmic in ES cells but appears more nuclear in the placenta 
(Ollinger et al., 2008; Reichmann et al., 2013). The effect of this differing intracellular 
localisation on TEX19.1 binding to KAP1 and molecular function are still unclear. To 
further investigate the role of Tex19.1 in retrotransposon repression in a placental 
context, using trophoblast stem cells null for Tex19.1 would allow ChIP assays on a 
more homogenous cell population. The epigenome of the placenta remains relatively 
unexplored and future conditional knockouts of key epigenetic modifiers such as 
KAP1 and SETDB1 in a variety of stages of trophectoderm development would 
enhance this understanding of retrotransposon regulation in this tissue. 
In summary, I have shown that Tex19.1 is the only gene to response to DNA 
hypomethylation in all different hypomethylated contexts assessed. This activation 
acts to augment repressive histone modifications at LINE-1 loci to limit their de-



















Chapter 4: Investigation of the role of Tex19.1 in 














The second aim of this thesis was to investigate why Tex19.1-/- placentas have 
developmental defects. As previously mentioned in chapter 3, DNA methylation is 
high in differentiated embryonic tissues, however is globally lower in placenta (Popp 
et al., 2010; Razin et al., 1984). Tex19.1 is the only methylation-sensitive, germline 
genome defence gene expressed in the placenta and Tex19.1-/- animals have 
developmental defects with trophectoderm derived cells being perturbed at an 
undefined point in gestation (Hackett et al., 2012; Reichmann et al., 2013). Tex19.1-/- 
pups exhibit intrauterine growth restriction (IUGR), however it is unclear when and 
why these placental defects are occurring. 
One interesting phenotype of the Tex19.1-/-placentas is the de-repression of 
retrotransposons. In chapter 3 I show that TEX19.1 can influence the KAP1 dependent 
transcriptional repressive, H3K9me3 mark at retrotransposon loci to compensate for 
reduced DNA methylation (figure 3.4). I also show that the increases in 
retrotransposon RNA in Tex19.1-/- placentas and testes is transcriptional, as 
demonstrated by gains in the transcriptionally active associated mark, H3K4me3 at de-
repressed retrotransposon loci (figure 3.2). This led me to hypothesise that the 
transcriptional de-repression of retrotransposons, due to changes in chromatin state, 
may be contributing to the defects in Tex19.1-/- placentas. One explanation may be the 
transcriptional de-repression of retrotransposons leading to an increase in 
retrotransposition to new genomic locations. Unique retrotransposition events may 
indeed be occurring in some cells, however the severity and uniformity of the placental 
phenotype between individual Tex19.1-/- mice suggests that this would be unlikely, 
requiring the same retrotransposition event to occur independently at early trophoblast 
stages of development of each Tex19.1-/- animal. A previously under-appreciated 
aspect of retrotransposons is their influence on transcriptional regulation of 
neighbouring genes, both in normal developmental contexts and in experimental 
contexts, where retrotransposon repression is defective (Chuong et al., 2013; 
Thompson et al., 2016). Chuong et al show that early transcriptional networks in 
trophoblast stem cells are regulated and driven by retrotransposon derived enhancers. 
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The gain of this regulatory capacity of retrotransposons was restricted to 
hypomethylated tissues, indicating that co-option of retrotransposons is generally 
restricted to tissues permissive for their activity (Chuong et al., 2013). An alternative 
hypothesis is that retrotransposon de-repression in Tex19.1-/- placentas could be 
causing increases in retrotransposon derived proteins or nucleic acids that interfere 
with host cell biology, or potentially induce innate immune responses leading to 
increased placental dysfunction and IUGR (Chiappinelli et al., 2015; Roulois et al., 
2015). Aberrant removal of endogenous nucleic acids is associated with a variety of 
autoimmune diseases in humans such as Aicardi-Goutières Syndrome (Crow and 
Rehwinkel, 2009). Mouse models of AGS which are null for proteins mutated in 
humans, indicate increases of retrotransposon nucleic acids in the cytoplasm of cells 
and likely leads to activation of a Type I interferon response and a variety of associated 
defects (Gall et al., 2012; Morita et al., 2004; Stetson et al., 2008). Despite these 
interesting hypotheses, it is also possible that Tex19.1 could be influencing placental 
development independently of any effect on retrotransposons and during this chapter 
I aimed to further characterise the Tex19.1-/- placental phenotype, whilst investigating 
the possible pathogenic causes of the placental defects observed. 
Previous transcriptional profiling of Tex19.1-/- placentas at E18.5 indicated an increase 
in many retrotransposons from the LINE-1 class to the LTR class (Reichmann et al., 
2013). This transcriptomic data, combined with histological analysis of Tex19.1-/- 
placental sections highlighted numerous compositional differences at E18.5. I 
therefore sought to investigate the developmental timing of defects in Tex19.1-/- 
placentas, with a view to performing transcriptome analysis at a developmental stage 
when Tex19.1-/- and control placentas have more similar cellular compositions. This 
would then allow me to determine genic and retrotransposon expression changes and 
gain potential insights into the pathology of the placental and IUGR phenotypes.  
During this chapter, I identify that placental defects precede IUGR and establish that 
placental weight reduction is likely due to defects in early junctional zone development 
between E10.5 and E12.5. This is accompanied by reductions in particular trophoblast 
derived marker gene mRNA, which is associated with upregulated LINE-1 
subfamilies, however the functional relevance of this association remains unclear. I 
also show that there is a type I interferon response in Tex19.1-/- placentas which may 
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be causative of the observed increased in apoptosis and reduced placental size. Thus, 
I have identified a possible role for Tex19.1 in maintaining placental immune 
homeostasis possibly via transcriptional repression of retrotransposons, which is 

























4.2.1 Reductions in Placenta Weight Precede Intrauterine Growth 
Restriction in Tex19.1-/- Animals  
 
Previous analysis of the Tex19.1-/- embryonic and placental phenotypes has only been 
performed on E18.5 animals (Reichmann et al., 2013). Therefore, it was unclear at 
what stage of embryonic development the placental defects and intrauterine growth 
restriction was occurring. To determine this, I analysed placenta and embryo weights 
earlier in development at E14.5 and E12.5 as midpoints in placental development 
where the labyrinth, junctional zone and decidua are all established (Coan et al., 2004).  
E14.5 Tex19.1-/- placentas had a significant 1.3 and 1.4 fold decrease in weight 
compared to Tex19.1+/+ and Tex19.1+/- placentas respectively (figure 4.1A & 
C)(Tex+/+ P<0.01, Tex+/- P<0.01, Mann Whitney U Test). To determine if there was a 
potential placental phenotype upon loss of one copy of Tex19.1 I compared 
heterozygous Tex19.1+/- to Tex19.1+/+ placentas. A small but significant 1.1 fold 
decrease in Tex19.1+/- placental weight was detected (figure 4.1A)(P<0.05, Mann 
Whitney U Test) which was not observed at E18.5 implying that heterozygous 
placentas recover through development (Reichmann et al., 2013).   These data indicate 
that loss of Tex19.1 is affecting placental development by E14.5. Having one copy of 
Tex19.1 also appears to be detrimental to early placental development, however to a 
far lesser extent than in Tex19.1-/- animals. This may imply that when comparing 
heterozygous Tex19.1+/- placental phenotypes to Tex19.1-/- placental phenotypes this 
is likely an underestimation of defects occurring in the Tex19.1-/- animals at E14.5. 
Furthermore, analysing the heterozygous phenotype in comparison to the Tex19.1+/+ 
may give an indication of more subtle dosage dependent phenotypes as a result of loss 
of Tex19.1. To further statistically assess differences in placenta and embryo weights, 
power calculations would enable the determination of the minimum sample size of 
placenta and embryos required to reduce the possibility of false negative differences 
in weights due to small sample sizes.      
To reach a time point closer to the onset of placental defects, I took litters at E12.5 and 
weighed the placentas. E12.5 Tex19.1-/- placentas were still significantly reduced in 
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weight 1.2 and 1.3 fold compared to Tex19.1+/+ and Tex19.1+/- respectively (figure 
4.1B)(P<0.05, P<0.01, Mann Whitney U Test), however to a lesser extent than at 
E14.5. Furthermore, preliminary data from E10.5 suggests that Tex19.1-/- placenta 
weights are similar to those of control placentas (Tex19.1-/- 34mg, n=2; Tex19.1+/- 
27mg, n=7, data not shown). The placental defects in Tex19.1-/- animals therefore 
likely arise between E10.5 and E12.5, however additional embryos need to be analysed 
at E10.5 to allow a proper statistical comparison to be made. Together these data 
indicate Tex19.1 is essential for correct placental development to E12.5 with reduced 
placental weight detectable at E12.5 and E14.5. 
To investigate if placental defects preceded IUGR I weighed embryos at E14.5 (figure 
4.1A & C) and E12.5 (figure 4.1B). At both E14.5 and E12.5 there was no reduction 
in Tex19.1-/- embryo weights compared to Tex19.1+/+ and Tex19.1+/- indicating that 
growth restriction of the embryos was likely initiating after these developmental time 
points (figure 4.1)( E14.5; Tex19.1+/+ P=0.06, Tex+/- P=0.08, E12.5; Tex19.1+/+ P=0.4, 
Tex19.1+/- P=0.06, Mann Whitney U Test). No decrease in embryo weight was found 
between Tex19.1+/- and Tex19.1+/+ animals at either time point. Taken together, these 













Figure 4.1: Tex19.1-/- placenta defects precede IUGR. (A) Boxplot showing weights 
of Tex19.1+/+, Tex19.1+/- and Tex19.1-/- embryos and placentas at E14.5. (B) Boxplot 
showing weights of Tex19.1+/+, Tex19.1+/- and Tex19.1-/- embryos and placentas at 
E12.5. Numbers of pups is shown above the genotype. Note difference in scale 
between E14.5 and E12.5 boxplots (*P<0.05, Mann-Whitney U-test). (C) Photograph 
of E14.5 embryos and placentas from one litter. Genotype is indicated above the 












4.2.2 E14.5 placentas have no increase in cellular senescence  
 
From previous analysis at E18.5 reductions in placental weight were deemed to be due 
to loss of different trophoblast derived cell types, however the cause of the cell loss 
was not investigated (Reichmann et al., 2013).  Tex19.1 placentas have de-repression 
of LINE-1 elements but also the VL30 elements of the LTR class retrotransposons 
(Reichmann et al., 2013). Cellular senescence, a stable cell cycle arrest which can be 
sustained for long periods, has recently been associated with a human LTR class 
retrotransposon (Chuprin et al., 2013). This LTR derived gene encodes the protein 
Syncytin, which facilitates the fusion of the syncytiotrophoblast in the human placenta, 
which contributes to the feto-maternal barrier and facilitates gas and nutrient exchange 
(Mi et al., 2000). Expression of the LTR derived gene in human fibroblasts and cancer 
cells was sufficient to form multinuclear cells via fusion, and induce cellular 
senescence (Chuprin et al., 2013). Due to this induction of cellular senescence upon 
the activation of this LTR, I hypothesised that this may be occurring in the Tex19.1-/- 
placentas where LTR retrotransposons are de-repressed. To assess this, E14.5 Tex19.1-
/- and control placentas were cryosectioned and stained for cellular senescence 
associated β-galactosidase (Campisi and d’Adda di Fagagna, 2007). To act as a 
positive control for the cellular senescence β-galactosidase assay I dissected the 
mesonephros from E14.5 embryos, as mesonephric tubules undergo p21 dependent, 
pre-programmed cellular senescence at this stage (Muñoz-Espín et al., 2013). The β-
galactosidase staining of the mesonephros exhibited very similar patterns to those 
observed by Munoz-Espin et al., indicating that the assay was working as expected 
and was detecting previously described senescent cells in an in vivo context (figure 
4.2A). Only a few sparse β-galactosidase positive cells were observed in control 
placentas (figure 4.2B). These were generally large polyploid trophoblast giant cells 
localised to the labyrinth. Tex19.1-/- placentas also had similar low numbers of β-
galactosidase positive cells as with the controls, which appeared to be largely 
trophoblast giant cells (figure 4.2B). Little staining was observed in 
syncytiotrophoblast cells unlike in human placentas (Chuprin et al., 2013). Therefore, 
the levels of senescent, β-galactosidase positive cells are unlikely to be sufficient to 
cause the large decrease in Tex19.1-/- placental weight at this developmental time point.  
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To further confirm that cellular senescence was not playing a major role in the 
reduction in placenta weight, I performed qRT-PCR for classical markers of cellular 
senescence on whole E14.5 placentas. Alternate reading frame protein (Arf/Cdkn2a) 
positively regulates p53 through the inhibition of the E3 ubiquitin protein ligase 
HDM2 which facilitates p53 degradation. The expression of the cyclin dependent 
kinase inhibitor p21 is then induced by p53 to induce cellular senescence directly or 
via activation of the p16-retinoblastoma protein tumour suppressor pathways (Campisi 
and d’Adda di Fagagna, 2007). Arf and p21 were expressed in control and knockout 
placentas but p16 was not. No increased expression was observed for Arf or p21 in 
Tex19.1-/- placentas (figure 4.2C). Furthermore, p21 was significantly down regulated 
1.5 fold, which is in contrast to the upregulation of p21 expected if the senescence 
pathway was activated (figure 4.2C)(P<0.05, Students-T Test, n=3). P21 can also act 
as an inhibitor of apoptosis in a number of systems. The downregulation of p21 may 
therefore suggest that an increase in apoptosis may be present in Tex19.1-/- placentas 
compared to controls (Gartel and Tyner, 2002). Together, the β galactosidase assay 
and the qRT-PCR results indicate that increased cellular senescence is unlikely to be 






 Figure 4.2: Senescence is unlikely to be a major cause of Tex19.1-/- placenta 
developmental defects at E14.5. (A) Cryosection of mesonephros from E14.5 embryo 
stained with senescence associated β galactosidase and counterstained with nuclear 
fast red. Blue colouring surrounding the mesonephric tubules indicates positive 
staining of senescent cells (Munoz-Espin et al, 2013). Scale bar=25µm. (B) 
Cryosections of littermate control and Tex19.1-/- placentas at E14.5 stained with 
senescence associated β galactosidase. Images from the labyrinth are shown with 
example positive trophoblast giant cells shown in the inset. Scale bar=50 µm, bottom 
scale bar=100µm. (C) qRT-PCR on whole E14.5 littermate control and knockout 
placentas for senescence associated cellular markers. Data is normalised to β actin 
and expressed relative to control (n=3, *P<0.05 Students T-test, n.d; not detected).   
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4.2.3 Tex19.1-/- placentas have increased cell death 
 
As the decrease in Tex19.1-/- placental weights could not be attributed to cellular 
senescence, I therefore aimed to determine if there was an increase in cell death 
throughout the different layers of the placenta. E14.5 and E12.5 placental tissue 
sections were investigated by the TUNEL assay to detect fragmented DNA, indicative 
of cell death. Tex19.1-/- placentas had a similar number of TUNEL positive cells as 
control placentas in the labyrinth layer at both E14.5 and E12.5 (figure 4.3). In the 
junctional zone of E14.5 placentas there was a significant 1.9 fold increase in the 
amount of TUNEL positive cells detected in Tex19.1-/- compared to control animals 
(figure 4.3A & C)(n=3, P<0.05, Students T-Test one-tailed). At E12.5 the junctional 
zone of Tex19.1-/- placentas had a significant 1.8 fold increase in the number of 
TUNEL positive cells compared to control placentas (figure 4.3B & D)(n=4, P<0.01, 
Students T-Test one-tailed). This suggests that the reduction in placental weight in 
Tex19.1-/- animals is due to an increase in cell death in the junctional zone. The loss of 
cells at this mid-gestational developmental time point may be resulting in the decrease 
in junctional zone area at E18.5 (Reichmann et al., 2013).  
  
Figure 4.3: Tex19.1-/- placentas have increased cell death in the junctional zone 
(figures overleaf). Images of PFA fixed sections of (A) E14.5 Tex19.1+/+ and Tex19.1-/- 
placentas and (B) E12.5 Tex19.1+/- and Tex19.1-/- placentas processed with the TUNEL 
assay. White dashed lines indicate the different layers of the placenta. Db, decidua 
basalis; Jz, junctional zone; Lb, labyrinth; Cp, chorionic plate. TUNEL positive cells are 
indicated by pointed white arrows, with auto-fluorescent background staining 
indicated by the square arrows. Negative control images are shown to indicate 
background fluorescence where no rTdT enzyme was added to the tissue sections. 
Auto-fluorescence was detected in the labyrinth, therefore only cells with a higher 
intensity than this background were scored as TUNEL positive. Nuclei were stained 
















Figure 4.3 (continued): Tex19.1-/- placentas have increased cell death in the 
junctional zone (C) Graph showing the number of TUNEL cells per mm2 in the 
labyrinth and junctional zone of control and Tex19.1-/- placentas at E14.5 (Control 
n=4, Tex19.1-/- n=3, Students 1 tailed T-Test) and (D) E12.5 (Control n=4, Tex19.1-/- 
n=4)(n.s = Non-significant, *P<0.05 Students 1 tailed T-test). Also see images in Figure 
4.3A and 4.3B on previous page. 
 
 
4.2.4 The junctional zone is significantly reduced in size in Tex19.1-/- 
placentas early in development 
 
Analysis at E18.5 indicated that junctional zone size was reduced in the absence of 
Tex19.1 (Reichmann et al., 2013). The modest but significant reduction in placental 
weight and increased cell death in the junctional zone at E12.5 indicated that placental 
developmental defects were still occurring at this time point. It was unclear if the 
increased cell death was resulting in a decrease in junctional zone size and if this could 
be contributing to the reduction in weight. I therefore measured the maternal decidua 
and the trophectoderm derived junctional zone and labyrinth areas of PAS stained 
sections of control and Tex19.1-/- placentas. E12.5 control placentas had similar 
proportions of decidua, labyrinth and junctional zone as has been previously reported 
(figure 4.4)(Coan et al., 2004). Tex19.1-/- placentas had a small but significant 1.3-fold 
increase in the contribution of the decidua (P=0.03, Students T-test) and a significant 
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1.5-fold decrease in the contribution of the junctional zone to the whole placenta 
(P=0.02, Students T-test). No change in the size of the labyrinth was detected. These 
results indicate that Tex19.1 is necessary for correct development of the junctional 
zone at these early time points which therefore results in a proportional increase in the 
contribution of the maternally derived decidua. Together, these data suggest that the 
decreased junctional zone is the major contributor to the decrease in placental weight 
of Tex19.1-/- animals. 
 
 
Figure 4.4: The junctional zone is reduced in Tex19.1-/- animals at E12.5. Graph 
showing the proportion contribution of different placental compartments to the 
whole placenta in E12.5 control and Tex19.1-/- animals. Db; Decidua basilis, Jz; 
junctional zone, Lb; Labyrinth (n=5, *P<0.05 compared to control animals, Students-










4.2.5 Trophoblast derived cell types are not reduced in E14.5 Tex19.1-/- 
placentas  
 
At E18.5 there was a reduction in the amount of trophoblast derived S-TGCs, 
spongiotrophoblast cells and glycogen trophoblast cells in the absence of Tex19.1 
(Reichmann et al., 2013). Despite only a smallincrease in TUNEL cells at E14.5 it was 
possible that decreased amounts of cells reflective of earlier defects could be 
contributing to the reduction in placental weight. To investigate if the number of 
trophoblast derived cells had already been perturbed by E14.5, I visually assessed the 
number of each cell type on H+E stained placental sections.  
Trophoblast giant cells are large mononuclear polyploid cells identified by distinct 
expression profiles and their spatial location in the murine placenta (Simmons et al., 
2007). S-TGCs line the maternal blood spaces in the labyrinth and have been shown 
to be reduced in the E18.5 Tex19.1-/- placenta. I therefore asked whether S-TGCs were 
reduced in number in E14.5 Tex19.1-/- placentas (Reichmann et al., 2013). Strict 
scoring criteria were used to determine S-TGCs where only cells larger than a defined 
area and adjacent to an obvious maternal blood space were counted as S-TGCs. 
Tex19.1-/- and control placentas had similar number of S-TGCs per area of labyrinth at 
E14.5 in contrast to the findings at E18.5 (figure 4.5). This indicates that the reduction 
in S-TGC number must be occurring after E14.5.   
At E18.5, trophectoderm derived syncytiotrophoblast and glycogen trophoblast cells 
of the junctional zone were also reduced in number in Tex19.1-/- animals (Reichmann 
et al., 2013). The junctional zone is a layer thought to play a role in endocrine 
signalling via hormone secretion and also has large glycogen stores (Christie, 1967; 
Soares, 2004; Tunster et al., 2010). To see if there was a reduction in number of these 
cells at E14.5 I counted the syncytiotrophoblast and glycogen trophoblast cells present 
in the junctional zone layer of E14.5 control and Tex19.1-/- placentas. As with S-TGCs, 
the number of trophoblast derived cells per area was similar between control and 
Tex19.1-/- placentas at this time point, again suggesting that the reduction in cell 




Figure 4.5: E14.5 Tex19.1-/- placentas have no reduction in numbers of trophoblast 
derived cells compared to control animals (A) PAS and haematoxylin stained sections 
of control and Tex19.1-/- E14.5 placentas. The black box represents the area of the 
placenta where cell types were scored, with the bottom rectangle corresponding to 
the labyrinth and the top corresponding to the junctional zone. An average cell count 
from three boxes per placenta was scored for 4 control and 4 Tex19.1-/- placentas (B) 
Graph showing the amount of sinusoidal-trophoblast giant cells (S-TGCs), 
spongiotrophoblast cells (SpT) and glycogen trophoblast cells (Gly-T) in the labyrinth 
(Lb) and junctional zone (Jz) per µm2 placenta. Scale bar=100µm 
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4.2.6 Gene expression changes in E14.5 Tex19.1-/- placentas  
 
Various changes in mRNA abundance were detected by microarray analysis in 
Tex19.1-/- placentas at E18.5 (Reichmann et al., 2013). Therefore, I next investigated 
various cellular biomarkers of expression at E14.5 that had lower mRNA abundance 
in E18.5 Tex19.1-/- placentas. To investigate the expression of marker genes for various 
cell types qRT-PCR was performed on whole E14.5 placentas. The general trophoblast 
derived cell marker Cdx2, S-TGC specific gene Ctsq, spongiotrophoblast specific gene 
Prl8a8 and glycogen trophoblast cell marker Gjb3 were expressed in control and 
Tex19.1-/- placentas. Significantly lower abundance of mRNA was detected for Cdx2 
and Ctsq in Tex19.1-/- animals (figure 4.6). As there is no decrease in the number of S-
TGCs at E14.5 this suggests these changes may be transcriptional. Prl8a8 and Gjb3 
showed no difference in abundance of mRNA in Tex19.1-/- placentas compared to 
controls supporting the cell counts from histology in the junctional zone (figure 4.5). 
Taken together, the large reduction in mRNA abundance for Cdx2 and Ctsq and the 
fact that no differences in cell composition were detected in E14.5 Tex19.1-/- placentas 
raised the intriguing possibility of a bona fide role for Tex19.1 in transcriptional control 






Figure 4.6: Gene expression changes are present in Tex19.1-/- placentas at E14.5 
qRT-PCR for trophoblast specific cell type marker genes from whole placentas at 

















4.2.7 LINE-1 retrotransposons are de-repressed at E12.5  
 
One aspect of the E18.5 Tex19.1-/- placenta phenotype is the de-repression of 
retrotransposons (Reichmann et al., 2013). Recent evidence suggests that 
retrotransposons contribute to the control of placental gene expression and that de-
repression of retrotransposons can having consequences on the transcription of 
neighbouring genes (Chuong et al, 2013)(Goke and Ng, 2016). Other findings 
implicate retrotransposon nucleic acids in activating the type I interferon response 
leading to cell death or disease (Chiapinelli et al., 2015)(Roulois et al., 2015)(Stetson 
et al., 2008). It is therefore possible that retrotransposon de-repression in Tex19.1-/- 
placentas is contributing to the developmental defects in this tissue. To address this, I 
focussed on the LINE-1 class of retrotransposons as these had the highest level of de-
repression in E18.5 Tex19.1-/- placentas (Reichmann et al., 2013). It was unclear when 
this LINE-1 de-repression was occurring in the development of Tex19.1-/- placentas 
and if this correlated with the onset of placental developmental defects. I therefore 
assessed expression of LINE-1 in control and Tex19.1-/- placentas at E10.5, E12.5 and 
E14.5. Interestingly, no difference in the expression of LINE-1 Orf2 was detected at 
E10.5 between control and Tex19.1-/- placentas (figure 4.7). In contrast, LINE-1 is 
significantly de-repressed 1.6 fold in E12.5 Tex19.1-/- placentas compared to controls 
(figure 4.7). This correlates with the onset of the placental defects. De-repression was 
further detected as a 1.7 fold increase at E14.5. The 1.6-fold increase in L1Orf2 
expression from E18.5 Tex19.1-/- from Reichmann et al., 2013 is shown as a 
comparison (figure 4.7). Therefore, once these retrotransposons become de-repressed 





Figure 4.7: LINE-1 is de-repressed in the placenta from E12.5 onwards. qRT-PCR of 
L1Orf2 expression in placentas from E10.5, E12.5, E14.5 and E18.5. Data is normalised 
to β actin and expressed relative to control values (n=2, n=5, n=6, n=6 respectively, 














4.2.8 Different classes of retrotransposons are de-repressed in 
Tex19.1-/- placentas 
 
As I hypothesised that the retrotransposon de-repression at E12.5 may be contributing 
to placental defects I aimed to determine if retrotransposons in addition to LINE-1 and 
VL30 were being de-repressed in Tex19.1-/- placentas. RNA was isolated from three 
whole Tex19.1-/- placentas and three control littermate placentas (2 Tex19.1+/+ and 1 
Tex19.1-/-) and sent for paired end, 125bp read length, RNAseq. The RNAseq data was 
mapped to the mouse genome using TopHat allowing two mismatches, and reads 
mapping to loci belonging to each class of repeat as defined by Repeatmasker 
annotation were counted. Multiple mapping reads were randomly assigned to a 
matching locus. Around 4% of control and Tex19.1-/- RNAseq reads mapped to 
repetitive elements with the highest proportion of reads being from the SINE class of 
elements (1.8%)(figure 4.8A). LTR elements comprised 1.2% of all mapped reads, 
with LINE-1 and DNA elements comprising 0.5% and 0.2% of all reads respectively 
(figure 4.8A). The number of different subfamilies within each class is shown on the 
pie chart. The proportion of reads for each class of retrotransposon was similar for 
control and Tex19.1-/- placentas. 
The placenta is a highly permissive environment for repetitive element de-repression 
presumably due to it containing hypomethylated components (Reichmann et al., 2013). 
To determine if any additional repetitive elements were de-repressed in the absence of 
Tex19.1, I performed differential expression analysis on the repeat mapped RNAseq 
data from control and Tex19.1 whole placentas. A 0.01 false discovery rate (FDR) cut 
off was utilised to determine those repetitive elements whose changes in mRNA 
abundance were likely to be bona fide expression alterations. Of the 1099 repetitive 
element subfamilies with mapped reads, a total of 23 different repetitive elements were 
significantly upregulated in Tex19.1-/- placentas versus control placentas (figure 4.8B 
& figure 4.9). Two of these corresponded to the LINE-1 family, 18 to the LTR class 
and 3 to the DNA elements. 25 repetitive elements were significantly downregulated 
in Tex19.1-/- placentas compared to controls with 4 LINE-1 elements, 20 LTR 





Figure 4.8: Different repetitive elements are de-repressed in E12.5 Tex19.1-/- 
placentas in addition to LINE-1 and VL30. (A) Pie chart illustrating the proportion of 
all RNAseq reads mapping to repeat and non-repeat regions of the genome. The pie 
chart on the right represents the proportion of each repetitive class that reads are 
mapped to with the number of different subfamilies in brackets. (B) Graph showing 
the average Log2 expression values (fragments per kilobase of transcript per million 
mapped reads, FPKM) for repetitive elements in Tex19.1 littermate control (n=3) and 
Tex19.1-/- placentas (n=3). Each point represents a different repetitive element 
subfamily and are coloured dependent on their class if their expression is changing 
significantly (FDR<0.01). The number of repetitive element subclasses are indicated 
in the legend by triangles signifying elements changing up or down. Black points 
correspond to repetitive elements with no significant changes in expression between 
control and Tex19.1-/- placentas. 
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4.2.9 Distinct subfamilies of repeat elements are differentially 
controlled in Tex19.1-/- placentas 
 
I next aimed to determine which subfamilies of elements were being de-repressed in 
Tex19.1-/- placentas. Of the 23 upregulated elements two corresponded to LINE-1 
(figure 4.9).  Earlier qRT-PCR results from E12.5, indicated that the KAP1 bound, 
L1MdF2 is significantly de-repressed in Tex19.1-/- placentas compared to control 
placentas (Chapter 3 - figure 3.13). This was confirmed in the placental RNAseq data. 
The other LINE-1 element corresponds to L1MC and represents a different LINE-1 
subfamily potentially controlled by TEX19.1. Another confirmation that our RNAseq 
repeat analysis approach was working as expected was the detection of the 
RLTR6_Mm repeat which is the LTR driving expression of the VL30 retrotransposon, 
which has previously been shown to be de-repressed in Tex19.1-/- placentas (figure 
4.9)(Reichmann et al., 2013).  
Interestingly, the most upregulated element was MLT1A (figure 4.9). This ancient 
element predates the human-mouse speciation and is present in both species (Smit 
1993; Waterston et al. 2002). Recent evidence indicates that human MLT1A elements 
are associated with placental specific genes and have been proposed to have enhancer 
functions in a tissue specific manner (Pavlicev et al., 2015). Similar observations have 
also been made for MER52 (Pavlicev et al., 2015) which is also upregulated in 
Tex19.1-/- placentas. A member of the RLTR13 subfamily is also de-repressed in 
Tex19.1-/- placentas. In mouse trophoblast stem cells, the mouse superfamily of 
RLTR13 LTR elements play important roles as placental specific enhancers (Chuong 
et al., 2013).  RLTR13D5 acts as enhancers for the core genes of the TSC 
transcriptional network Cdx2, Eomes and Elf5 (Chuong et al., 2013). The de-repression 
of the closely related element RLTR13D3 in Tex19.1-/- placentas raises the possibility 
that enhancer function may be being perturbed though development in the absence of 
Tex19.1. Recent studies also indicate LTR elements as alternative promoters for a 
variety of different genes (Thompson et al., 2016). The permissive environment of the 
placenta likely allows detection of the de-repression of many different 
retrotransposons due to reduced DNA methylation and the absence of other genome 
defence genes (Reichmann et al., 2013). 
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25 repetitive element subfamilies had reduced mRNA abundance in Tex19.1-/- 
placentas. The reason for this is not clear, however this may either indicate additional 
defence mechanisms acting in a compensatory way to repress these repetitive elements 
in the absence of Tex19.1 or that at least a subset of these elements are controlled by 
DNA methylation and may reflect alterations in the contribution of the 
hypomethylated trophectoderm derived cells in Tex19.1-/- placentas. The repetitive 
element with the most reduced abundance of mRNA was Lx4A. In a global screen for 
KRAB-ZFP repressors of repetitive elements Ecco et al. included an Lx4A sequence 
in their analysis. No KRAB-ZFP repression of this sequence was detected in mESCs 
suggesting that this element is unlikely to be repressed by KRAB-ZFPs and may 
therefore by more susceptible to DNA methylation mediated repression. Also mRNA 
abundance from IAP elements was significantly reduced in Tex19.1-/- animals. IAP is 
highly expressed in the trophectoderm derived, hypomethylated cells of the junctional 
zone and labyrinth (Reichmann et al., 2013) which suggests that the reductions in the 




Figure 4.9: Many subtypes of repetitive element are differentially regulated in 
Tex19.1-/- placentas. Plot indicating repetitive elements significantly down and 
upregulated with FDR<0.01 in Tex19.1-/- placentas. Elements are ordered by their 
Log2 FC from most downregulated to most upregulated. Classes of repetitive 
elements are coloured as follows: LINE-1 = red, SINE=grey, LTR=blue, DNA=green.  
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4.2.10 E12.5 Tex19.1-/- placentas have numerous gene expression 
changes 
 
No retrotransposon de-repression or decrease in placental weight was detected at 
E10.5. At E12.5 LINE-1 has increased mRNA abundance (figure 4.7, 4.8 & 4.9) but 
the extent of alterations of mRNA abundance for genic loci was unclear. I therefore 
focussed specifically on addressing if there were any changes in mRNA abundance in 
E12.5 Tex19.1-/- placentas where retrotransposon de-repression is first detectable.  
Paired end reads from RNA sequencing of 3 matched littermate control and Tex19.1-/- 
whole placentas were mapped to the genome using the TopHat read mapper, with 
mRNA detected for 14118 genes across all biological replicates. A false discovery rate 
cut off of 0.05 was applied to the data to determine genes with significantly different 
transcript abundance between control and knockout placentas. An initial arbitrary 
threshold of 2-fold change in mRNA abundance was applied to the significantly 
differentially expressed genes. This resulted in the identification of 77 genes with 
significantly increased RNA abundance and 65 genes with significantly reduced RNA 
abundance (figure 4.10A). These will be referred to as ‘strongly differentially 
expressed genes’. The subsets of genes being differentially expressed is discussed 
further in from sections 4.2.17.  It is possible that some of these changes may reflect 
changes in cell composition in the Tex19.1-/- placenta compared to control placentas, 
but for at least some genes such as the S-TGC marker gene Ctsq, these changes are 
likely to be transcriptional.   
 
4.2.11 Analysis of all significantly up and downregulated genes  
 
The strict 2-fold change in expression was an arbitrary cut off to determine those 
subsets of genes which were changing the most, meaning that some of the genes 
changing expression to a lesser extent would have been missed. Because of this, I 
determined how many genes were significantly up and down regulated, regardless of 
the extent of the changes. This resulted in 731 genes significantly upregulated and 599 
174 
 
genes significantly downregulated (figure 4.10B) and are discussed further from 
section 4.2.17.  
At E18.5 it was shown that mRNAs of imprinted genes are not specifically altered in 
Tex19.1-/- placentas. To investigate if this was the case at E12.5, I determined how 
many of the 151 imprinted genes in the mouse genome (imprinted gene list from: 
http://www.har.mrc.ac.uk/research/genomic_imprinting/) were significantly changing 
in Tex19.1-/- compared to control placentas. Similar proportions of imprinted genes 
(11/151) and non-imprinted genes (1319/12648) showed significantly different levels 
of mRNA in Tex19.1-/- placentas compared to controls (χ2-test, P=0.366)(Data not 















Figure 4.10: RNAseq gene expression analysis from control and Tex19.1-/- placentas 
Graphs showing the average Log2  expression values for Tex19.1 littermate control 
(n=3) and Tex19.1-/- placentas (n=3). Points coloured blue or orange correspond to 
upregulated or downregulated genes changing greater than (A) 2 fold compared to 
control and (B) no fold change cut off for genes with a false discovery rate of less than 
0.05. Black points correspond to genes with no significant changes between control 
and Tex19.1-/- placentas. 
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4.2.12 Full length LINE-1 elements preferentially flank strongly 
downregulated genes 
 
As the Tex19.1-/- placentas have numerous gene expression changes, along with 
retrotransposon de-repression I aimed to explore the possibility that de-repression of 
retrotransposons may be contributing to placental gene expression changes. When 
utilising the UCSC genome browser to view genes with significantly increased and 
decreased mRNA in Tex19.1-/- placentas, it appeared that placental genes significantly 
reduced in expression such as Ctsq (figure 4.6 & 4.10) were flanked by large regions 
of LINE-1 elements (figure 4.11A). I therefore initially focussed analysis on LINE-1 
elements.  
As many LINE-1 elements are 5’ truncated and likely transcriptionally incapable 
(Waterston et al., 2002), I generated a dataset containing coordinates of LINE-1 
elements greater than 5kb in length, to enrich for those most likely to be full length 
(~6kb). This resulted in a dataset containing 15,141 ‘full length’ LINE-1 elements. 
3951 L1MdF2, 5059 L1MdT and 3304 L1MdA elements were identified in the total 
full length LINE-1 dataset compared with the older more degenerate LINE-1 families 
such as L1Mus2 (n=350) and L1Mus3 (n=451). Because of this, further analysis was 
focussed on L1MdF2, L1MdT and L1MdA. I have also shown previously that 
L1MdF2 elements are significantly de-repressed in Tex19.1-/- placentas (Chapter 3 - 
figure 3.13 and figure 4.9). It is also of note that significant 1.3-fold de-repression of 
L1MdT (FDR=0.04) elements also occurs which was not reported in figure 4.9 as it 
was above the 0.01 FDR cut off.  
In order to determine if the 13976 non-changing or 77 upregulated and 65 strongly 
differentially expressed downregulated genes (2 fold change, FDR<0.05)(figure 
4.10A) showed any enrichment for either of these full length LINE-1 elements in the 
regions flanking their transcriptional start sites (TSS), TSS coordinates from placenta 
RNAseq and full length LINE-1 datasets were intersected with BedTools.  Some genes 
had multiple full length LINE-1 elements either upstream, downstream or both, 
however for the initial analysis, only the presence or absence of a full length LINE-1 
element was scored. No cut off for distance from the neighbouring gene was used with 
the largest distance from a gene being 1.1Mb. 
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I initially focussed on the L1MdF2 element. 3.9% of upregulated genes and 2.9% of 
non-changing genes had an L1MdF2 element either upstream or downstream of their 
TSS. Surprisingly, 15.4% of downregulated genes were flanked by L1MdF2 
(P=0.00002, Fishers Exact Test) (figure 4.11B). This suggests that there is an inverse 
correlation between the presence of a full length L1MdF2 element and the 
downregulation of its neighbouring gene. I then aimed to determine if there was an 
association of the different gene groups with the L1MdT elements. A similar pattern 
was observed, whereby 4%, 9% (P=0.03, Fishers Exact Test) and (P=0.0003, Fishers 
Exact Test) of non-changing, upregulated and downregulated genes were flanked by 
L1MdT elements respectively (figure 4.11B). It is important to note that the 15.4% of 
downregulated genes flanked by L1MdT were different to the 15.4% of genes flanked 
by L1MdF2. This indicated that there is a significant association of both upregulated 
and downregulated genes with full length L1MdT elements. L1MdA, which has no 
significant de-repression in Tex19.1-/- placentas, flanks 2.7%, 2.6% and 7.7% (P=0.03, 
Fishers Exact Test) of non-changing, upregulated and downregulated genes 
respectively (figure 4.11B). This suggests that there is a weaker but still significant 
enrichment of full length L1MdA elements in downregulated gene flanks. Psg29 was 
the only gene to be proximal to each of the three subtypes. Therefore, there is a 
significant association of downregulated gene with full length LINE-1 elements of 
different subtypes.  
The spatial relationship of this association was unclear, I therefore next aimed to 
determine the position of the full length LINE elements up or downstream relative to 
its neighbouring gene. Around half of non-changing, strongly differentially 
upregulated and downregulated genes flanked by full length L1MdF2, L1MdT or 
L1MdA have the element upstream of the TSS and half have the element downstream 
(data not shown). Together these data indicate an association of gene downregulation 
and full length LINE-1 families which are de-repressed in Tex19.1-/- placentas, both 





4.2.13 L1MdF2 elements are in close proximity to their neighbouring 
downregulated genes  
 
I next aimed to determine if the transcriptional start sites of strongly differentially 
expressed genes in Tex19.1-/- placentas are closer to full length LINE-1 elements than 
non-changing genes expressed in the placenta. Only genes associated with full length 
LINE-1 elements determined in the previous analysis (figure 4.11A) were used for this 
analysis. The average distance from TSS was calculated regardless of LINE-1 location 
up or downstream. The genes not changing in expression were an average distance of 
approximately 50kb from each subfamily of LINE-1 (figure 4.11C). Both upregulated 
and downregulated genes were an average distance of around 35kb from the L1MdF2 
elements, however it is important to note that the number of genes included in this 
analysis is relatively small for the upregulated, LINE-1 flanked gene (upregulated n=3, 
downregulated n=10). This was the shortest distance for any subfamily tested, as up 
and downregulated genes were an average of 40kb and 60kb from L1MdT elements 
respectively. L1MdA was an average of 78kb and 30kb from nearby upregulated and 
downregulated genes respectively (figure 4.11C). The small number of genes present 
in these categories precluded statistical analysis. This indicates that downregulated 
genes are not only significantly enriched in L1MdF2, but they are also in close 
proximity. This association possibly suggests a detrimental role for L1MdF2 de-
repression perturbing placental gene expression in the absence of Tex19.1, which in 
turn may be contributing to placental developmental defects.  
I next aimed to determine if there was a relationship between the extent of gene 
expression alterations and the distance from full length L1MdF2 elements. The fold 
change of each significantly differentially expressed gene was plotted against distance 
to its neighbouring L1MdF2 element. This indicated a very small correlation with R2 
value of 0.18 for strongly differentially expressed downregulated genes (n=12) 
compared to all non-significantly changing genes with an R2 of 0.0057 (n=519)(Data 
not shown). The correlation for upregulated genes flanked by L1MdF2 could not be 
performed due to only 3 upregulated genes being flanked by L1MdF2. Together these 
data suggest that any contribution of full length L1MdF2 de-repression on nearby gene 








Figure 4.11: Downregulated genes are flanked by increased numbers of full length 
LINE-1 elements compared to non-changing genes in Tex19.1-/- placentas, with no 
up or downstream bias (A) UCSC browser track indicating Ctsq (blue line) and the 
large amount of flanking LINE-1 sequences (black/grey bars). The lighter shading 
reflects an increase in of base mismatch, base deletion, and base insertion associated 
with a repeat element compared to consensus sequence. (B) Bar chart showing the 
percentage of all placental genes (purple, FDR >0.05), significantly upregulated genes 
(blue, Log2FC>1, FDR<0.05) and significantly downregulated genes (green, Log2FC<-
1, FDR<0.05) which have at least one neighbouring full length LINE-1 element. The 
number of LINE-1 flanked genes is shown above each bar. The subfamily of LINE-1 
element is shown below the bars. (*P<0.05, Fishers exact test) (C) Boxplots showing 
the distance of non-changing, upregulated and downregulated genes in Tex19.1-/- 
placentas from full length LINE-1 elements (statistical testing was not performed on 
























4.2.14 Antisense transcripts are detectable from L1 promoters but are 
not enriched in Tex19.1-/- placentas 
 
I have shown in the previous analyses that highly differentially downregulated genes 
are enriched and closer to full length L1MdF2 elements, however the functional 
relevance of this association is unclear. In other mouse mutants, retrotransposon de-
repression can have effects on neighbouring genes. For example, mouse hepatocytes 
null for Trim24 exhibit retrotransposon de-repression which results in long non-coding 
RNAs likely altering nearby gene expression (Göke and Ng, 2016; Herquel et al., 
2013). Interestingly, the Psg gene cluster has 5 highly significantly down regulated 
genes, 3 of which have full length L1MdF2 elements in the antisense orientation less 
than 5kb from the neighbouring TSS (figure 4.12A&B). The mouse LINE-1 element 
initiates an antisense transcript from the L1ORF1 protein (Li et al., 2014) which could 
potentially interfere with transcription of nearby genes. I therefore asked if an 
antisense transcript was increased in Tex19.1-/- knockout placentas from L1MdF2 
elements flanking neighbouring Psg genes. 
qRT-PCR for L1 antisense transcripts was performed on cDNA from control and 
Tex19.1-/- placentas. Robust amplification was detected for L1MdF2 antisense 
transcripts upstream of Psg18 and Psg28 in control animals, indicating that these 
elements are transcriptionally active in normal circumstances (figure 4.12C). These 
antisense transcripts were detected to the same extent in Tex19.1-/- placentas and are 
therefore unlikely to be affecting Psg18 and Psg28 gene expression in Tex19.1-/- 
animals (figure 4.12C).  No transcript was detected for the L1MdF2 element upstream 
of Psg21 in either control or Tex19.1-/- placentas. Together these results show that 
flanking LINE-1 elements are transcriptionally active in this gene cluster, however 
antisense transcripts are unlikely to be directly interfering with neighbouring gene 
expression at the loci analysed. The mechanism of disruption of gene expression by 
L1MdF2 elements, if any, remains to be elucidated and warrants further investigation.  
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Figure 4.12: L1MdF2 antisense transcripts are present in control and Tex19.1-/- 
placentas to a similar extent. (A & B) UCSC genome browser image of the repeat 
genomic environment upstream of Psg18 and Psg28 (blue bars). The large black 
rectangle on the right indicates a full length L1MDF2 element on the sense strand 
with arrows indicating its transcriptional direction. The dotted oval indicates the 
location of primer pairs to detect antisense transcripts for the qRT-PCR reaction. 
These lie upstream of the L1MdF2 TSS and between a SINE B3 element in both 
examples. Chromosome and genomic coordinates are shown at the top of each chart 
below a 5kb scale bar. Other small repeat regions are indicated by additional 
rectangles. (C) qRT-PCR for L1MdF2 antisense transcripts using primers shown in A 
and B. Fold change relative to wild type is shown following the ΔΔCT method of 
quantification with control levels indicated by a horizontal dotted line (n=3 control 





4.2.15 LTR elements are not enriched in flanking placental gene 
regions  
 
LTR elements have been observed to be controlling gene expression in a variety of 
trophoblast and placental contexts and have recently established roles in controlling 
transcriptional networks beyond pluripotency (Chuong et al., 2013; Ecco et al., 2016; 
Göke and Ng, 2016). 18 different subfamilies of LTR repeats are de-repressed in 
Tex19.1-/- placentas, I therefore hypothesised that this de-repression may be having 
consequences for placental gene expression, as with LINE-1 de-repression. I therefore 
aimed to determine if the LTR retrotransposons with the highest expression level and 
significant de-repression in Tex19.1-/- placentas are associated with up or 
downregulation of neighbouring genes.  
RLTR6, the LTR flanking VL30 elements, has a significant 1.8-fold increase in 
expression and the highest expression level for any LTR de-repressed in Tex19.1-/- 
placentas compared to control (figure 4.9).  RLTR4, RLTR13D3 and RLTR19 were 
all also analysed for this association with nearby differentially expressed genes. All 
individual elements from these subfamilies were extracted from the RepeatMasker 
dataset and identified 237 RLTR6, 239 RLTR4, 339 RLTR13D3 and 944 RLTR19 
elements throughout the genome. These coordinates were intersected with genome 
TSS coordinates for all genes expressed in our placental RNAseq dataset to determine 
if non-changing, all significantly upregulated or all significantly downregulated genes 
were associated with de-repressed LTR retrotransposons. The presence or absence of 
a flanking LTR element was scored regardless of whether multiple LTRs were flanking 
a gene. For most assessed LTR elements, there was no significant association of 
significantly differentially expressed genes with flanking LTR loci (figure 4.13A). 
Interestingly, downregulated genes were significantly enriched for RLTR4 in the 
regions flanking the TSS suggesting possible regulatory roles for this element in gene 
downregulation (P=0.02, Fishers Exact Test)(figure 4.13A).  
There was generally no up or downstream bias for LTR positioning relative to the TSS. 
Another de-repressed retrotransposon in Tex19.1-/- placentas, RLTR13D3, was also 
not significantly enriched at either upregulated or downregulated genes, therefore the 
functional relevance of these RLTR associations remain to be seen. As these were 
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detected at only a small number of loci, they are unlikely to represent a major 
mechanism contributing to the changes in RNA abundance in Tex19.1-/- placentas. 
Overall, these data suggest that there is little association of these de-repressed LTR 
elements with increases or decreases in genic transcription and these are unlikely to be 
driving large proportions of the changes in RNA abundance in the RNAseq from 
Tex19.1-/- placentas.  
 
4.2.16 RLTR6 elements are close to upregulated genes 
 
I next aimed to investigate if there were any differences in the distance of each 
subfamily of element from each flanked gene. This was performed regardless of up or 
downstream orientation. Non-changing gene TSS’s were an average distance of 80kb 
from an RLTR6 element (4.13B). Interestingly this was highly reduced to only 19kb 
for the 10 upregulated genes with associated RLTR6 elements, whilst for 
downregulated genes RLTR6 elements could be found an average of 175kb away for 
the 3 genes flanked (4.13B). This indicates that upregulated genes are flanked by 
RLTR6 far closer than would be expected from the non-changing gene category. The 
non-changing, upregulated and downregulated genes associated with RLTR13D3 had 
the element similar distances away. In contrast, upregulated genes flanked by RLTR4 
had the element less than 2kb away, however this was only two RLTR4 elements 
which represented the 5’ and 3’ LTR of a single LTR element. Interestingly, where 
non-changing genes are flanked by RLTR19 these are an average of 100kb away. In 
contrast, upregulated genes with RLTR19 associations are far closer to the element at 
45kb away (figure 4.13B). As with the LINE-1 analysis the small amount of data has 
precluded statistical analysis. Functional analysis of these associations will need to be 
performed to elucidate the possible relevance of these findings. The lack of up or 
downregulated genes being significantly enriched in LTR elements up or downstream 
of their TSS suggests that major gene expression changes are likely not occurring as a 
result of the de-repression of the RLTR elements analysed, despite reduced distances 





Figure 4.13: No enrichment is detected for LTR elements flanking up or 
downregulated compared to non-changing genes in Tex19.1-/- placentas (A) Bar 
chart showing the percentage of non-changing genes (purple, FDR >0.05), 
significantly upregulated genes (blue, Log2FC >0, FDR<0.05) and significantly 
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downregulated genes (green, Log2FC>0, FDR<0.05) which have at least one 
neighbouring LTR element. The number of LTR flanked genes is shown above each 
bar. The subfamily of LTR element is shown below the bars. *P<0.05 Fishers Exact 
Test. (B) Barchart indicating the distance of a genic TSS from a significantly de-
repressed LTR family. If a gene is flanked by multiple full length LTR elements these 
are included in the data. The number of flanked genes and the number of LTR 
elements in the downstream region are indicated above the bars in (A). 
 
4.2.17 Gene ontology analysis of genes changing mRNA abundance in 
Tex19.1-/- placental RNAseq 
 
To gain a better appreciation of the general roles of the genes altered in the E12.5 
Tex19.1-/- placentas, PANTHER gene ontology analysis was performed on the 77 
upregulated and the 65 downregulated strongly differentially expressed genes. For the 
65 genes with decreased mRNA abundance, the only GO terms significantly enriched 
in Tex19.1-/- placentas were hormone activity and receptor binding (40-fold 
enrichment, P=4.83x10-14; 4-fold enrichment, P=0.00412 respectively) indicating that 
a decrease in hormonal gene expression and signalling in the Tex19.1-/- placentas may 
be contributing to the defects in placental development. No GO terms were 
significantly enriched in the 77 significantly 2-fold increased genes and unlike the 
genes with reduced mRNA abundance, no obvious gene clusters were being perturbed. 
The genes significantly reduced over 2 fold largely corresponded to the prolactin (Prl), 
cathepsin and pregnancy specific glycogen (Psg) families. The 23 Prl genes clustered 
on chromosome 13 each have distinct temporal and spatial expression patterns largely 
restricted to spongiotrophoblast and glycogen trophoblast cells of the junctional zone 
(Simmons et al., 2008). The cathepsin gene cluster comprises 8 genes expressed in a 
variety of distinct and overlapping cell types. Ctsm and Ctsq are downregulated and 
expressed in the spongiotrophoblast, and sinusoidal trophoblast giant cells respectively 
(Bode et al., 2005). Psg genes were also reduced and are also found in the 
spongiotrophoblast layer. Many of the significantly down regulated genes had been 
identified previously at E18.5 and possibly reflect compositional changes present at 
this earlier time point (Reichmann et al., 2013). However, as Ctsq RNA abundance is 
reduced in Tex19.1-/- placentas at E14.5 in the absence of any change in the number of 
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S-TGCs (figure 4.5 & 4.6) it is possible that some of these changes in RNA abundance 
reflect changes in gene transcription. 
To determine any enrichment in GO categories missed by using only the strongly 
differentially expressed genes, I re-ran all 731 significantly upregulated genes through 
the PANTHER software. This revealed 23 GO categories significantly enriched 
P<0.01 (figure 4.14A). The top significantly enriched GO category was ‘positive 
regulation of apoptotic process’ (3.16 fold enrichment, P=2.01x10-8) which supported 
the increase in TUNEL positive cells in Tex19.1-/- placentas at E12.5, confirming that 
cells are likely dying via the apoptotic pathway (figure 4.14A & 4.3). A variety of 
other GO terms related to placental function were significantly enriched in the 
upregulated gene category, giving insights into the possible reasons for placental 
dysfunction in Tex19.1-/- animals. Taken together, ‘regulation of angiogenesis’ (3.8 
fold enrichment, P=0.000379), ‘negative regulation of vasculature development’ (5.47 
fold enrichment, P=0.00388) and ‘angiogenesis’ (2.13 fold enrichment, P=0.0044) all 
indicate that there may be problems with the development of blood vessels and blood 
supply within the placenta (figure 4.14A). A study analysing gene expression in the 
maternal decidua indicated that GO terms associated with ‘angiogenesis and blood 
vessel development’ are enriched in the decidua which would suggest that these results 
may partially reflect the compositional differences in Tex19.1-/- placentas (Knox and 
Baker 2008). However, defects in correct vasculature of the placenta has been shown 
before to contribute to IUGR due to hypoxia as a result of reduced blood supply and 
nutrient transport to the fetus (Cetin and Alvino, 2009). 
Additional significantly enriched categories could be largely grouped into immune 
response categories. ‘Innate immune response’ (2.7 fold enrichment, P=0.000768), 
‘positive regulation of immune system process’ (2.3 fold enrichment, P=0.00224) and 
‘regulation of immune effector process’ (2.78 fold enrichment, P=0.00458) all 
indicated that an immune response may be occurring in the Tex19.1-/- placentas, 
however these categories have again been indicated as a property of the maternal 
decidua. Interestingly however, one of the most highly enriched and significant 
categories was ‘cellular response to interferon beta’ which had a 12.61 fold enrichment 
(P=1.81x10-5)(figure 4.14A). ‘Cellular response to interferon beta’ was not reported 
as enriched in the maternal decidua of E12.5 placentas (Knox and Baker, 2008), 
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indicating that a bona fide immune response may be occurring in Tex19.1-/- placentas, 
possibly leading to the increased apoptosis and placental defects. 
Far fewer terms were enriched in the significantly reduced mRNA category from 
‘anion binding’ (1.8 fold enrichment, P=5.2x10-5), ‘hormone activity’ (5.5 fold 
enrichment, P=0.00024) and ‘Ras guanyl-nucleotide exchange factor activity’ (5.3 
fold enrichment, P=0.00024). These categories likely indicate a major cause of 
placental dysfunction in Tex19.1-/- animals as disruptions in the levels of hormones of 
the placenta are known to have consequences for placental and fetal development 






Figure 4.14: Gene ontology categories significantly enriched in Tex19.1-/- RNAseq. 
(A) GO analysis of all significantly upregulated genes with FDR<0.05. (B) GO analysis 
of all significantly downregulated genes with FDR <0.05. For both plots the enriched 
GO category is shown on the left of the barplot ordered by significance of enrichment 
(-Log P-value, blue bars). Fold enrichment is shown by the orange bars. Only GO 





4.2.18 The interferon pathway is activated in Tex19.1-/- placentas 
 
As the GO category of ‘Cellular response to interferon β’ had the highest enrichment 
level for the upregulated genes I aimed to confirm the mRNA changes observed in the 
interferon and immune response categories from the RNAseq (figure 4.15A). I 
performed qRT-PCR in control and Tex19.1-/- placentas and confirmed the small but 
significant increase in expression of genes in the ‘cellular response to interferon-beta’ 
category (figure 4.15B). Importantly, the extent of upregulation of these genes is 
modest but in line with other mouse knockout models where an interferon β response 
is induced such as in Samhd1-/- mice (Maelfait et al., 2016). When significantly 
upregulated genes in the GO category ‘Cellular response to interferon beta’ were 
overlapped with genes in ‘cellular response to interferon gamma’ only, Gbp2, Gbp3, 
ifitm2, ifitm3 were common to both. When intersected with ‘cellular response to 
interferon alpha’ only the upregulated genes Ifit1, Tgtp1, Ifitm2 were common 
suggesting this interferon response is specific for interferon β. Interferon β is known 
to be involved in nucleic acid sensing and the immune response to retrotransposons in 
other mouse knockouts and experimental models of retrotransposon activation, further 
supporting activation of the interferon β response (Chiappinelli et al., 2015; Herquel 
et al., 2013; Maelfait et al., 2016; Roulois et al., 2015). Interestingly, recent evidence 
from Mov10L null testes which have LINE-1 de-repression, suggest that this activation 
of interferon β can occur not only in response to LTRs but also to LINE-1 elements 
(Yu et al., 2015). Together, these results indicate that an increase in the interferon β 
immune response may be present in the absence of Tex19.1.  
Type I interferons function via signalling through activation of the Janus activated 
kinases (JAKs) which results in tyrosine phosphorylation of STAT1, leading to 
formation of interferon stimulated gene complexes (ISGs) which activate interferon 
stimulated response elements (ISREs)(Chapter 1 – figure 1.3)(Platanias, 2005). I 
therefore, aimed to determine if phosphorylation of STAT-1 is occurring in Tex19.1-/- 
placentas, as an indicator that the increased expression of the ISREs detected in the 
RNAseq is as a response to activation of the interferon β pathway.   
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Control and Tex19.1-/- placentas were dissected into junctional zone and labyrinth 
compartments at E12.5 to see if activation of interferon was specific to a particular 
layer of the placentas. Western blot for phosphorylated STAT1 indicated that STAT1 
was phosphorylated in both layers of the control and Tex19.1-/- placentas. Interestingly, 
there was increased abundance of p-STAT1 specifically in the labyrinth of Tex19.1-/- 
placentas compared to control (n=2)(figure 4.16). No difference was observed in the 
junctional zone between control and knockout placentas. Although more Tex19.1-/- 
placentas need to be analysed to confirm this effect, this indicates that the upregulation 
of interferon β associated genes represents a response to activation of the interferon 
pathway in the labyrinth. Taken together, these data suggest that loss of Tex19.1 




Figure 4.15: Immune genes are activated in Tex19.1-/- placentas (A) Heatplot of 
RNAseq genes corresponding to the ‘Cellular response to interferon β’ GO category 
ordered by significance of fold change. Yellow indicates upregulated genes whilst red 
indicates genes not changing expression. Those genes with an FDR of <0.05 are 
indicated by the bracket to the left of the plot. (B) qRT-PCR confirmation of classical 
interferon stimulated genes and immune response genes. Data is normalised to β-








Figure 4.16: The interferon response is active predominantly in the labyrinth of 
Tex19.1-/- placentas. (A) Western blot for phosphorylated STAT1 as an indicator of 
activation of an interferon response. E12.5 control and Tex19.1-/- placentas were 
dissected into junctional zone and labyrinth and probed with antibody to 
phosphorylated STAT1 and histone H3 as a loading control. Protein size is indicated 













In this chapter I aimed to gain a better understanding of the etiology of the Tex19.1-/- 
placental phenotypes previously investigated at E18.5 by Reichmann et al. I identified 
that placental defects precede IUGR of the embryo in the absence of Tex19.1 and that 
Tex19.1 has a novel role in the regulation of placental specific genes (summarised in 
table 4.1). I next sought to further characterise the retrotransposon de-repression in the 
placentas of Tex19.1-/- animals and provided evidence for intriguing potential links 
between retrotransposon de-repression and alterations in gene expression in the 
placenta. I finished the chapter with an analysis of differentially expressed genes in 
Tex19.1-/- placentas and have discovered that an aberrant innate immune response is 
occurring (table 4.1). I propose that this may be a major contributor to defects in 
placental development, such as the increased cell death, which is then leading to the 






Table 4.1: Summary of Tex19.1-/- placental phenotypes identified in this study 
4.3.1 Tex19.1-/- placental defects precede IUGR  
 
Embryos lacking Tex19.1 are born significantly smaller than their littermate 
counterparts but it was not clear if placental defects were contributing to this reduction 
in embryo size (Reichmann et al., 2013). Going back in development enabled me to 
show that there is increased cell death at E12.5, which likely leads to the reduction in 
junctional zone size (chapter results summarised in table 4.1). These defects precede 
any reduction in embryo size. This is consistent with other mouse mutants with IUGR, 
whereby a reduction in the junctional zone results in IUGR (Hitz et al., 2005; Tunster 
et al., 2010), possibly due to reduced placental hormones influencing fetal maternal 
blood supply, which in turn reduces the exchange of nutrients to the developing 
embryo (John 2013; Simmons et al., 2008; Tunster et al., 2016). The fact that Tex19.1-
/- embryos do not exhibit early embryonic lethality, such as Mash2 null embryos with 
defective spongiotrophoblast development, indicates that Tex19.1 is not absolutely 
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necessary for placental development (Guillemot et al., 1994; Reichmann et al., 2013; 
Rossant and Cross 2001). 
Placental development occurs from the polar trophectoderm layer of the blastocyst at 
E4.5, with the development of the ectoplacental cone following implantation into the 
maternal uterine wall from E6.5 to E9.5 (Watson and Cross, 2005). The 
hypomethylated trophoblast derived cells of the ectoplacental cone gives rise to 
hypomethylated cells of the junctional zone and the different types of TGCs (Hu and 
Cross, 2010). Previous analysis indicates that Tex19.1 is highly expressed in the 
ectoplacental cone in both post-implantation extra-embryonic and epiblast tissues at 
E6.5 and is maintained in the extra-embryonic tissue at E7.5, whereas expression is 
downregulated in the epiblast (Hackett et al., 2012). This raises the possibility that 
perturbing Tex19.1 may have effects earlier in placental development than is 
investigated in this study. However, the preliminary data suggesting that there is no 
difference in weights of  E10.5 Tex19.1-/- and control placentas possibly suggests that 
any defects in developing hypomethylated cell types are either more subtle at these 
earlier stages or are occurring after this time point, however more samples will be 
needed to investigate this further. Another possibility is that differentiation of some 
common precursors of spongiotrophoblast and glycogen trophoblast cells of the 
junctional zone may be being perturbed, leading to the reduced junctional zone size. 
Careful analysis of the ectoplacental cone earlier in development would need to be 
performed to assess this possibility.  
 
4.3.2 Effects of retrotransposons and their transcriptional control of 
placental genes 
 
The association of de-repressed L1MdF2 retrotransposons with downregulated genes 
in Tex19.1-/- placentas is the inverse of what has generally been reported previously 
(figure 4.11)(Goodier 2016). Largely, evidence exists for the LTR family of 
retrotransposons acting to enhance transcription via behaving as alternative promoters 
producing long non coding RNAs, or acting as enhancers upon their de-repression 
(Ecco et al., 2016; Herquel et al., 2013; Rowe et al., 2013b). The SINE class of 
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elements has also been shown to have a regulatory role in genome regulation with 
some SINE B2 elements functioning as insulators or enhancer blockers to facilitate 
gene expression in humans (Lunyak et al., 2007; Raab & Kamakaka 2010). This data 
suggested that transcription of repetitive elements may represent a strategy to establish 
functionally distinct domains within the mammalian genome to control gene activation 
(Lunyak et al., 2007). The importance of this association of retrotransposons with the 
regulation of these placental genes, along with potential mechanisms of genic 
regulation is unclear at present. Indeed, antisense transcripts from two full length 
L1MdF2 loci which are flanking significantly downregulated Psg genes was detected 
to the same extent in control and Tex19.1-/- animals. This likely points to a different 
mechanism of retrotransposon mediated repression distinct from antisense transcript 
interference, at least at the loci tested. Furthermore, the mechanism of retrotransposon 
repression could possibly be due to the perturbed function of KAP1 in the absence of 
TEX19.1 at some retrotransposon loci as indicated in chapter 3 of this thesis. 
Also, the RNAseq analysis discussed in this chapter incorporated multiple mapping 
repeats. Repeating the analysis to include only uniquely mapping repeats may shed 
more light on the specific repeat loci which are being de-repressed and address if all 
elements of a retrotransposon subfamily are de-repressed or if it is a subset which are 
sensitive to repression by Tex19.1. The differential sensitivity of different elements of 
the same subfamily to histone based repressive mechanisms has been previously 
established (Brunmeir et al., 2010).   
 
4.3.3 Gene expression changes in Tex19.1-/- placentas 
 
When genic loci were analysed from the mapped RNAseq data, it is important to note 
that many of the strongly differentially downregulated genes in Tex19.1-/- placenta are 
normally expressed in the junctional zone, which I indicate is reduced in E12.5 
Tex19.1-/- placentas. Therefore, mRNAs expressed in the junctional zone may be under 
represented in Tex19.1-/- placentas in the RNAseq data, due to this compositional 
difference. Despite this, transcriptional regulation by Tex19.1 is likely occurring for at 
least some genes as indicated by the significant reduction in the expression of the S-
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TGC marker gene, Ctsq despite similar amounts of S-TGCs. The caveat of the possible 
contribution of compositional differences was further addressed for highly 
differentially expressed transcripts, when GO terms enriched in Tex19.1-/- placentas 
were compared  alongside published GO analysis from the trophectoderm derived 
placenta compartments and the decidua (Bode et al., 2005; Knox and Baker, 2008; 
Simmons and Cross, 2005; Simmons et al., 2007, 2008). This allowed identification 
of enriched pathways unlikely to be a consequence of compositional differences. 
The fact that many genes encoding placenta derived hormones were reduced in 
expression, such as the Psg genes and placental lactogens, likely indicates reduced 
hormone secretion into maternal blood. This may therefore be negatively influencing 
maternal-fetal processes and reducing communication across the fetal-maternal 
interface (John, 2013, Simmons et al., 2008). PSG proteins have roles in protecting the 
fetus from the maternal immune system, along with roles in remodelling both placental 
and maternal vasculature (Wu et al., 2008). Interestingly, reduced levels of these 
hormones in maternal blood in humans is associated with placental dysfunction and 
pregnancy complications such as pre-eclampsia and IUGR (Bersinger and Ødegård, 
2004).  
In addition to placental specific gene clusters, some interesting genes were detected as 
highly down regulated out-with these genes families. For example, Keratin 
intermediate filament 5 (Krt5) was downregulated 16 fold (P=2.14x10-33). This gene 
is hypermethylated in low birth weight human females compared to normal 
birthweight (Rumbajan et al., 2016). The expression of this gene as a consequence of 
this increased DNA methylation is unclear but indicates an association of this gene 
with low birth weight humans and mice (Rumbajan et al., 2016). Interestingly, mice 
null for Krt5 die shortly after birth due to defective development of the basal 
epidermis, indicating an essential role for this gene in development, however the role 
of this gene in the mouse placenta remains unclear (Peters et al., 2001b).  
Some individual highly expressed genes provided interesting links to placental 
dysfunction. The most highly upregulated gene Adamdec1 (4-fold upregulation, 
P=3.80x10-8) is localised to the spongiotrophoblast layer at E12.5 and is negatively 
regulated by prolactin when expressed in the uterus (Baran, 2002). This suggests that 
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the reduction in the expression of prolactin genes from the junctional zone leads to 
upregulation of Adamdec1 which is thought to have functional consequences on the 
immune environment and angiogenesis of placentas (Baran, 2002). The upregulation 
of this gene in response to the reduction in prolactins indicates that perturbations in 
the hormonal environment of the placenta can have dramatic regulatory effects on 
placental genes. 
 
4.3.4 Response to Interferon β 
 
To investigate further mechanism which may be contributing to impaired placental 
development GO analysis was performed. Interestingly, the most highly enriched and 
significantly changing GO category was ‘cellular response to interferon β’. This is 
likely not explained by the overrepresentation of the maternal decidua as this GO 
category has not been reported to be enriched in genes expressed in the decidua (Knox 
and Baker 2008). To further address this I confirmed that the GO category represented 
a bona fide activation of the interferon β pathway by demonstrating an increase in the 
phosphorylation of STAT1, a major effector protein responsible for activation of 
interferon stimulated genes (Kassiotis and Stoye 2016). This was specifically detected 
in the labyrinth compartment and suggests that the increased cell death that is 
occurring in the junctional zone may be likely due to paracrine effects of secreted 
interferon β, if this is indeed causative of the cell death. More animals will be needed 
to confirm this finding and additional analysis of proteins such as ISG15, an interferon 
inducible, ubiquitin-like protein modifier with antiviral functions, will provide further 
evidence for the activation of a bona fide type I interferon response in the labyrinth of 
Tex19.1-/- placentas (Maelfait et al., 2016; Morales and Lenschow, 2013). The 
response to interferon β in Tex19.1-/- placentas and its potential contribution to IUGR 
of the embryo is also intriguing due to evidence from humans. Interferon β is used as 
a therapy for multiple sclerosis and in multiple studies has been associated with IUGR, 
however the placental pathology in these patients has never been assessed (Amato et 
al. 2010; Boskovic 2015). 
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At present the cause of the increased interferon β response in Tex19.1-/-is unclear, 
however a few intriguing possibilities have arisen from this study and other recent 
research. The first thing to hint at a possible cause of the interferon response was the 
enrichment in GO categories ‘regulation of defence response’ and ‘defence response 
to virus’ (P<0.01, 2.73 fold and 4.6 fold respectively). The de-repression of 
retrotransposons in Tex19.1-/- placentas raises the possibility that the interferon 
response is activated to sense these retrotransposons. Indeed, mice null for the 
methylation sensitive genome defence gene Mov10L have de-repression of LINE-1 in 
spermatocytes accompanied activation of interferon β (Yu et al., 2015; Zheng et al., 
2010). The activation of interferon β was shown to be due to LINE-1 increases by in 
vitro overexpression experiments (Yu et al., 2015).  Numerous studies in humans and 
mice indicate activation of interferon β responses are induced via the sensing of de-
repressed retrotransposon derived nucleic acids in the cytosol of affected cells 
(Chiappinelli et al., 2015; Herquel et al., 2013; Roulois et al., 2015). This response can 
be mediated by the cytosolic DNA sensor Tmem173 (Sting) or the cytosolic dsRNA 
sensors Rig1 or Mda5 (Paludan and Bowie, 2013). Interestingly, Tmem173 was 
significantly upregulated in Tex19.1-/- placentas. To determine if the interferon β 
response and placental developmental defects are dependent on the sensing of 
increased cytosolic retrotransposon DNA, inter-crosses of Tex19.1+/- and Tmem173-/- 
mice could be performed, to generate double Tex19.1-/-Tmem173-/- mice. If mutating 
Tmem173 abrogates the IUGR phenotype of Tex19.1-/- pups, this would provide 
evidence that inappropriate activation of an innate immune response is contributing to 
the placental defects and IUGR seen in Tex19.1-/- mice.  
From my findings in this chapter, I propose that the response to interferon β, along 
with reduced hormonal gene expression, are likely exerting combined effects on 
development of the placenta, which is exacerbated throughout gestation and 














Chapter 5: Investigation of the contribution of the 
TEX19.1 interacting proteins, the E3 ubiquitin 

















TEX19.1 is a protein comprised of two unique domains, the sequence of which gives 
no indication of its biochemical function. Therefore, to impart potential mechanistic 
functions of TEX19.1 it is useful to consider its interacting partners. The phenotype of 
mice null for an interacting protein can then give an indication of the possible 
functional contribution of that protein interaction to the Tex19.1-/- phenotype. TEX19.1 
interacts with the E3 ubiquitin ligase UBR2 (Yang et al., 2010). Ubr2-/- testis have 
severe atrophy owing to the arrest of meiotic spermatocytes early in prophase I, similar 
to Tex19.1-/- animals (Kwon et al., 2003). The de-repression of MMERVK10C 
retrotransposons that are observed in Tex19.1-/- animals (Ollinger et al., 2008) has 
never been investigated in Ubr2-/- mice and it is unclear if other interacting partners 
may also contribute to the phenotypes observed in Tex19.1-/- testes. Therefore, the final 
aim of my PhD is to investigate the hypothesis that the defective spermatogenesis and 
transcriptional retrotransposon de-repression phenotypes observed in Tex19.1-/- testes 
may be, at least in part, due to loss of TEX19.1 interacting partners. 
To determine other interacting partners of TEX19.1 in addition to UBR2, Marie 
MacLennan performed co-immunoprecipitation (Co-IP) mass spectrometry on the 
cytoplasmic fraction of TEX19.1-YFP ES cells. This indicated that TEX19.1 can also 
be co-immunoprecipitated with the E3 ubiquitin ligases UBR5 and KAP1 (figure 5.1 
& figure 3.3). Each interaction determined by mass spectrometry was confirmed by 
Co-IP in TEX19.1-YFP ES cells and western blot for GFP confirmed successful 
immunoprecipitation of YFP or TEX19.1-YFP (figure 5.1 & figure 3.3 Marie 
MacLennan). Conditional germ line deletion of Kap1 has no gross effect on meiosis 
(Weber et al., 2002), has well characterised roles in retrotransposon repression (Rowe 
et al., 2010) and has been previously investigated, however potential roles for Ubr5 in 
spermatogenesis and retrotransposon regulation have never been studied. 
UBR5 is a HECT domain E3 ligase implicated in a broad array of processes such as 
N-end rule proteolysis and ubiquitin mediated degradation (Varshavsky, 2011), cell 
cycle checkpoint control (Munoz et al., 2007) and regulation of histone ubiquitylation 
at sites of DNA damage (Gudjonsson et al., 2012). It is unknown if Ubr5 is necessary 
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for spermatogenesis or retrotransposon repression, as embryonic lethality upon loss of 
Ubr5 has precluded previous analysis (Saunders et al., 2004). To address this, I 
generated Stra8-Cretg Ubr5flox/Δ (Ubr5CKO) mice where Ubr5 expression is 
conditionally ablated in undifferentiated spermatogonia due to the expression of the 
Stra8-Cre transgene from 3 days post-partum onwards (Sadate-Ngatchou et al., 
2008).The main objective of this chapter is to determine the extent to which the 
TEX19.1 interacting partners UBR5 and UBR2 may be contributing to the Tex19.1-/- 












Figure 5.1: TEX19.1 interacts with UBR5 (experiment performed by Marie 
Maclennan). Western blot of co-immunoprecipitation experiment confirming the 
interaction of TEX19.1 and UBR5 identified by IP-mass spectrometry. Bands 
corresponding to UBR5 are identified in the input lanes of both Tex19.1-YFP and YFP 
ES cells. Immunoprecipitation was performed using GFP beads and a band 
corresponding to UBR5 is detected in Tex19.1-YFP ES IP but is absent from YFP ES IP 











5.2.1 Ubr5 is expressed throughout spermatogenesis 
 
Ubr5 mRNA and protein is present in rat gonocytes and spermatogonia and in humans 
Ubr5 has the highest levels of expression in testis compared to other tissues (Callaghan 
et al., 1998; Manku et al., 2012). The extent of Ubr5 expression in mouse testis has 
never been investigated. Therefore, to address the expression levels of the TEX19.1 
interacting partners Ubr5 and Ubr2 in mouse testis in relation to a range of different 
tissues, I analysed publicly available mouse gene expression microarray datasets 
(Thorrez et al., 2008; GSE9954). Ubr5 expression is highest in ovaries, placenta and 
testis, with slightly lower expression in muscle and heart (figure 5.2A). The lowest 
levels of Ubr5 expression are present in liver, lung, kidney, spleen and brain. Ubr2, 
has highest expression in the ovaries, placenta and muscle, however lowest expression 
in the testis (figure 5.2A). The germline specific gene Dazl is shown as a positive 
control for testis expression and the trophoblast specific gene, Cdx2 is shown as a 
positive control for placental expression (figure 5.2A).  
The high levels of Ubr5 expression in the testis prompted me to more specifically 
determine at what stage of spermatogenic development Ubr5 is expressed. 
Spermatogenic development in seminiferous tubules can be divided into twelve stages 
in the mouse. Each stage has characteristic combinations of spermatogonia, 
spermatocytes and spermatozoa synchronously proceeding through the spermatogenic 
cycle (figure 1.11)(Russell et al., 1990). I therefore analysed gene expression 
microarray data from different microdissected seminiferous tubule stages (Hasegawa 
and Saga, 2012; GSE34758). This indicated that Ubr5 has consistent expression in 
each stage of tubule, similar to Ubr2 (figure 5.2B). It is not clear why there is disparity 
between Ubr2 and Ubr5 expression data in figure 5.2A compared to figure 5.2B. 
Expression of the germline specific gene Dazl is indicated as a marker of germline 
expression and Cdx2, a placental specific gene which exhibits no germline expression, 
acted as a negative control (figure 5.2B). Interestingly, Ubr5 and Ubr2 are 
significantly more highly expressed in seminiferous tubules than FACs sorted sertoli 
cells, indicating that the majority of expression is likely due to developing germ cells.  
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In order to determine if this was the case, I investigated the expression dynamics of 
Ubr5 and Ubr2 throughout spermatogenesis using publicly available RNAseq datasets 
of purified germ cells (Gan et al., 2013; GSE35005 Supplementary data 2). Ubr5 is 
expressed throughout spermatogenesis from primary spermatogonia-A to elongating 
spermatids and has a 1.8 fold increase in expression from pre-leptotene spermatocytes 
to pachytene spermatocytes (figure 5.2C). Ubr2 is also expressed at all stages of 
spermatogenesis, however undergoes a 2.1 fold reduction in expression from 
preleptotene spermatocytes to pachytene spermatocytes (figure 5.2C).  Ubr2 null mice 
are infertile and exhibit numerous defects in progression through spermatogenesis as 
previously discussed (An et al., 2012; Kwon et al., 2003). These data indicate that 
Ubr5 may be functioning at all stages of spermatogenesis, with the increase in 





 Figure 5.2: Ubr5 is expressed throughout spermatogenesis with peak expression in 
pachytene spermatocytes and round spermatids. (A) Microarray expression levels 
(mean ± standard error for three replicates) for the TEX19.1 interacting partners 
UBR5 and UBR2 in a range of different tissues. Dazl and Cdx2 are included as germline 
and placenta specific genes respectively (Data from Thorrez et al., 2008, GSE9954). 
(B) Microarray expression levels from microdissected seminiferous tubule stages 
(Mean shown. No standard error bars due to only two replicates; data from 
Hasegawa & Saga 2012, GSE34758). (C) RNAseq expression levels from sorted 
spermatogenic cell types. Primary spermatogonia-A (priSG-A), spermatogonia-A (SG-
A), spermatogonia-B (SG-B), pre-leptotene spermatocyte (plp-SC) and pachytene 
spermatocyte (pacSC) are from prepubertal mice undergoing the first wave of 
spermatogenesis and round spermatids (rST) and elongating spermatids (eST) are 
from 60 day postpartum adult mice (Gan et al., 2013, GSE35005, Supplementary data 
2). (Mean shown. No standard error bars due to only two replicates; data from Gan 
et al., 2013, GSE35005, Supplementary data 2). 
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5.2.2 Generation of conditional Ubr5CKO animals   
 
Loss of UBR5 is embryonic lethal due to failure of yolk sac vascularisation and 
chorioallantoic fusion (Saunders et al., 2004), therefore to assess the potential role of 
UBR5 during spermatogenesis I generated conditional Stra8-Cretg Ubr5flox/Δ 
(Ubr5CKO) mice. To interfere with mRNA expression and UBR5 protein function 
C57BL/6J mice carrying the EUCOMM Ubr5 conditional gene trap (EUCE0171f01)  
in the antisense orientation between exons 20-21 were obtained from Mark Ditzel 
(figure 5.3A)(Kinsella et al., 2016; Schnütgen et al., 2005).  
This conditional Ubr5 gene trap allele contains a splice acceptor site, a β-
galactasidase:aminoglycoside 3’ phosphotransferase (βGEO) coding sequence 
conferring X-gal staining and Neomycin resistance followed by a poly-adenylation 
signal (figure 5.3A). The cassette is flanked by two site-specific recombination loci 
(FLPe/frt and Cre/loxP) which allow for gene trap cassette inversions from the sense, 
coding strand of Ubr5 to the antisense, noncoding strand and back (figure 5.3A). In 
the antisense orientation the cassette does not disrupt Ubr5 gene expression and the 
UBR5 protein retains all domains (Ubr5flox)(figure 5.3A). After CRE-mediated 
recombination, the cassette recombines in the sense, mutagenic orientation where the 
predicted fusion protein consists of βGEO fused to UBR5’s UBA domain (Ubr5Δ) 
(figure 5.3B). This UBR5 fusion protein is predicted to be functionally impaired due 
to lack the UBR domain responsible for N-end rule function (Kozlov et al., 2007), the 
HECT domain E3 ubiquitin ligase activity (Matta-Camacho et al., 2012) and miRNA 
regulatory function via the Poly(A)-binding protein C-terminal (PABC) domain 
(figure 5.3B) (Lim et al., 2006).  
Ubr5 expression was conditionally ablated in undifferentiated spermatogonia by 
crossing with mice transgenic for Stra8-Cre (Sadate-Ngatchou et al., 2008). This 
transgene drives expression of Cre recombinase, which recombines the gene trap 
cassette in the mutagenic, sense orientation specifically in male germ cells from 3 days 






Figure 5.3: Schematic of the Ubr5 gene trap allele and resultant protein domains 
before and after STRA8-CRE mediated recombination (Modified from Kinsella et al., 
2016). (A) Schematic of the EUCOMM EUCE0171f01 gene trap introduced between 
exon 20 and 21 of Ubr5. The orientation of FRT, loxP and lox511 recombination sites 
are shown as triangles flanking the gene trap which contains a splice acceptor site 
(SA), a LacZ and neomycin coding sequence (βgeo) and a poly-adenylation signal (pA). 
This allele codes for whole UBR5 protein as indicated below the schematic. (B) 
Representation of the effect of Cre mediated recombination on the gene trap allele 
and the resultant non-functional fusion protein with UBR, PABC and HECT domains 








5.2.3 Ubr5CKO mice are born at normal Mendelian ratios 
 
Generally, heterozygous male Stra8-Cretg Ubr5flox/wt mice were crossed with 
heterozygous female Stra8-cre- Ubr5flox/wt mice to generate the male specific 
conditional Ubr5 knockout genotype Stra8-Cretg Ubr5flox/Δ (Ubr5CKO) at an expected 
frequency of 1:16 (see section 2.7.1 for further information about breeding strategy). 
To ensure the Stra8-cre transgene was present and the animals were heterozygous for 





Figure 5.4: Genotyping of Ubr5 transgenic animals. Genotyping PCR results from tail 
tips of Ubr5 transgenic mice. (A) The presence of the Stra8-Cre transgene is 
determined by the detection of a lower band indicated by the arrow. The upper band 
is a control PCR in a non-transgenic region of the genome. (B) The wild type allele is 
detected by primers flanking the βGEO gene trap cassette determined by the lower 
band indicated by the arrow. The upper band is detected due to the presence of the 
βGEO cassette. (C) Presence of a band is used to detect the βGEO cassette in the 
antisense orientation (flox). (D) The sense orientation βGEO cassette, resulting in 
non-functional UBR5 fusion protein, is determined by the presence of a lower band 
indicated by the arrow. * indicates the Ubr5CKO genotype. (E) Schematic indicating the 




To ensure there was no embryonic lethality associated with any particular genotype, 
Chi-squared tests were performed. Ubr5wt homozygous, heterozygous and Ubr5flox 
homozygous offspring were obtained at the expected Mendelian ratio of 1:2:1 
respectively (χ2-test p=0.3, n=142)(table 5.1). Males and females were born at the 
expected 1:1 ratio (χ2-test p=0.4, n=142) and Stra8-Cretg and Stra8-Cre- alleles were 





Table 5.1: Observed and expected distribution of all Ubr5CKO genotypes. Table 
indicating the observed and expected ratios of pup genotypes from crosses of male 







Number of Pups 
Observed
Number of Pups 
Expected
Stra8- wt/wt 20 17.75
Stra8- wt/flox(del) 29 35.5
Stra8- flox/flox(del) 12 17.75
Stra8+ wt/wt 22 17.75
Stra8+ wt/flox(del) 43 35.5
Stra8+ fox/flox(del) 16 17.75
Total 142 142




Recombination by Cre transgenes can have varying efficiencies (Sadate-Ngatchou et 
al., 2008). Therefore, to determine the excision efficiency of Stra8-Cre for the Ubr5flox 
allele, male Stra8-cretg Ubr5flox/wt and female Stra8-cre- Ubr5flox/wt animals were mated 
and the frequency of the transmission of the Ubr5del allele was determined in the 
offspring. Stra8-cre is male specific and has no activity in the female germline, 
therefore the Ubr5del allele must be generated in the paternal germline (Sadate-
Ngatchou et al., 2008). If Stra8-cre was 100% efficient, no Ubr5flox/flox pups would be 
expected. The ratio of Ubr5flox/flox and Ubr5flox/del pups therefore indicates the excision 
efficiency of Stra8-Cre. A total of 3 pups were homozygous Ubr5flox/flox, whereas 25 
pups were heterozygous Ubr5flox/del. This indicates an 89% Ubr5flox excision efficiency, 
suggesting incomplete excision of theUbr5flox allele in 11% of spermatocytes. 
 
5.2.4 Ubr5 protein levels are reduced in Ubr5CKO testes  
 
I next aimed to determine if there were lower levels of UBR5 protein in seminiferous 
tubules of Stra8-Cretg Ubr5flox/Δ (Ubr5CKO) animals, indicative of successful knockout 
of Ubr5. Immunostaining with an anti-UBR5 antibody was performed on cross 
sections of seminiferous tubules from control and Ubr5CKO animals (figure 5.5). 
 Previous studies have identified UBR5 protein in rat spermatogonia and my 
microarray and RNAseq data analysis identified Ubr5 expression in cells in all stages 
of spermatogenesis from spermatogonia to elongating spermatids (Manku et al., 
2012)(figure 5.2B&C). In line with this expression analysis, UBR5 protein was 
detected in adult control testis, in the nuclei of spermatogonia (triangle arrow), with 
strongest staining detected in meiotic spermatocyte nuclei (arrowhead)(figure 5.5B). 
Sertoli cells were not stained for UBR5, in line with expression analysis (pointed arrow 
(figure 5.5B & 5.2B). Moderately weaker nuclear staining was detected in round 
spermatids and UBR5 staining was largely absent from elongating spermatids (figure 
5.5). Modest staining in interstitial cells possibly reflects background staining as was 
also detected in sections assessed with a negative isotype control (figure5.5A 
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Secondary only).  In contrast, reduced amounts of staining was observed in Ubr5CKO 
testes in all spermatogenic cell types, indicating that conditional Ubr5 deletion results 
in reduced protein levels as expected (figure 5.5). Interestingly, some spermatocytes 
still stain for UBR5 despite neighbouring cells being largely devoid of staining (* in 
figure 5.5B) suggesting that these are retaining Ubr5 expression and have escaped 
excision by Stra8-Cre.  
 
Figure 5.5: UBR5 staining is present in all cell types through spermatogenesis and is 
reduced in Ubr5CKO testes (figures 5.5A and 5.5B on subsequent full pages) (A) 
Immunofluorescent staining of cross sections of adult control and Ubr5CKO testis with 
antibody to UBR5 protein. Scale bar represents 100µm. (B) Higher magnification 
images of control and Ubr5CKO testis. Sertoli cells negative for UBR5 are indicated by 
the pointed arrow, UBR5 positive spermatogonia by the triangle arrow and meiotic 
spermatocytes by the arrowhead. Spermatocytes retaining UBR5 expression in 
Ubr5CKO testis are indicated by *. A secondary antibody only, negative isotype control 
















5.2.5 Ubr5CKO animals have significantly reduced testes weight and 
sperm count  
 
To determine if there were any overt defects in testis development after Ubr5 deletion, 
I weighed the testes and performed epididymal sperm counts. Adult control mice had 
an average testis weight of 90mg which was reduced 1.7 fold to 52mg in Ubr5CKO mice 
(figure 5.6A)(n=8, P<0.01, Mann Whitney U test). This is a less severe phenotype than 
the 2.6 fold reduction in testis weights from adult control (111mg) to Tex19.1-/- animals 
(42.5mg) (Ollinger et al., 2008). Testis were visibly reduced in size, however there 
were no apparent perturbations in general shape compared to control animals (figure 
5.6B). To determine if this reduction in weight was in part due to a reduction in mature 
spermatozoa I counted sperm from the epididymis. There was a 7 fold reduction in 
sperm count from 1.9x107 cells/epididymis in control animals to 2.9x106 
cells/epididymis in Ubr5CKO animals, indicating that Ubr5 is contributing to germ cell 
development (figure 5.6C&D)(n=6, P<0.01 Mann Whitney U test). This reduction in 
sperm is less severe than the 100 fold reduction in Tex19.1-/- animals where control 
testes have 1.3x107 sperm/ml versus 1.3x105 sperm/ml in Tex19.1-/- mice (Ollinger et 
al, 2008). This is likely partially due to the Stra8-Cre being 86% efficient and leaving 
around 11% of spermatocytes with Ubr5flox alleles, but also indicates that the Ubr5CKO 
spermatogenic defect may be distinct from the meiotic defects in Tex19.1-/- testes.  
Different previously studied mutant mice with defects in spermatogenesis exhibit 
different dynamics of testicular degeneration over time (Crichton et al., 2013). For 
example, Tex19.1-/- mice showed no correlation between the severity of testis 
degeneration and the age at which the mice were examined from 6 weeks to 9 months, 
whereas Ubr2-/- mice have severe testicular defects at 2 weeks post-partum with 
progressive decline in testis weight to 9 (Kwon et al., 2003; Ollinger et al., 2008). Mice 
lacking the Zfp145 gene which encodes the undifferentiated spermatogonia restricted 
protein, PLZF have a progressive, age dependent decline (Costoya et al., 2004). To 
determine if there was a progressive decline in Ubr5CKO testis weight upon aging I 
analysed 6-7 week and 5 month testis weights. 5 month old control mice had a 1.1 fold 
increase in testis weight compared to 6 to 7 week old control mice. In contrast, 
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Ubr5CKO mice has a 1.3 fold decrease in testes weights from 6-7 week old to 5 month 
Ubr5CKO animals, suggesting that there is only moderate progressive testes 
degeneration with age (See appendix figure 7.2 for comparison of 6 week and adult 
testes weights and sperm counts).      
 
 
Figure 5.6: Testes weight and sperm count of adult Ubr5CKO animals is significantly 
reduced. (A) Boxplot showing the median testis weights of adult control and Ubr5CKO 
mice (n=8 for both genotypes, *P<0.01, Mann Whitney U-test). (B) Photograph 
showing that testes from Ubr5CKO animals are smaller in size than control animals. 
Scale bar=500µm. (C) Boxplot showing that median epididymal sperm count is 
significantly reduced in Ubr5CKO mice (n=6, *P<0.01, Mann Whitney U-test). (D) Image 
of a cross section of adult control and Ubr5CKO epididymis after haematoxylin and 
eosin staining. Tubules contain visibly less mature spermatozoa and confirm the 





5.2.6 Ubr5CKO animals are fertile and produce offspring at Mendelian 
ratios 
 
To investigate if the severe testicular atrophy and 5.2 fold reduction in sperm count in 
adult Ubr5CKO animals rendered the mice infertile, three 5 month Ubr5CKO males were 
mated with wild type C57BL/6 females. Each mating pair was allowed to produce two 
litters.  Offspring were born at the expected 1:1 ratio of Ubr5wt/flox and Ubr5wt/del (table 
5.2) and the transmission of the Stra8-Cre transgene was also 1:1 as expected as 
transmission was from the father. There was an average litter size of 10 pups, 
indicating that the Ubr5CKO males are fertile despite the reduction in sperm count. This 
also suggests that Ubr5 is essential for spermatogenesis and that the sperm contributing 
to offspring represent germ cells where excision of the Ubr5flox allele has not occurred.   
  
 
Table 5.2: Observed and expected ratios of pups from Ubr5CKO males and WT 
females. Table indicating the number of pups observed from mating experiment and 
their possible genotypes. Stra8- or + indicates the absence or presence of the Stra8-
Cre transgene in offspring. wt/flox or wt/del indicates the combination of Ubr5 alleles 
each offspring may inherit. The Chi2 test represents the ratios of genotypes in the 
table compared to their expected ratios of 1:1. The numbers of genotypes do not 






Number of Pups 
Observed
Number of Pups 
Expected
Stra8- wt/flox 13 15.25
Stra8- wt/del 20 15.25
Stra8+ wt/flox 16 15.25
Stra8+ wt/del 12 15.25
Total 61 61




5.2.7 Ubr5CKO animals have severe testicular atrophy and increased 
apoptosis  
 
Spermatogenesis occurs in a synchronised wave of development from mitotic 
spermatogonia lining the edge of the tubule, followed by meiotic progression via 
reductional chromosome divisions of primary spermatocytes, equational division of 
secondary spermatocytes followed by mature spermatozoa being released into the 
lumen (figure 1.11)(Russell et al., 1990). To investigate whether the reduced testis 
weight and sperm count reflected defective spermatogenesis, testes were fixed for 
histology and stained with haematoxylin and eosin. In control animals the testis 
histology is normal with the seminiferous tubules containing sertoli cells, 
spermatogonia, spermatocytes in meiotic prophase, metaphase nuclei and round and 
elongating spermatids (figure 5.7A&B).        
In contrast, Ubr5CKO animals have a severe phenotype featuring many distinct vacuoles 
generally visible in the meiotic layer of the seminiferous tubules, indicating severe 
testicular atrophy in the absence of UBR5 (figure 5.7A&B). Despite these vacuoles, 
all cells types could be identified in many tubules (figure 5.7B) however, as in the 
Tex19.1-/- testes some tubules were more severely degenerated than others, at both 6 
week and 5 month time points. To quantify the severity of the testicular atrophy, I 
visually assessed 140 tubules from 3 control and 3 Ubr5CKO 5 month old testes, scoring 
tubules with the criteria of no vacuoles, one or more vacuoles or sertoli cell only 
tubules. Control animals had 99% intact tubules with very few vacuoles (figure 5.7C). 
The tubule degeneration in Ubr5CKO animals had varying degrees of severity with the 
most severely affected testis having 27% sertoli cell only tubules compared to only 1% 
for the least severely affected animal (figure 5.7C). Vacuoles were also detected in 
21dpp Ubr5CKO testes indicating that defects are present even at early stages and are 
no more severe at adult time points (data not shown). This indicates that Ubr5 deletion 
induces testicular atrophy with varying severity.  
The large quantity of vacuoles suggested that there could be increases in germ cell 
death in the absence of UBR5. I therefore performed the TUNEL assay to label dying 
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cells in 6 week old testes. Control animals had an average of 0.64 TUNEL positive 
cells per tubule compared to 1.75 TUNEL positive cells per tubule in Ubr5CKO testes 
(figure 5.7D)(n=3, Students T-test P<0.01). This indicates that the absence of UBR5 











Figure 5.7: Ubr5CKO testes have severe seminiferous tubule degeneration of varying 
severities. (A) H+E stained cross section of adult Ubr5 control and Ubr5CKO testis. 
Distinct voids can be seen in many tubules of the Ubr5CKO testis which are absent from 
the seminiferous tubules of control animals. (B) Higher magnification image of H+E 
stained testis. Pointed arrow head indicates meiotic spermatocytes in prophase I 
showing distinct staining of meiotic chromosomes, pointed arrow indicates round 
spermatids with a distinct round morphology and the absence of dense nuclear 
staining and triangle arrowheads indicate elongating spermatids maturing proximal 
to the lumen, prior to release. The * in the Ubr5CKO cross section indicates a void in 
the seminiferous tubule. Scale bars for all images represent 100µm. (C) Graph 
showing the proportion of tubules with or without voids or being sertoli cell only 
(n=3). (D) Graph showing the number of TUNEL positive cells per seminiferous tubule 
(n=3, *P<0.05 Students T-test) 
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5.2.8 No detectable pachytene arrest occurs in the absence of UBR5 
 
Nuclear morphology and location of the TUNEL positive cells was insufficient to 
determine their developmental stage, therefore I aimed to determine if the increases in 
cell death could be due to defects in the progression through meiotic prophase, similar 
to the meiotic pachytene arrest in Tex19.1-/- testes. To investigate this, meiotic 
chromosome spreads from three 6-7 week old Ubr5CKO and control testes were stained 
with antibodies for SCP1 and SCP3 to mark transverse filaments and axial/lateral 
elements of the synaptonemal complex respectively, to determine meiotic stages 
(figure 5.8A). Around 100 nuclei were staged per animal and no significant differences 
in the proportion of nuclei in specific substages of meiotic prophase were detected 
(figure 5.8A&B). This suggests that the defects leading to the severe testicular atrophy 
must be occurring before or after meiotic prophase. No increase in chromosome 
asynapsis was observed for Ubr5CKO pachytene nuclei, further indicating that the 
Ubr5CKO and Tex19.1-/- phenotypes are distinct (figure 5.8A&C). A caveat with this 
immunocytochemistry analysis is that I have been unable to co-stain chromosome 
spreads with UBR5 as the antibodies I used for immunocytochemistry on testis 
sections did not work on chromosome spreads. It is therefore possible that the meiotic 
nuclei analysed had a functioning copy of Ubr5flox that was incompletely excised, 
however at least some UBR5 negative spermatocytes were detected on testis sections 
(figure 5.5B). This would mean Ubr5 null spermatocytes may have been 










Figure 5.8: Absence of Ubr5 does not cause meiotic pachytene arrest or any 
increases in chromosome asynapsis (figures on subsequent pages) (A) Pachytene 
and diplotene spermatocytes from Ubr5 control or Ubr5CKO mice stained with axial 
element marker SYCP3 (red) and the central element marker (SYCP1). Genotype and 
antibody is represented at the left and above the images respectively. Co-localisation 
of SYCP3 and SYCP1 indicates chromosome synapsis in pachytene images (arrow 
heads). Pachytene was determined by the detection of at least one fully synapsed 
chromosome (arrow heads). Sex chromosomes synapsed at their pseudoautosomal 
region are indicated by triangle arrows. The white dashed line separates two nuclei 
in close proximity. Representative images of diplotene spermatocytes are shown to 
indicate that Ubr5CKO spermatocytes can progress beyond pachytene. Pointed arrows 
indicate autosomal chromosomes undergoing de-synapsis in both Ubr5 control and 
Ubr5CKO spermatocytes (Scale bar = 50µm) (B) Graph showing the percentage of 
spermatocytes in each particular stage in meiotic prophase in control and Ubr5CKO 
animals. Legend is shown on the left. Control and Ubr5CKO animals n=3, 
spermatocytes scored=~100). (C) Graph indicating the percentage of asynapsed 
spermatocytes from control and Ubr5CKO animals. (Number of control and Ubr5CKO 




















5.2.9 Ubr5CKO animals have reduced PLZF positive spermatogonia 
 
As no defects were observed in meiotic spermatocytes I explored the possibility that 
loss of Ubr5 may affect the number of spermatogonia in the testis. I therefore 
performed immunostaining of testis sections with antibodies to the transcription factor 
PLZF. PLZF is reported to be expressed in undifferentiated spermatogonia and in the 
absence of PLZF male mice exhibit a progressive testicular degeneration and age-
dependent loss of germ cells, due to an inability to maintain the spermatogonial stem 
cell population (Costoya et al., 2004). Consistent with previous reports, cells with 
strong anti-PLZF staining in their nuclei were present in the basal layer of the 
seminiferous tubules where undifferentiated spermatogonia reside (figure 5.9C white 
arrows). There was no clear enrichment of these PLZF-positive cells in specific 
seminiferous tubule sub-stages. PLZF staining was confined to the nuclei of cells at 
the basal layer in both control and Ubr5CKO testis. Quantification of the number of 
these positive cells indicated control animals had an average of 7.2 PLZF positive 
spermatogonia per tubule whereas Ubr5CKO tubules had a significant 1.5 fold reduction 
to 4.7 PLZF positive spermatogonia per tubule (figure 5.9 & figure 5.10A)(n=3, 
P=0.034 Students T-Test). The reduction in PLZF-positive cells presumably reflects 
a loss of undifferentiated spermatogonia in Ubr5CKO testes. However, it is also possible 
that the reduction in PLZF staining reflects a loss of Plzf expression rather than a loss 
of undifferentiated spermatogonia. Immunostaining with additional markers of 
undifferentiated spermatogonia would help to distinguish between these possibilities. 
Together, this analysis suggests that UBR5 has a role in maintaining undifferentiated 
spermatogonia populations in mouse testes. This is in contrast to Tex19.1-/- testes 
where there is change in the number of PLZF-positive cells (Ollinger et al., 2008).  
I previously noted that the severity of tubule degeneration was variable between 
Ubr5CKO animals. PLZF counts were also variable between Ubr5CKO animals (figure 
5.10A), I therefore aimed to investigate if the severity of the tubule degeneration and 
number of PLZF positive spermatogonia were related. Interestingly, the average 
number of PLZF positive spermatogonia per tubule is positively correlated with the 
differing levels of tubule degeneration in figure 5.7C (figure 5.10B, R2=0.8969). 
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Taken together, these data suggest that tubule degeneration in Ubr5CKO testes may be 
due to the reduced number of PLZF spermatogonia.  
 
Figure 5.9: The number of PLZF stained spermatogonia are reduced in adult Ubr5CKO 
testes (A) Cross section of seminiferous tubules of adult Stra8-Cre Ubr5wt/flox (Ubr5 
control) testis and (B) Ubr5CKO testis stained for DAPI and PLZF. (Scale bar=100µm). 
(C) Higher magnification of white boxes in merged images from A and B. (Scale 






Figure 5.10: The decrease in spermatogonia is correlated to the extent of tubule 
degeneration in adult Ubr5CKO testes (A) Graph indicating the average number of 
PLZF positive spermatogonia per tubule of adult Stra8-Cre Ubr5wt/flox (Control) and 
Ubr5CKO testis (n=3). 30 tubules were analysed per animal. (B) Scatterplot indicating 
correlation between the average number of PLZF positive spermatogonia per tubule 
from figure 5.10A and the extent of tubule degeneration from figure 5.7C for control 
(Ctrl) and Ubr5CKO  (CKO) testis. Animal number on the graph corresponds to animals 
in A. R2=0.8969.  
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5.2.10 MMERVK10C is transcriptionally regulated in the testes by 
UBR2 and not UBR5  
 
Many mouse mutants with defective spermatogenesis also have de-repression of 
retrotransposons (Crichton et al., 2014). Previous work from Ollinger et al (Ollinger 
et al., 2008) has shown that RNA for the LTR retrotransposon, MMERVK10C is 
increased in Tex19.1-/- testes and experiments in this thesis indicate this is likely at the 
transcriptional level (chapter 3 - figure 3.2A). To investigate if this transcriptional 
repression could be mediated by one of the TEX19.1 interacting partners from the 
UBR family I performed in situ hybridisation for MMERVK10C env transcripts on 
Ubr2-/- and Ubr5CKO adult testis and the corresponding control animals. Tex19.1-/- 
testes were used as a positive control. 
In control animals of each genotype, low levels of MMERVK10C env transcripts were 
present in a subset of seminiferous tubules as has been reported previously (figure 5.11 
& figure 5.12)(Ollinger et al., 2008). Adult Tex19.1-/- testes acted as a positive control 
for the detection of MMERVK10C RNA and increased levels of transcript were 
detected in some Tex19.1-/- seminiferous tubules (figure 5.11A & 5.12A)(Ollinger et 
al., 2008). Interestingly, Ubr2-/- testes also have increased MMERVK10C RNA in 
some tubules compared to control testes (figure 5.11B & 5.12B). In contrast, Ubr5CKO 
testes had little increase in MMERVK10C RNA compared to control testes (figure 
5.11C). Importantly, all samples probed with a negative control MMERVK10C sense 
probe showed no staining (figure 5.11).  . 
MMERVK10C is de-repressed in meiotic spermatocytes of Tex19.1-/- animals 
(Ollinger et al., 2008). To determine if this was also the case in Ubr2-/- testes, higher 
magnification images were taken. Tex19.1+/- control testes indicated very modest 
staining in spermatocytes of a low number of tubules (figure 5.12A). The increased 
levels of MMERVK10C in Tex19.1-/- testes appear to be due to strongly expressing 
cells towards the lumen region of the tubules, likely corresponding to meiotic 
spermatocytes as previously determined (figure 5.12A – black arrows)(Ollinger et al., 
2008). In Ubr2+/- sections as with Tex19.1+/- testes, faint staining could be detected in 
meiotic spermatocytes of some tubules (figure 5.12B). Interestingly Ubr2-/- testes have 
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a defined increase in MMERVK10C expression in the layer corresponding to meiotic 
spermatocytes when compared to Ubr2+/- testes (figure 5.12B black arrows). For 
Ubr5Ctrl tubules weak staining was detected in two different locations in differing 
seminiferous tubules. Staining for MMERVK10C RNA was detected in basal regions, 
likely corresponding to meiotic spermatocytes of some tubules, but was also present 
closer to the lumen in other tubules, possibly corresponding to staining in round 
spermatids (figure 5.12C). No increase in the amount of MMERVK10C transcript was 
detected in Ubr5CKO testes compared to control testes (figure 5.12C), however, some 
staining was detected possibly in round spermatids near to the lumen of the tubule.  
MMERVK10C signal was also detected in the spermatocytes of some tubules in 
Ubr5CKO testes, but to a similar extent as Ubr5Ctrl tubules (figure 5.11C & 5.12C). 
Together, these data identify UBR2, but not UBR5, as a novel transcriptional repressor 
of retrotransposons in the germline. This also further indicates a distinct overlap 
between the Tex19.1-/- and the Ubr2-/- phenotypes, but differences with the Ubr5CKO 
phenotype.  
To determine if UBR2 is functioning in transcriptional repression of retrotransposons 
specifically in the testes or if this extends to other tissues, I performed qRT-PCR 
expression analysis for retrotransposons on RNA extracted from P16 Ubr2-/- and 
control testes and cerebellum. Ubr2-/- testes had a 1.5-fold increase in MMERVK10C 
expression compared to Ubr2+/- testes, which was absent from the cerebellum 
(P=0.003, Students T-test)(figure 5.12D). This indicates the transcriptional repressive 
capacity of UBR2 may be specific to the germ line however, the mechanism for this 
tissue specific repression is still unclear. No de-repression was observed for LINE-1, 
however a small but significant 1.2 fold de-repression of VL30 (P=0.02, Students T-
test) was detected in Ubr2-/- testes compared to Ubr2+/- testes indicating that in the 
testes, UBR2 specifically represses not only MMERVK10C, but also VL30 (figure 
5.12D). This increase in expression of VL30 was not detected in Ubr2-/- cerebellum 
and has not been reported in Tex19.1-/- testes (figure 5.12D)(Ollinger et al., 2008).  
In Tex19.1-/- testes, the increase in MMERVK10C expression is around 4 fold, 
compared to the modest 1.5 fold expression increase observed in Ubr2-/- animals 
(Ollinger et al., 2008). It is possible that this may reflect differences in genetic 
background as repetitive element expression is known to be variable between mouse 
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strains (Nellåker et al., 2012). Previously MMERVK10C expression was assessed in 
Tex19.1-/- mice on a 129/Ola X CD1 mixed genetic background (Ollinger et al., 2008), 
whereas Ubr2-/- mice are of the C57/BL/6 background. In line with this hypothesis, 
qRT-PCR for MMERVK10C in Tex19.1-/- testes on a C57/BL/6 background show a 2 
fold increase in RNA (Reichmann et al., 2012), similar to the 1.5 fold increase 
observed in Ubr2-/- testes (figure 5.12D). Together, this provides the first evidence of 




Figure 5.11: Expression of MMERVK10C is upregulated in Ubr2-/- testes. (A) In situ 
hybridisation with an antisense MMERVK10C probe (brown precipitate) in Tex19.1+/- 
and Tex19.1-/-, (B) Ubr2+/- and Ubr2-/-, (C) Ubr5Ctrl (Stra8-Cre Ubr5wt/flox) and Ubr5CKO 
testes from littermates. Images show the whole cross section of one testis to indicate 
the extent of MMERVK10C staining. The column on the right (Tex19.1-/- Control, Ubr2-
/- Control and Ubr5CKO Control) shows representative images from control ISH with a 






Figure 5.12: UBR2 represses MMERVK10C specifically in meiotic spermatocytes and 
not the cerebellum (A) A) Higher magnification images of In situ hybridisation with 
an antisense MMERVK10C probe (brown precipitate) in Tex19.1+/- and Tex19.1-/-, (B) 
Ubr2+/- and Ubr2-/-, (C) Ubr5Ctrl (Stra8-Cre Ubr5wt/flox) and Ubr5CKO testes from 
littermates. Boxes in middle column indicate the images shown on the right hand 
column at higher magnification. Black arrows indicate positively stained 
spermatocytes. Scale bar=100µm. (D) qRT-PCR on RNA extracted from whole P16 
Ubr2-/- testes and cerebellum for retrotransposon transcripts. Data is normalised to 






In this chapter I aimed to gain an understanding of the potential contribution of two 
TEX19.1 interacting partners, UBR5 and UBR2, to the Tex19.1-/- testicular phenotype 
(Ollinger et al., 2008). I show for the first time that UBR5 is essential for 
spermatogenesis, as conditional deletion of Ubr5 early in spermatogenesis results in 
reduced testicular weight, reduced sperm count and large vacuoles in some 
seminiferous tubules of Ubr5CKO animals, accompanied by an increase in cell death 
(summarised in table 5.3). I have also identified a role for UBR5 in maintaining the 
undifferentiated spermatogonia population which is likely contributing to the severe 
testicular degeneration in the absence of UBR5 (table 5.3).  Together, these data 
suggest distinct differences between Ubr5CKO and Tex19.1-/- testes phenotypes which 
was extended to the lack of MMERVK10C retrotransposon de-repression in Ubr5CKO 
animals (table 5.3). Conversely, I have shown that repression of MMERVK10C in the 
testes is dependent on UBR2, suggesting overlapping roles of TEX19.1 and UBR2 in 





Table 5.3: Summary table of Ubr5CKO phenotypes compared to Tex19.1-/- 
phenotypes  
 
5.3.1 UBR5 is essential for spermatogenesis and maintains 
spermatogonial stem cells in mouse testes 
 
Quantifying the number of PLZF positive undifferentiated spermatogonia in Ubr5CKO 
testes identified a role of UBR5 in maintenance of undifferentiated spermatogonia. 
This is distinct from Tex19.1-/ mice which have similar PLZF positive spermatogonia 
numbers as control testes (Ollinger et al., 2008).  Mice null for Zfp145, which encodes 
PLZF, undergo progressive testicular degeneration in an age dependent manner due to 
an inability to maintain the spermatogonial stem cell population (Costoya et al., 2004). 
This phenotype is severe with many adult tubules being devoid of germ cells (Costoya 
et al., 2004). Indeed the number of PLZF positive spermatogonia per tubule in Ubr5CKO 
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animals correlated with severity of tubule degeneration, however it is difficult to 
determine if this correlation is a direct effect of loss of Ubr5 on undifferentiated 
spermatogonia, or if spermatogonia are being lost in a non-cell autonomous manner.  
This may occur as a direct result of disrupted paracrine signalling, such as the 
hedgehog pathway or due to composition differences (Makela et al., 2011). Analysing 
Ubr5CKO testes earlier in development before global composition alterations would 
address if this decrease in PLZF positive spermatogonia is directly contributing to the 
defects in progression through spermatogenesis.   
Paracrine hedgehog signalling has been shown to play a major role in spermatogenesis 
(Bitgood et al., 1996). Desert hedgehog (Dhh) expression is initiated and maintained 
in Sertoli cells of the testes and is a small signalling molecule essential for 
spermatogenesis (Bitgood et al., 1996). Mice null for Dhh exhibit loss of germ cells 
and a severe 90% decrease in testicular mass by six weeks of age, however the 
molecular pathology is unclear (Bitgood et al., 1996). Generally when hedgehog 
molecules reach a target cell it binds to its receptor, PTCH1, which then inhibits 
Smoothened (SMO) and consequently GLI transcription factors which regulate normal 
gene expression (Briscoe and Therond, 2013).  
Interestingly, UBR5 has roles in the maintenance of other stem cell populations such 
as chondrocytes in bone development (Mark Ditzel, personal communication). 
Conditional removal of Ubr5 from chondrocyte precursors caused a decreased number 
of chondrocytes, along with perturbed expression of members of the hedgehog 
signalling pathway, Ihh, Ptch and Gli (Mark Ditzel, personal communication). Also, 
Ubr5 has been determined as a negative regulator of hedgehog expression in 
Drosophila (Lee et al., 2002; Moncrieff et al., 2015). Therefore, misregulation of 
UBR5 mediated hedgehog paracrine signalling may be an additional mechanism 
leading to defective spermatogenesis in Ubr5CKO testes, which requires further 
investigation with antibody staining or gene expression analysis. 
Alternatively, UBR5 has been demonstrated to have key roles in mitosis (Scialpi et al., 
2015). The UBR5 protein physically interacts with components of the spindle 
assembly checkpoint and depletion of Ubr5 by treatment with siRNA dramatically 
reduced mitotic cell viability (Scialpi et al., 2015). Undifferentiated spermatogonia are 
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proliferative cells, therefore if mitosis is perturbed in the absence of Ubr5 it may be 
contributing to the loss of undifferentiated spermatogonia. 
 
5.3.2 UBR2 represses MMERVK10C in spermatocytes  
 
UBR2 has previously been shown to have roles in spermatogenesis and Ubr2-/- testes 
have been proposed to phenocopy Tex19.1-/- mice (Kwon et al., 2003). Furthermore, 
Tex19.1 is transcribed in Ubr2 null germ cells but TEX19.1 protein is absent, 
indicating that UBR2 stabilises TEX19.1 protein in the germline (Yang et al., 2010). 
Data from Marie MacLennan indicates that TEX19.1 is not required for the stability 
of UBR2 in the testes, as similar UBR2 protein levels to wild type are detected in 
Tex19.1-/- testes (Marie MacLennan personal communication). This suggests that the 
phenotypes occurring in both Ubr2-/- and Tex19.1-/- testes are possibly due to specific 
roles of TEX19.1, which is absent in both mutants, or both proteins acting together in 
a complex. Subunits of many protein complexes are unstable if differing binding 
partners are absent (Eskeland et al., 2010). I indicate for the first time that UBR2 is 
essential for repression of MMERVK10C in the testes, however as with other 
spermatogenic phenotypes of Ubr2-/- mice, this may be a consequence of loss of 
TEX19.1 (Yang et al., 2010). The differences in the extent of de-repression of 
MMERVK10C in each mutant may be a result of the different genetic background of 
the strains however, direct roles for UBR2 in transcriptional repression of 
MMERVK10C cannot be ruled out. 
TEX19.1 has been shown to enhance poly-ubiquitination of LINE-1 ORF1 protein via 
UBR2, however effects on ubiquitination of other potential substrates such as KRAB-
ZFPs, many of which have retrotransposon targets, is yet to be investigated (Ecco et 
al., 2016; Wolf et al., 2015a). UBR2 has also been suggested to regulate transcription 
of meiotic genes by histone ubiquitination in meiosis, however only representative 
ICC images were shown indicating reductions in H2A ubiquitination (Young An et 
al., 2010). It is unclear how much differences in cell composition, caused by the 
meiotic arrest of Ubr2-/- spermatocytes, are contributing to the loss of H2A 
ubiquitination on transcriptional repression reported from this study (Young An et al., 
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2010). The mechanism of TEX19.1/UBR2 mediated transcriptional repression of 
MMERVK10C in the germline is unclear and will require further study, however it is 
unlikely to involve UBR5 as no increase in MMERVK10C RNA was detected in 
Ubr5CKO testes compared to control testes. 
In summary, I have determined that UBR5 is essential for spermatogenesis and has a 
phenotype distinct from that of Tex19.1-/- testes. This suggests that the contribution of 
UBR5 to the Tex19.1-/- phenotype is minimal, with the retrotransposon de-repression 










































6.1 Mechanism of TEX19.1 mediated genome defence 
 
The main aim of this thesis was to gain a better understanding of TEX19.1 mediated 
genome defence in hypomethylated contexts, from the mechanism of retrotransposon 
repression, to the possible developmental defects associated with their activation. 
Furthermore, I aimed to investigate the possible contribution of the TEX19.1 
interacting partners to these Tex19.1-/- phenotypes.    
Tex19.1-/- mice have numerous developmental defects, from meiotic pachytene arrest 
and male infertility, to defective placental development, with de-repression of different 
retrotransposons in both contexts (Ollinger et al., 2008; Reichmann et al., 2013). 
Modification of histones is a major mechanism contributing to retrotransposon 
repression in ES cells, however is thought to play a lesser role in differentiated cells, 
where repression is mainly facilitated by DNA methylation (Karimi et al., 2011; 
Matsui et al., 2010; Rowe et al., 2010). In the germline, the piRNA pathway is an 
additional mechanism which ensures retrotransposon repression via endonuclease 
‘slicer’ activity and de novo methylation of retrotransposons (Bortvin, 2013). Despite 
these differing mechanisms, a certain amount of redundancy in their target loci ensures 
continued repression throughout development and into adult tissues (Goodier 2016).  
One outstanding question arising when considering the Tex19.1-/- phenotype is why 
different retrotransposons are de-repressed in different Tex19.1-/- tissues. Is the 
Tex19.1 mediated repressive mechanism the same in ES cells, testes and the somatic 
placenta? Are the transcriptional repressive interacting partners of TEX19.1 different 
in each tissue, possibly based on the different cytoplasmic and nuclear localisations of 
TEX19.1? Is redundancy in repressive mechanisms masking retrotransposon de-
repression in the absence of Tex19.1?  
In this thesis I have identified that TEX19.1 functions, at least in part, through the 
KAP1 repressive mechanism in ES cells to augment repressive histone modifications 
to compensate for loss of DNA methylation in development (figure 3.4). This only 
targets a subset of LINE-1 elements, L1MdF2, which are known KAP1 targets in ES 
cells (Castro-Diaz et al., 2014). These are de-repressed in the Tex19.1-/- placenta, 
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suggesting that the KAP1 repressive mechanism may be perturbed in vivo in the 
absence of Tex19.1 (figure 3.13)(Castro-Diaz et al., 2014).  
One inherent property of the KAP1 repressive mechanism is its targeting to specific 
genomic loci by KRAB-ZFPs (Wolf et al., 2015b). KRAB-ZFPs constitute the largest 
transcription factor family in mice and humans with around 200 and 300 genes 
respectively (Emerson and Thomas, 2009). This provides redundancy in the KRAB-
ZFPs targeting specific retrotransposons loci and regulating their expression (Castro-
Diaz et al., 2014; Ecco et al., 2016; Najafabadi et al., 2015). Previously, the KRAB-
ZFP mechanism was thought to establish transcriptional repression in embryonic 
development, with the majority of repression in somatic differentiated tissues being 
due to DNA methylation (Wolf et al., 2015), however at least some KRAB-ZFP:KAP1 
complexes can continually facilitate retrotransposon repression into adult cells, 
suggesting a more dynamic transcriptional regulation than previously appreciated 
(Ecco et al., 2016; Playfoot and Adams 2016). If TEX19.1 is affecting KRAB-ZFPs 
in the placenta is currently unclear but if so, it would provide another somatic context 
for their transcriptional repressive function. Indeed, many KRAB-ZFPs are highly 
expressed in evolutionarily young adult somatic tissues such as the mammalian 
placenta, but to a lesser extent in other cell types (Liu et al., 2014a). Furthermore, co-
IP mass spectrometry indicates that TEX19.1 interacts with a known KRAB-ZFP, 
ZNF295, however any role for this ZFP in retrotransposon repression is yet to be 
established (Marie MacLennan, unpublished data).  
Tex19.1-/- placenta has de-repression of a subfamily of LINE-1, L1MdF2 and the LTR 
element VL30, whereas testes have de-repression of a subfamily of the MMERVK10C 
elements (Ollinger et al., 2008; Reichmann et al., 2013). L1MdF2, VL30 and 
MMERVK10C are all known targets of different KRAB-ZFPs and KAP1 in ES and 
somatic cells (Castro-Diaz et al., 2014; Ecco et al., 2016; Wolf et al., 2015). In ES cells 
the specific KRAB-ZFP targeting KAP1 to L1MdF2 is Gm6871, which is distinct from 
the KRAB-ZFPs targeting VL30, ZFP809 and MMERVK10C, Gm15446 (Castro-
Diaz et al., 2014; Ecco et al., 2016; Wolf et al., 2015). Each KRAB-ZFP is expressed 
to a similar extent in control and Tex19.1-/- placentas (data not shown). Interestingly, 
when I assessed the Tex19.1-/- placentas for additional retrotransposons repressed by 
TEX19.1, I identified a number of significantly upregulated retrotransposons which 
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are known targets of KRAB-ZFP and the H3K9me3 machinery. For example, the most 
upregulated element in Tex19.1-/- placenta RNAseq (figure 4.9) was MLT1A, the 
human homolog of which is bound by ZNF264 and ZNF519 in HEK293T cells 
(Najafabadi et al., 2015). In addition, the second most highly de-repressed element in 
Tex19.1-/- placentas, MER52, is also bound by KRAB-ZFPs in humans, specifically 
ZNF273 and is marked by H3K9me3 (Najafabadi et al., 2015). If these elements are 
regulated by KRAB-ZFPs in mouse remains to be seen, however this gives further 
support to the hypothesis that TEX19.1 may be playing an important role in this 
repressive mechanism depositing H3K9me3, to compensate for the low levels of DNA 
methylation in this tissue. The specific targeting of H3K9me3 mediated by TEX19.1 
could therefore possibly be due to interactions with different KRAB-ZFPs, alongside 
KAP1, however it is unclear if TEX19.1 is binding with KRAB-ZFPs previously 
associated with specific de-repressed retrotransposons. Generally the majority of 
KRAB-ZFPs were not detected in the CoIP-mass spectrometry experiment by Marie 
MacLennan, however this was performed on the cytoplasmic fraction from ES cells. 
Therefore, this may not necessarily represent the physiological interacting partners 
detected in the placenta where TEX19.1 localisation appears more nuclear (Reichmann 
et al., 2013). Additionally, the permissive environment of the placenta due to reduced 
DNA methylation and the absence of other genome defence genes likely allows 
detection of retrotransposon repressed by TEX19.1, whereas any transcriptional de-
repression of LINE-1 in the testis would presumably be prevented by the action of the 
PIWI proteins (Crichton et al., 2013).  
A study by Collins et al., also highlighted that reduced levels of H3K9me3 upon loss 
of Setdb1 in somatic cells does not necessarily result in de-repression of the affected 
retrotransposon loci (Collins et al., 2015). For example, loss of KAP1:SETDB1 
dependent H3K9me3 at L1MdF2 loci does not result in their transcriptional activation 
in SETDB1 deficient B-lymphocyte cells (Fig. 2A). In these cells they determined that 
tissue specific transcription factors are necessary for the de-repression of at least some 
retrotransposons with reduced H3K9me3 but not others (Collins et al., 2015). This 
may provide another explanation as to the highly tissue specific de-repression of 
particular retrotransposons in different Tex19.1-/- tissues. 
243 
 
Kap1 is expressed in the placenta and its precursors, however any roles for KAP1 in 
retrotransposon repression or molecular aspects of development in this tissue are yet 
to be fully determined (Cammas et al., 2000; Shibata et al., 2011). ChIPseq 
experiments to assess KAP1 binding to the genome have never been performed on 
wild type placental tissue. Investigation of the retrotransposons de-repressed in the 
absence of Kap1 in the placenta has also never been assessed as the embryonic lethality 
of global Kap1-/- embryos around E5.5, post-implantation has precluded any analysis 
(Cammas et al., 2000).  It would be informative to perform a conditional Kap1 
knockout in placental lineages by crossing a Tpbpa-Cre mouse with a Kap1flox/flox 
mouse to delete Kap1 in progenitor cells of differentiated trophoblast cells at around 
E8.5 (Simmons et al., 2007). This would allow analysis of the extent of KAP1 
mediated retrotransposon repression, if any, in this tissue, but also of the roles of KAP1 
in placental development. So far, in somatic contexts, KAP1 has roles repressing 
retrotransposons in neural progenitor cells (Fasching et al., 2015) and examples of 
retrotransposon de-repression in somatic tissues has only been detected in a few mouse 
genetic knockouts or knockdowns of KRAB-ZFPs with offspring generally being 
fertile and healthy, however the eaerly trophoblast or mature placentas have only been 
assessed for ZNF568 (Ecco et al., 2016; Wolf et al., 2015; Wolf et al., 2015b). A 
mutation resulting in hypomorphic expression of Znf568 results in defective placental 
development correlated with defects in migration of the embryonic derived 
extraembryonic mesoderm leading to defective yolk sac development (Shibata and 
Garcia-Garcia, 2011). A direct role for ZNF568 in trophoblast development was not 
detected, however the vast number of KRAB-ZFPs and their generally high expression 
in the placenta could possibly indicate as yet undiscovered roles for these transcription 
factors in placental development (Emerson and Thomas, 2009; Liu et al., 2014a).  
Furthermore, deletion of Tex19.1, Kap1 or particular KRAB-ZFPs in trophoblast stem 
cells would provide an alternative, more homogenous cellular model to address their 
roles in both retrotransposon and gene regulation, along with placental development 
at earlier time points. Specific LTR retrotransposons have been shown to act as 
enhancer elements facilitating the control of key TSC lineage regulators such as Cdx2, 
Eomes and Elf5, therefore disruption of the expression of these elements early in 
development may have serious consequences in the progression of the trophoblast 
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lineages (Chuong et al., 2013). This would also address the caveat of the differences 
in composition detected in Tex19.1-/- placentas compared to controls which, for at least 
some genes, will be causative of their significant increases or decreases in RNA 
detected in the RNAseq experiment (figure 4.10). Undirected differentiation of 
Tex19.1-/- ES cells did not result in de-repression of any retrotransposons (figure3.10), 
however differentiation of Tex19.1-/- TS cells to TGCs may provide an in vitro model 
of retrotransposon de-repression in a hypomethylated somatic context. Tex19.1-/- ES 
cells do not de-repress retrotransposons in normally methylated conditions (figure 3.9) 
and upon hypomethylation, de-repression appears to be transient, with different 
dynamics for different retrotransposons, however the reason for this remains unclear 
(figure 3.12). Additionally, it is unclear if any of the genes changing in RNA 
abundance in Tex19.1-/- placentas are targets of KAP1. KAP1 ChIPseq on TS cells 
would provide an informative dataset to determine which genes and retrotransposons 
are targeted by KAP1, in a more relevant context to placenta than existing genome 
wide KAP1 datasets from ES cells and normally methylated somatic tissues.  
At present, the molecular mechanism of TEX19.1 binding to KAP1 and promoting 
deposition of H3K9me3 is unclear. A number of differing mechanisms are possible. 
For example, TEX19.1 may be stabilising the interaction of KAP1 and KRAB-ZFPs 
to facilitate targeting of the complex to specific genomic loci. Alternatively, TEX19.1 
binding to KAP1 may be disrupting its E3 ubiquitin ligase capacity as has been 
determined for the interaction of TEX19.1 and UBR2, whereby TEX19.1 inhibits the 
binding of UBR2 to its N-end rule substrates (Diana Best unpublished). Interactions 
between KAP1 and SETDB1 are sumoylation-dependent (Zeng et al., 2008), with 
sumolyated KAP1 being highly transcriptionally repressive, due to stimulation of the 
HMT activity of SETDB1 (Ivanov et al., 2007). If this sumoylation mechanism of 
KAP1 is disrupted in Tex19.1-/- animals leading to reduced activity of SETDB1 and 
therefore a reduced repressive capacity, is unclear. A future experiment to assess if 
TEX19.1 is affecting the sumoylation of KAP1 would be an in vitro sumoylation assay 
similar to the in vivo ubiquitination assays used in this thesis (Li et al., 2010). By co-
transfecting cells with tagged KAP1 and SUMO expression constructs, with and 
without Tex19.1, any effect of TEX19.1 on KAP1 sumoylation levels would be 
detectable by Western blotting.   
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Interestingly, I have determined that UBR2 is a novel repressor of MMERVK10C 
transcription in mouse testes but has no role in transcriptional repression of LINE-1 in 
this tissue, similar to TEX19.1 (figure 5.11 & 5.12). Analysis of placentas in Ubr2-/- 
mice may be informative to test if there is any similarity with Tex19.1-/- phenotypes. 
Although IUGR has not been reported in Ubr2-/- mice, loss of Ubr2 is associated with 
female embryonic lethality (Kwon et al., 2003) and it will be of interest to determine 
if there are placenta defects and IUGR in these embryos. 
In testes UBR2 is necessary to stabilise TEX19.1 as TEX19.1 protein is undetectable 
in Ubr2-/- testes (Yang et al., 2010). In contrast, UBR2 is present at similar amounts in 
Tex19.1-/- testes as control testes (Marie MacLennan unpublished results). Despite this, 
it is unclear if UBR2 is required to stabilise TEX19.1 in different contexts such as the 
placenta. In the placenta TEX19.1 protein is largely detectable in the nucleus, 
compared to mainly the cytoplasm in germ cells (Ollinger et al., 2008; Reichmann et 
al., 2013). The significance of this difference in localisation is yet to be determined, 
however if some TEX19.1 protein is detectable in Ubr2-/- placentas it may suggest a 
different mechanism of retrotransposon repression is occurring in the placenta, distinct 
from the testes.  
Another unexplored possibility may be that in both tissues, the association of TEX19.1 
and UBR2 is having an effect on KAP1. This may extend to effects on the molecular 
function of KAP1 or perturbations of the binding to other proteins in the KAP1 
repressive complex (Iyengar and Farnham, 2011). Indeed, both KAP1 and UBR2 are 
RING domain E3 ubiquitin ligases and TEX19.1 has a role in UBR2 dependent poly-
ubiquitination of LINE-1 ORF1p, leading to its degradation (MacLennan et al., 
submitted). If KAP1 is a substrate for UBR2:TEX19.1 mediated ubiquitination has not 
been investigated, however there appears to be no reduction in global KAP1 protein 
levels or ubiquitination levels when TEX19 is overexpressed in human cells and no 
difference in KAP1 levels in the junctional zone of Tex19.1-/- placenta compared to 
control animals (figure 3.6, 3.7 & 3.8). 
An alternative possibility is that the E3 ubiquitin ligase activity of KAP1 itself may be 
being perturbed in the absence of Tex19.1. KAP1 E3 ubiquitin ligase activity has been 
determined to be promoted by a subclass of proteins with similar expression patterns 
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as Tex19.1 called the MAGE proteins (Doyle et al., 2010). MAGE proteins can 
promote KAP1 dependent ubiquitination of KRAB-ZFPs thereby increasing their 
turnover, similar to the role of TEX19.1 in promoting UBR2 dependent poly-
ubiquitination and turnover of LINE-1 ORF1p (MacLennan et al., submitted; Xiao et 
al., 2011). If this is extending to KAP1 and the KRAB-ZFPs is unclear. Alternatively 
it is possible that TEX19.1 may be preventing MAGE proteins interacting with KAP1, 
thus leading to reduced ubiquitination of KRAB-ZFPs. If TEX19.1 was regulating 
KAP1 in this manner this would result in an increase in KRAB-ZFP proteins and 
therefore presumably an increased binding of KRAB-ZFP proteins to their target loci. 
The effects of having increased KRAB-ZFP and KAP1 repressive complexes binding 
would possibly result in increased retrotransposon repression, the converse of Tex19.1-
/- tissues (Jacobs et al., 2014; Castro-Diaz et al., 2014; Ecco et al., 2016), however if 
TEX19.1 dependent ubiquitination of KRAB-ZFPs is actually occurring remains to be 
investigated. Furthermore, no MAGE proteins have yet been associated with 
retrotransposon de-repression (Feng et al., 2011). 
Together, an arsenal of defence mechanisms from DNA methylation, transcription 
factor availability, tissue specific KRAB-ZFPs and KAP1 dependent histone 
modifications are co-ordinately regulating retrotransposon expression to varying 
extents in different contexts (Goodier 2016). 
 
6.2 Relationship between retrotransposon de-repression and 
developmental defects 
 
In a somatic context, any retrotransposition events are not heritable and are unlikely to 
be occurring in the same progenitor cells, at the same loci in each mouse, causing the 
same phenotype. Expanding evidence exists, distinct from classical de novo insertion 
events, for the role of LTR and non-LTR retrotransposon expression itself. The de-
repression of some retrotransposon loci can control expression of neighbouring genes, 
both in normal development and in genetic knockouts experiments (Elbarbary et al., 
2016; Göke and Ng, 2016; Thompson et al., 2016). Retrotransposons regulate the 
genome in a variety of ways, from behaving as alternative promoters producing long 
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non coding RNAs, to acting as enhancers for nearby genes (Ecco et al., 2016; Herquel 
et al., 2013; Rowe et al., 2013). Therefore, the number of retrotransposon subfamilies 
de-repressed and the amount of gene expression changes in Tex19.1-/- placentas led me 
to investigate if the two could be correlated. Generally, I observed an association of 
full length elements of the de-repressed L1MdF2 subfamily with downregulated genes, 
however if this association is causative remains unclear (figure 4.11). Generally, 
LINE-1 dependent genic repression can occur via different mechanisms such as 
antisense interference which alters chromatin state of nearby regions (Cruickshanks et 
al., 2013). Antisense transcripts of full length LINE-1 flanking downregulated genes 
were detected at similar levels in control and Tex19.1-/- placentas (figure 4.12). 
Therefore this is unlikely causative of neighbouring gene expression changes, at least 
at the loci assessed. The fact that little association was detected for the LTR 
subfamilies analysed, further suggests that this is possibly not a major cause of the 
RNA abundance changes, however de-repression of a retrotransposon which is altering 
the expression of a single gene critical for placental development could be causative 
of the downstream Tex19.1-/- placental phenotype.  
Other genome defence mutant mice, along with Tex19.1-/- mice, have de-repression of 
numerous retrotransposons in the germline along with defective spermatogenesis 
(Crichton et al., 2013). In this thesis I have expanded the repertoire of genes involved 
in germline genome defence to include Ubr2 (figure 5.11 & 5.12). In each of these 
knockout mice it is unclear if retrotransposon de-repression is the cause of 
developmental defects in the germline (Crichton et al., 2013). No developmental defect 
has yet been directly associated with perturbed expression of a gene with a known 
function in the defective pathway due to nearby retrotransposon de-repression, but 







6.3 The innate immune response 
 
Far from any intricate effects on gene expression, recent evidence from a multitude of 
different cell types and developmental contexts has identified a substantial role for 
retrotransposon de-repression in the activation of the immune system (Kassiotis and 
Stoye, 2016). For example, germ cells of mice lacking the methylation sensitive 
genome defence gene Mov10l have increased LINE-1 expression, alongside an 
interferon β response (Yu et al., 2015). Yu et al demonstrated in an in vitro experiment, 
transfecting MEFs with a LINE-1 expressing plasmid, that endonuclease dependent 
LINE-1 retrotransposition stimulates interferon β expression in somatic cell lines (Yu 
et al., 2015). Furthermore, interferon β and associated interferon stimulated genes 
restrict LINE-1 propagation, implying a role for the interferon pathway in genome 
defence and stability (Yu et al., 2015). Interestingly, I have detected a response to 
interferon β in the placentas of Tex19.1-/- animals (figure 4.14, 4.15 & 4.16) and it is 
tempting to hypothesise that this is due to increases in retrotransposon de-repression 
(see chapter 1, section 1.5 for details). 
Despite this alternate possibilities the innate immune response appears to provide an 
additional mechanism of defence against increased retrotransposons in developmental 
contexts or in the absence of genome defence genes. For example, mice null for the 
transcriptional repressor Trim24 exhibit increases in VL30 and MMERVK10C cDNA 
in the cytoplasm of null hepatocytes, the same retrotransposon subfamilies de-
repressed in Tex19.1-/- contexts (Herquel et al., 2013; Ollinger et al., 2008; Reichmann 
et al., 2013). This correlates with the activation of the viral defence IFNβ response and 
an increase in apoptosis (Herquel et al., 2013). 
Furthermore, human somatic tumour cell lines treated with the DNA demethylating 
drug 5-Aza induce a potent IFNβ response due to recognition of retrotransposon 
dsRNA and cytosolic DNA by the MDA5-MAVs proteins and TMEM173 respectively 
(Chiappinelli et al., 2015; Roulois et al., 2015). Tmem173 was significantly 
upregulated in Tex19.1 suggesting possible activation of this cytosolic DNA sensing 
pathway. Crossing the Tex19.1+/- and Tmem173-/- mice would determine if the 
interferon response was operating via TMEM173 and presumably sensing 
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retrotransposon DNA in the cytoplasm of trophoblast derived cells. If this abrogated 
the immune response, placental defects and IUGR this would suggest that cytosolic 
DNA sensing is leading to the immune response which may be causative of 
developmental defects in Tex19.1-/- animals. Additionally, determining if this same 
response is occurring in Tex19.1-/- and Ubr2-/- testes in response to MMERVK10C de-
repression would lend further support to the hypothesis that de-repression of 
retrotransposons is causing an interferon response leading to apoptosis and 
developmental defects in multiple cellular contexts. The investigation of interferon 
autoimmune activation in a number of human diseases also provides evidence of 
significant associations with retrotransposon de-repression (Kassiotis and Stoye, 
2016). One such disease is Aicardi-Goutières syndrome which is discussed in section 
1.5. 
It is important to note that mouse ESCs are thought to have limited IFNα and IFNβ 
activity (Cross et al., 1990; Wang et al., 2013), however somatic cells have a robust 
interferon response (Wang et al., 2013). The general roles for interferons in mouse and 
human somatic contexts is well characterised, however the role of interferons in 
placental development is still to be fully elucidated (Platinas 2005). The experimental 
evidence for a role of interferons in mouse placentation is very sparse, especially for 
IFNβ. Most evidence of IFN in normal placental development supports roles for IFNγ 
which, in the post-implantation placenta, is produced by NK cells of the uterine 
decidua and is important for spiral artery dilation (Ashkar et al., 2000). TGCs can 
secrete hormones to prevent natural killer (NK) cells producing IFNγ to regulate this 
process (Hu and Cross, 2010; Muller et al., 1999). Both rodent and human trophoblast 
cells show dampened responses to INFγ. IFNα is released by trophoblast giant cells in 
the mouse placenta which, as with IFNγ, stimulates the expression of interferon 
stimulated genes in the decidua (Bany and Cross, 2006; Hu and Cross, 2010; Platt and 
Hunt, 1998).  
As regards placental pathogenesis and the interferon response, in humans interferon β 
is used as a therapy for multiple sclerosis (Patti et al., 2008). Numerous studies have 
assessed the effects on fetal outcome from pregnant women taking interferon β in the 
first trimesters of pregnancy. In four separate studies, exposure to formulations of 
interferon β was associated with low birth weight, shorter birth length or shorter 
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gestation periods, but no increased risk of pregnancy loss or health problems later in 
life (Amato et al., 2010; Boskovic, 2015; Hellwig et al., 2012; Patti et al., 2008; Weber-
Schoendorfer and Schaefer, 2009). Together, these data suggest that increased 
interferon β during pregnancy has negative effects on gestation, however the reason 
for this remains unclear, and effects on placenta are uncharacterised.   
One interesting line of research is starting to provide insight into the defences against 
viral invasion of the placenta. The number of human diseases with maternal-fetal 
transmission has stimulated intense research into the mechanisms of defence and viral 
replication occurring in trophoblast cells. For example, Zika virus infection in pregnant 
women causes IUGR, spontaneous abortion and microcephaly of the offspring (Miner 
et al., 2016). Viral transmission from the mother to the offspring occurs by the virus 
crossing the maternal-fetal blood barrier of the syncytiotrophoblasts in infected mice 
(Miner et al., 2016). In humans an innate immune response is activated upon infection 
of the placenta with Zika virus, with increased IFNλ (Bayer et al., 2016). This IFNλ is 
sufficient to protect primary human syncytiotrophoblasts from infection in an 
autocrine and paracrine manner, providing an efficient immune response to exogenous 
viral infection (Bayer et al., 2016). Whether an immune response occurs due to de-
repression of retrotransposons, leading to IUGR in humans is unclear and few studies 
have investigated the consequences of aberrant retrotransposon de-repression in the 
human placenta. This highlights the value of the Tex19.1-/- mouse when considering 
the possible pathogenic consequences of loss of genome defence mechanisms in 




Overall, I have identified that Tex19.1 is the only methylation sensitive genome 
defence gene activated in response to reduced levels of DNA methylation in all 
hypomethylated tissues in the mouse. This activation acts to augment repressive 
histone modifications at specific retrotransposon loci to compensate for reduced DNA 
methylation, thereby limiting retrotransposon de-repression and possibly a 
retrotransposon sensing innate immune response which may be detrimental to 
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development. I have identified a role for the interacting partner of TEX19.1, UBR2, in 
defending the genome from activation of MMERVK10C in the mouse germline and 
have determined that UBR5 is likely not making a large contribution to the Tex19.1-/- 
phenotype. Despite this, I establish UBR5 as a novel factor for the maintenance of 
spermatogonia and progression of spermatogenesis in the mouse germline.  
Taken together, this thesis highlights the inherent importance of defending the genome 
from retrotransposons and provides insights into the potential far reaching 
physiological consequences when these mechanisms fail. Indeed, we cannot live with 
them, nor without them and it is becoming increasingly apparent that striking the 
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Table 7.1: Genes commonly expressed in hypomethylated placenta, PGCLCs and 2i 
cultured ES cells compared to whole embryo (see Figure 3.1B). A 274tringent 6 fold 
cut off in expression difference was applied and only genes with a false discovery rate 
P<0.05 were included. 
Symbol logFC_Placenta logFC_PGCLCs logFC_2iES
4933402E13Rik 7.983185158 3.961511196 4.179866353
A4galt 3.737236305 2.930979413 4.309420306
AA467197 6.417371007 3.736588066 5.402206519
Abcb1a 3.814330111 3.57831586 4.91421334
Abcb1b 4.369522631 3.676160665 5.352394988
AU018091 5.857654313 5.500459258 6.32521332
Cbx7 3.203157974 3.680920776 3.383435617
Cul4b 3.036131778 2.914766316 2.593616571
Dpp7 2.729644104 3.049419123 3.091902914
Fmr1nb 6.433691764 4.637685407 6.011252617
Folr1 5.586053317 4.231227271 4.784011553
Gcnt2 3.024394769 2.759626933 3.313339825
Gjb3 3.600998384 4.758097435 5.776291172
Hic2 2.968619883 2.718687479 3.250494199
Ildr1 2.849969542 3.052900878 4.580187712
Itpka 2.679080264 3.120155307 3.940295059
Jade1 2.922938861 2.992270133 3.434462249
Klf9 3.150905644 3.549836128 4.985934759
L1td1 3.486774498 7.247493591 6.960350571
Liph 4.633272039 3.721535787 3.701884199
Mageb16 3.307315339 4.603314251 5.181832026
Manba 2.762748999 3.791015622 3.873169169
Nabp1 3.954014382 3.411020412 3.384798759
Nmrk1 2.92345741 3.160769684 3.157196729
Pfkp 3.026999762 2.597023375 3.285298645
Plekhh1 4.431253702 3.417931103 3.104544519
Pramef12 5.877864928 3.647035173 3.70088934
Rhox5 7.94329767 6.834147562 5.337591616
Slc30a2 4.421529677 3.979874367 4.322193751
Slc35f2 2.623168212 4.082909855 4.329657991
Slc4a5 2.85062507 2.692356882 2.914986113
Stk31 5.492047732 5.08420851 3.341806772
Stx3 3.440116423 3.671175366 3.782642486
Taf7 2.916138833 2.991875457 4.500128901
Tdrp 5.33352406 3.812611925 4.534097239
Tex19.1 4.64023022 3.989158083 5.945526078
Tfap2c 4.682119987 4.851598927 3.081758011
Trap1a 8.222338447 6.924496437 8.641808957
Trim6 4.26142354 6.371426027 6.868824669
Upp1 3.972513128 2.813811106 6.35300458




Table 7.2: Genes determined as methylation sensitive in Hackett et al., 2012. (See 
figure 3.1B) 
 
7.1: Optimisation of ChIP on placental tissue 
The initial ChIP protocol was performed and optimised on around 10 million ES cells 
and ChIP was confirmed to be working as expected by use of positive and negative 
control loci such as the actin promoter for the mark of active transcription H3K4me3 
and an intergenic region respectively. For H3K9me3 positive control loci were 
retrotransposons and imprinted genes whereas actin promoter was used as a negative 
control as it is not marked by H3K9me3. ChIP on 16dpp testes material was performed 
essentially as with ES cells due to the ease of generating a single cell suspension and 





























to limit cell loss. The major optimisation step in performing ChIP on whole placenta 
was the generation of a single cell suspension. In initial experiments placentas were 
enzymatically digested with collagenase or trypsin whilst being agitated at 37oC for 
differing incubation lengths, followed by filtering for single cells. For all incubation 
lengths, a low number of cells were recovered. Maceration of the tissue with razor 
blades, followed by homogenisation with a hand homogeniser provided a greater yield 
of single cells recovered and was therefore used in all future experiments. Next, it was 
necessary to optimise sonication of extracted chromatin as different cells require 
different lengths of sonication to achieve the desired 200- 400bp DNA fragments. For 
ES cells, lysing in Farnham lysis buffer (detergent 0.5% Np-40) and sonicating for 9x 
30 seconds on/off in RIPA buffer (detergent 1% Np-40, 0.1% SDS) was sufficient to 
shear chromatin to a size of 100 - 400bp (figure 7.1A). This was not sufficient for 
shearing E12.5 placental chromatin which remained a high molecular weight 
indicating inefficient sonication (figure 7.1A). Use of a different lysis buffer 
containing more concentrated detergent at 1% SDS and 0.1% Triton X-100 resulted in 
effective sonication even when sonicating for 3x 30 seconds on/off (figure 7.1B). 
These conditions were used in all future ChIP experiments on placental material. 
Positive and negative control loci were used in qPCR reactions on ChIP IP and input 
material and indicated differing enrichment in different tissues, likely reflecting both 
technical differences in the preparation of the tissues and real biological differences in 
the enrichment of histone modifications at certain control loci (for H3K4me3 compare 
figure 3.2 (testes and placenta) and figure 3.9E (ESCs), for H3K9me3 compare figure 





Figure 7.1: Optimisation of ChIP on E12.5 placenta. (A) Gel electrophoresis showing 
DNA fragment sizes after sonication of E12.5 placenta and ES cells for 3x, 6x or 9x 30 
seconds on/off after lysis in Farnham lysis buffer and RIPA buffer. (B) DNA fragment 
sizes of E12.5 placenta after lysis in 1% SDS lysis buffer and sonication for 3x, 6x or 9x 
30 seconds on/off.  DNA ladder is along the left side of both gels with 500bp and 





Table 7.3: Proteins identified as binding to TEX19.1-YFP in mass spectrometry 





pericentriolar material-1 [Mus musculus]
E3 ubiquitin-protein ligase UBR4 [Mus musculus]
alpha-fetoprotein [Mus musculus]
midasin homolog (yeast) [Mus musculus]
leucine zipper protein 1 [Mus musculus]




leucine zipper protein 1 [Mus musculus]
KRAB-A interacting protein [Mus musculus]
mKIAA1227 protein [Mus musculus]
TI-225 [Mus musculus]
mCG13235 [Mus musculus]
nuclear receptor subfamily 0 group B member 1 [Mus musculus]
matricin [Mus musculus]
ruvB-like 2 [Mus musculus]
TI-225 [Mus musculus]
ATP-dependent zinc metalloprotease YME1L1 [Mus musculus]
prolyl-tRNA synthetase (mitochondrial)(putative), isoform CRA_a [Mus musculus]
L-threonine 3-dehydrogenase, mitochondrial precursor [Mus musculus]
translocase of inner mitochondrial membrane 50 homolog (yeast), isoform CRA_a [Mus musculus]
fructose-bisphosphate aldolase A isoform 2 [Mus musculus]
TI-225 [Mus musculus]
Wdr18 protein [Mus musculus]
Otx2 [Mus musculus]
coatomer subunit epsilon [Mus musculus]
transforming growth factor-beta homolog [Mus sp.]
aldolase 1 A retrogene 1 [Mus musculus]
26S protease regulatory subunit 7 [Mus musculus]
Rfc5 protein [Mus musculus]
mCG13052 [Mus musculus]
histone H2A [Mus musculus domesticus]
ubiquitin-conjugating enzyme E2 A [Mus musculus]






GeneSymbol logFC FDR GeneSymbol logFC FDR
3300005D01Rik 1.029278 0.000534 1600012P17Rik -1.29707 5.99E-05
4932415M13Rik 1.276428 0.005945 1600015I10Rik -1.02898 0.039436
A2m 1.031734 0.033304 Adra2c -1.13998 1.37E-05
Adamdec1 2.044209 3.8E-08 Aldh1a3 -1.07004 3.03E-05
Adcy2 1.187963 0.044569 Apc2 -1.21629 1.86E-07
Adrb2 1.01024 0.007003 Brsk1 -1.10599 0.0048
Ankrd1 1.708689 0.014032 Ceacam11 -1.27393 3.77E-05
Anxa8 1.00943 0.00025 Ceacam12 -2.05259 1.69E-10
Aqp1 1.214705 0.031963 Ceacam13 -1.22688 1.41E-08
Arl4d 1.045138 0.00199 Ceacam14 -1.40467 0.003365
Bok 1.04439 0.001141 Ceacam3 -1.3127 8.61E-09
C1qtnf9 1.267154 2.2E-05 Ceacam5 -1.40655 1.35E-07
Calm4 1.382947 0.002826 Ceacam9 -1.37514 8.52E-05
Cck 1.276482 0.027942 Creg1 -1.47472 9.57E-05
Cldn1 1.145211 0.008903 Cts3 -1.73347 1.86E-07
Cldn10 1.402986 0.007085 Ctsm -2.24019 1.42E-17
Ctla2a 1.061052 0.000691 Ctsq -1.71 1.69E-07
Cxcl14 1.123491 9.44E-05 Cxcl12 -1.1133 0.024546
Cyp11b1 1.082185 0.016763 Cyp4f18 -1.12622 5.14E-06
Cyp2ab1 1.151176 0.014514 Fa2h -1.40411 0.036957
Des 1.065278 0.002138 Fbln7 -1.24311 0.013239
Dppa4 1.381569 1.12E-05 Flt1 -1.31618 0.000144
Dppa5a 1.065411 0.000746 Fndc5 -1.13143 0.000725
Ear1 1.616574 9.43E-05 Gm16565 -1.6193 6.61E-06
Ear10 1.41865 0.000255 Gm5155 -1.37879 3.53E-06
Ear2 1.523278 2E-07 Gm5506 -1.01909 0.031963
Edn1 1.088938 0.000832 Gpr156 -1.07276 0.000146
Eno2 1.135123 0.006025 Gpr44 -1.14329 0.002991
Epdr1 1.015268 0.01455 Hsd11b2 -1.01211 7.59E-09
Eva1c 1.018623 0.00475 Krt5 -4.04683 2.14E-33
Fabp4 1.017015 0.000651 Mmp1a -1.48207 0.000267
Fam13c 1.141139 0.031829 Mn1 -1.08153 9.99E-05
Fam189a2 1.19341 0.003003 Pappa2 -1.29173 0.000534
Fbln2 1.043691 0.021354 Prl2b1 -1.36814 0.000522
Gdf10 1.522726 0.005528 Prl3b1 -1.09815 4.07E-06
Gml 1.157103 0.001679 Prl3c1 -1.5419 9.94E-09
Golga7b 1.096617 0.000675 Prl4a1 -1.46978 1.06E-09
Gpihbp1 1.069785 1.31E-05 Prl6a1 -1.30845 6.86E-15




Table 7.4: Genes significantly up and downregulated in Tex19.1-/- placentas 
compared to control placentas. Genes have LogFC >= 1 and FDR <= 0.05 and 
correspond to points shown in figure 4.10.  
 
Gpr87 1.12969 0.027023 Prl7a1 -1.05781 0.037819
Havcr1 1.211973 0.035784 Prl7a2 -1.4327 3.01E-09
Hemgn 1.112949 0.036095 Prl7c1 -1.16321 1.44E-11
Hemt1 1.030674 0.040951 Prl8a6 -1.04913 0.041918
Hist1h2bp 1.008618 9.89E-05 Prl8a8 -1.42854 0.038621
HOXA11-AS1_6 1.017666 0.000671 Prl8a9 -1.09554 2.67E-05
Hoxd10 1.116209 5.93E-05 Psg16 -1.56743 0.005213
Hsd11b1 1.006912 0.001468 Psg17 -1.75492 7.89E-05
Ifne 1.189526 9.09E-05 Psg18 -1.55582 1.32E-05
Igfbp6 1.081969 0.000384 Psg19 -1.39033 5.57E-07
Klra7 1.078566 0.028572 Psg21 -2.22963 1.1E-05
Krt14 1.246553 0.000376 Psg23 -2.4419 4.7E-05
Mfap5 1.023264 0.000396 Psg25 -1.76078 3.01E-09
Mir295 1.458335 3.8E-08 Psg26 -1.7005 8.06E-06
Mir322 1.015705 4.29E-05 Psg27 -2.01002 4.97E-07
Mt3 1.8738 0.00162 Psg28 -1.51336 7.76E-05
Mustn1 1.057059 0.000248 Psg29 -1.44549 4.1E-18
Mybpc3 1.117705 0.010629 Ptch1 -1.10514 0.009094
Prkg2 1.145144 0.014032 Ptpru -1.08068 9.39E-07
Prss23 1.190848 0.021679 Rgs5 -1.3205 1.54E-22
Qpct 1.010915 0.018972 Slc26a4 -1.07783 0.003716
Ramp1 1.080112 5.8E-05 Slc39a5 -1.05929 0.013246
S100a4 1.020215 2.2E-05 Stc1 -1.09586 0.00025
Sfrp4 1.426423 0.003152 Stox2 -1.14883 0.000255
Sfrp5 1.061702 0.000972 Tet1 -1.78423 1.69E-10
Shisa3 1.009005 0.033951 Tex19.1 -12.4887 3.96E-84

















Figure 7.2: Comparison of testis weights and sperm counts from 6 week and 5 
month old Ubr5CKO animals (A) Boxplot showing the median testis weights of 5 month 
control and Ubr5CKO mice and (C) 6 week old mice (5 month: n=3 for both genotypes, 
6 week: n=5 for both genotypes  *P<0.05, Mann Whitney U-test). (B) Boxplot showing 
the median sperm count from 5 month old epididymis from control and Ubr5CKO mice 
and (D) 6 week old epididymis (5 month: n=3 for both genotypes, 6 week: n=5 for 
both genotypes. *P<0.05, Mann Whitney U-test) 
 
